IMS HEOR Bibliographies

Search criteria
Condition: Oncology

A real-world, retrospective, observational study examining treatment patterns and clinical outcomes in patients with FLT3m + AML in Japan
Authors: Toru Kiguchi 1, Masaya Sakurai 2, Yusuke Tanaka 2, Kazuyuki Kuramoto 2, Yuki Kado 3, Sono Sawada 3, Takeshi Mitomi 2 (rwesheorj 3)
Affiliations: 1) Dokkyo Medical University Saitama Medical Center, Saitama, Japan 2) Astellas Pharma Inc., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: Current Medical Research and Opinion
Document Types: , Abstract, Online article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2271390
Condition	Year	Language	Analysis type
, Oncology	2023	English	, Database Study, Retrospective cohort analysis


The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
Authors: Paul Cottu 1, Scott David Ramsey 2, Oriol SolÃ -Morales 3, Patricia A Spears 4, Lockwood Taylor 5
Affiliations: 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, AragÃ³ 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com.
Publications: Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
Document Types: , Article
Countries: , France, Italy, USA
Abstract: https://pubmed.ncbi.nlm.nih.gov/34959093/
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory	2022	English	, Review


POSB392 Understanding the Secondary Care Characteristics and Pathways of Multiple Myeloma Patients Who Reach Second-Line Therapy Using the Hospital Episode Statistics (HES) Database
Authors: E Mary Babu S Fermahan S Chavda M Chetty S Navani A Matthew R Hudson
Affiliations: Sanofi, Reading, RDG, UK IQVIA, London, UK
Publications: Mary Babu, E et al. Value in Health, Volume 25, Issue 1, S257
Document Types: , Abstract, Article
Countries: , England
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(21)03050-3/fulltext#%20
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Burden of illness, clinical setting: Secondary care, Database Study, Population Based Study, Retrospective database analysis


Assessing the correlation between second progression-free survival (PFS2) and overall survival (OS) in advanced prostate cancer patients using medical data vision (MDV) claims database in Japan
Authors: Masaki Shiota 1, Raf De Moor 2, Yosuke Koroki 2, Dae Young Yu 3, David Bin-Chia Wu 4 (rwesheorj A)
Affiliations: 1) Department of Urology, Graduate School of Medical Sciences, Kyushu University Hospital, Fukuoka, Japan 2) Integrated Market Access, Janssen Pharmaceutical KK, Tokyo, Japan 3) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore 4) Janssen Pharmaceutical Companies of Johnson and Johnson, Asia Pacific Regional Office, Singapore, Singapore;e Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore;f School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2096353
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Database Study


Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
Authors: Arena PJ, Huang K, LÃ¶fling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, SundbÃ¸ll J, Rasmussen TR, LÃ¸kke A, Ehrenstein V.
Affiliations: "Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland."
Publications: Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
Document Types: , Article
Countries: , Denmark, Finland, Netherlands , Sweden, USA
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582
Condition	Year	Language	Analysis type
, Database Validity and methodology, Drug safety, Oncology	2022	English	, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis


Patients' preferences for attributes of molecular targeting therapies for advanced non-small cell lung cancer with EGFR mutations in Japan - a discrete-choice experiment
Authors: Kazuhiko Nakagawa 1, Yoshinori Tanizawa 2, Zhihong Cai 2, Tomoko Matsui 2, Sotaro Enatsu 2 (rwesheorj A)
Affiliations: 1) Kindai University, Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan 2) Eli Lilly Japan K.K., Japan Drug Development and Medical Affairs, Kobe, Japan
Publications: Japanese Journal of Cancer and Chemotherapy
Document Types: , Article
Countries: , Japan
Abstract: https://www.pieronline.jp/content/article/0385-0684/49120/1329
Condition	Year	Language	Analysis type
, Oncology	2022	Japanese	, Patient questionnaire


Budget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer
Authors: Hiroyuki Matsuda 1, Toru Ogawa 2*, Yasunari Sadatsuki 3, Toshiaki Tsujino 3, Shingo Wada 1, Seok-Won Kim 1, Yutaka Hatanaka 4 (rwesheorj 1)
Affiliations: 1) Real World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan 2) Market Access Oncology, Bayer Yakuhin, Ltd, Osaka, Japan 3) Medical Affairs & Pharmacovigilance, Bayer Yakuhin, Ltd, Osaka, Japan 4) Research Division of Genome Companion Diagnostics, Hokkaido University Hospital, Hokkaido, Japan
Publications: Respiratory Investigation
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S2212534522001435?via%3Dihub
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Budget impact, Database Study


Characteristics, treatment patterns, and healthcare costs of advanced/metastatic biliary tract cancer patients in Japan
Authors: CC Chen 1, X Wang 1, Seok-Won Kim 2*, Shingo Wada 2, J Garside 3, ES Reese 4 (rwesheorj 2)
Affiliations: 1) IQVIA, Plymouth Meeting, PA, USA 2) IQVIA, Tokyo, Japan 3) GlaxoSmithKline, London, UK 4) EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA
Publications: Japanese Society of Medical Oncology Annual Meeting
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.c-linkage.co.jp/jsmo2022/en/index.html
Condition	Year	Language	Analysis type
, Oncology	2022	English	, Database Study


Prognosis of lung cancer patients treated with immune checkpoint inhibitors with or without antimicrobial history
Authors: Ryohei Kobayashi 1, Kenji Kanagawa 1, Sanesue Yasukawa 1, Takuma Kondo 1, Shingo Wada 2 (rwesheorj 2)
Affiliations: 1) IQVIA Services Japan K.K. 2) IQVIA Solutions Japan K.K.
Publications: The 27th Annual Meeting of the Japanese Society for Pharmacoepidemiology
Document Types: , Conference, Oral presentation
Countries: , Japan
Abstract: https://www.jspe.jp/meeting/soukai/272022.html
Condition	Year	Language	Analysis type
, Oncology	2022	Japanese	, Database Study, Retrospective cohort analysis


Highâ€‘Expenditure Disease in the EUâ€‘28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?
Authors: Wolfgang Greiner, Keyur Patel, Christina-Jane Crossman-Barnes, Troels Vingtoft Rye-Andersen, Christian Hvid, Tom Vandebrouck
Affiliations: Department for Health Economics, Bielefeld University, Bielefeld, Germany; IQVIA Ltd, HEOR, London, UK; Novo Nordisk Region Europe Pharmaceuticals A/S, Copenhagen, Denmark; Novo Nordisk Region Europe Pharmaceuticals A/S, Brussels, Belgium
Publications: PharmacoEconomics-Open. 2021 Jan; doi.org/10.1007/s41669-020-00253-4
Document Types: , Article
Countries: , Europe
Abstract: https://link.springer.com/epdf/10.1007/s41669-020-00253-4?sharing_token=k4IP2sUMn4HrAsHs0WBqlPe4RwlQNchNByi7wbcMAY4Tirkz8MqaNXdxznG7LjXgeeOE1lL_TUFtfOXdhNB_IQ05wAS6SyWtTgC3QV4GkZ1V3rKbHAI_lwyKV2fZ5OfrjVrTPTsYaJr4E7ZctQaMI_Yhmg_dNtoFcG1705dWSU4%3D
Condition	Year	Language	Analysis type
, Diabetes, Health economics, Oncology	2021	English	, Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Quality of life, Retrospective database analysis, Review


Analisi di impatto sul budget sanitario italiano di gilteritinib per il trattamento della leucemia mieloide acuta FLT3+ recidivante o refrattaria
Authors: Fiorentino F, La Malfa P, Di Rienzo P
Affiliations: Fiorentino F: IQVIA Solutions Italy Srl, RWS
Publications: GIHTAD (2021) 14:4
Document Types: , Article
Countries: , Italy
Abstract: https://springerhealthcare.it/GIHTAD/2021/07/05/analisi-di-impatto-sul-budget-sanitario-italiano-di-gilteritinib-%E2%80%A8per-il-trattamento-della-leucemia-mieloide-acuta-flt3-recidivante-%E2%80%A8o-refrattaria/
Condition	Year	Language	Analysis type
, Health economics, Oncology	2021	Italian	, Budget impact, clinical setting: Secondary care


Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan
Authors: Elaine Chang Takahashi 1, Shiho Wakase 2, Masayuki Ito 1, Todd D Taylor 3 (rwesheorj 3)
Affiliations: 1) Novartis Pharma K.K., Minato-ku, Japan 2) Novartis Pharma K.K., Tokyo, Japan 3) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publications: ISPOR Europe 2021
Document Types: , Conference, Poster, Presentation
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2021-3407/111943
Condition	Year	Language	Analysis type
, Oncology	2021	English	, Database Study, Real World Evidence


Descriptive study on burden and communication of fatigue among castration-resistant prostate cancer patients in Japan
Authors: Taro Iguchi 1, Yusuke Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Department of Urology, Kanazawa Medical University 2) Market and Regional Access, Bayer Yakuhin, Ltd 3) Real World Evidence Solutions, IQVIA Solutions Japan K.K.
Publications: Current Medical Research and Opinion
Document Types: , Article
Countries: , Japan
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.2006534
Condition	Year	Language	Analysis type
, Oncology	2021	English	, Burden of illness, Observational study, Patient questionnaire, Population Based Study, Real World Evidence, Survey research


Modernizing Oncology Approvals
Authors: Christina Mack
Affiliations: CAEG
Publications: PharmaVoice. 2021 Mar
Document Types: , Article
Countries: , USA
Abstract: https://www.pharmavoice.com/news/2021-03-modernizing-oncology-approvals/612107/
Condition	Year	Language	Analysis type
, Oncology	2021	English	, clinical setting: Secondary care


Trifluridine/tipiracil hydrochloride in the treatment of polytreated metastatic colorectal carcinoma: a cost-effectiveness analysis in the private payer perspective in Brazil
Authors: Fernando Meton de Alencar Camara Vieira (1); Ana Paula Ornellas de Souza Victorino (1); Kelly Borges AraÃºjo (1); Bianca Oesterreicher (2); Pedro Vitor Pereira Lima (2); Luciana Calvo Mardegan (3); Sandro Albuquerque (3); Juliana SimÃµes Festa de Vasconcellos (3)
Affiliations: 1: Instituto COI de EducaÃ§Ã£o e Pesquisa, Rio de Janeiro, RJ, Brasil; 2: IQVIA Solutions, Real World Insights, SÃ£o Paulo, SP, Brasil; 3: LaboratÃ³rios Servier, Rio de Janeiro, RJ, Brasil.
Publications:
Document Types: , Article
Countries: , Brazil
Abstract: https://jbes.com.br/wp-content/uploads/2022/01/DOI_10_21115_JBES_v13_n3_p242-52.pdf
Condition	Year	Language	Analysis type
, Health economics, Oncology	2021	Portuguese	, Cost effectiveness


Modernizing Regulatory Evidence with Trials and Real-World Studies
Authors: Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE
Affiliations: IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE
Publications: Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
Document Types: , Article
Countries: , USA
Abstract: https://link.springer.com/article/10.1007%2Fs43441-020-00131-5
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective database analysis


The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: GÃ³mez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, PÃ©rez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2020	English	, Burden of illness, Observational study, Retrospective Field Study


Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France
Authors: Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4
Affiliations: 1 Sorbonne UniversitÃ©, medical oncology department, AP-HP, hÃ´pital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France
Publications: ESMO GI, Barcelona, Spain 1-4 July 2020
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study, Retrospective Field Study


Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
Authors: Gomez-Ulloa D1, Amonkar M2, Kothari S3, Cheung WY4, Chau I5, Zalcberg J6, Lara N1, Falcone A7
Affiliations: 1 IQVIA, Barcelona, Spain 2 Merck & Co., Inc., North Wales, PA, US 3 Merck & Co., Inc., Kenilworth, NJ, US 4 British Columbia Cancer Agency, Vancouver, BC, Canada 5 Royal Marsden Hospital, London, UK 6 Alfred Health, Melbourne, Australia 7 University of Pisa, Pisa, Italy
Publications: BMC Gastroenterology BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Article
Countries: , Australia, Canada, Italy, UK
Abstract: https://doi.org/10.1186/s12876-020-01232-z
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective cohort analysis


Nivolumab-treated non-small cell lung cancer patients in the United Kingdom
Authors: Carroll R1, Tanna N1, Ghosh S2, Sanchez E3, Stawiarska Z4, Gemmen E5
Affiliations: 1 Bristol-Myers Squibb, Uxbridge, UK 2 IQVIA, Gurugram, India 3 IQVIA, Barcelona, Spain 4 IQVIA, Warsaw, Poland 5 IQVIA, Rockville, MD, US
Publications: BMC Gastroenterology
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study, Retrospective Field Study


Annualized Hospitalization Rate With Natalizumab vs Fingolimod in Second-Line Treatment for RRMS in the Public Healthcare System in Brazil: A Claim Database Approach
Authors: Guilherme Silva Julian 1, Ricardo PapalÃ©o Rosim 2, Estela Cristina Carneseca 3, JÃ©ssica Rigolon 2
Affiliations: 1 IQVIA Brasil, SÃ£o Paulo-SP, Brazil. 2 Biogen Brasil, SÃ£o Paulo-SP, Brazil. 3 Proestat Consultoria EstatÃstica, RibeirÃ£o Preto-SP, Brazil.
Publications: PMID: 32119696 PMCID: PMC7051079 DOI: 10.1371/journal.pone.0229768
Document Types: , Article
Countries: , Brazil
Abstract: https://pubmed.ncbi.nlm.nih.gov/32119696/
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Retrospective database analysis


Descriptive study on perceptions and communication of fatigue among castration resistant prostate cancer (CRPC) patients in Japan
Authors: Taro Iguchi 1, Y Nakamura 2, Takeshi Akiyama 3, Krishant Chand 3, Eric Yu 3 (rwesheorj 3)
Affiliations: 1) Osaka City University Graduate School of Medicine Urology and Pathology 2) Bayer Yakuhin Co., Ltd. Market Access Headquarters 3) IQVIA Solutions Japan Co., Ltd. Real World Evidence Solutions
Publications: Japanese Urological Association 2020 Annual Meeting
Document Types: , Abstract, Conference, Presentation
Countries: , Japan
Abstract: http://www.congre.co.jp/jua2020/program/files/program_1223.pdf
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Patient questionnaire, Survey research


Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study
Authors: Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco Dâ€™Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5
Affiliations: 1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 UniversitÃ Campus Bio-Medico di Roma, Rome, Italy
Publications: COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020
Document Types: , Poster
Countries: , Canada, Italy, UK
Condition	Year	Language	Analysis type
, Hematology, Oncology	2020	English	, Population Based Study


A RETROSPECTIVE COHORT STUDY OF THE NATIONAL HEALTHCARE RESOURCE UTILISATION (HCRU) AND COSTS OF TREATING MULTIPLE MYELOMA (MM) IN FRANCE USING THE SYSTÃˆME NATIONAL DES DONNÃ‰ES DE SANTÃ‰ (SNDS) DATABASE
Authors: A. Bessou X. Colin J. De Nascimento W. Sopwith S.A. Ferrante B. Gorsh B. Gutierrez L. Sansbury J. Willson S. Sapra F. Wang
Affiliations: 1 IQVIA, Paris, France 2 GlaxoSmithKline, Rueil Malmaison, 92, France, 3 IQVIA,La Defense Cedex, 75, France, 4 IQVIA, London, UK, 5 Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA, 6 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA, 7 Value Evidence and Outcomes, GlaxoSmithKline, London, UK
Publications: DOI:https://doi.org/10.1016/j.jval.2020.08.250
Document Types: , Abstract
Countries: , France
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)32506-7/fulltext
Condition	Year	Language	Analysis type
, Oncology	2020	English	, Observational study, Population Based Study


Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Authors: Alejandra Martinez De Pinillos, Isabel Ricote Lobera, Cristina Martinez, Caroline Anger, Filippo Guglielmetti, Roberto Jorge Bitton
Affiliations: IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publications: Journal of Clinical Oncology 2019 37:15_suppl, e20631-e20631
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Retrospective database analysis


Validating an algorithm for multiple myeloma based on administrative data using a SEER tumor registry and medical record review.
Authors: Brandenburg NA1, Phillips S2, Wells KE3, Woodcroft KJ3, Amend KL4, Enger C4, Oliveria SA2
Affiliations: 1 - Global Drug Safety and Risk Management, Celgene Corporation, Summit, New Jersey, USA. 2 - IQVIA, New York, New York, USA. 3 - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. 4 - Department of Epidemiology, Optum, Ann Arbor, Michigan, USA
Publications: Front Oncol. 2016;6:224. Published 2016 Oct 27. doi:10.3389/fonc.2016.00224
Document Types: , Article
Countries: , USA
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4711
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology	2019	English	, Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis


A REVIEW OF SWEDISH HEALTH TECHNOLOGY ASSESSMENTS BASED ON INDIRECT COMPARISONS OF HOSPITAL DRUGS IN ONCOLOGY
Authors: Rongrong Zhang, Heller Vincent, Maximilian Schlueter, Ashley Pitcher
Affiliations: IQVIA
Publications: ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Abstract
Countries: , Sweden
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: Home care, Review


Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
Authors: Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y
Affiliations:
Publications: Cancer Inform. 2019 Mar 15;18:1176935119835538. doi: 10.1177/1176935119835538. eCollection 2019
Document Types:
Countries:
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30906191
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Methodology


Real-world evidence on patients with relapse/refractory FLT3 mutation-positive acute myeloid leukemia in Italy
Authors: La Malfa P1, Arenga A1, De Santo E1, Urbinati D1
Affiliations: 1 IQVIA, Milan, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Real World Data, Real World Evidence


Change in treatment paradigm of ALK+ Non-Small Cell Lung Cancer (NSCLC) in the Italian real practice
Authors: Tucci C1, Urbinati D1, De Santo E1, Fico M2, Fioravanti L2, Demma F2
Affiliations: 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Public Health, Real World Data, Real World Evidence


Brentuximab Vedotin for consolidation therapy after ASCT in CD30+ Hodgkin's limphoma: a sustainable pharmaceutical expenditure for the Italian National Health Service
Authors: Peduto I1, Heiman F1, Morelli P2, Fioravanti L2, Demma F2
Affiliations: 1 IQVIA, Milan, Italy 2 Takeda, Rome, Italy
Publications: ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Cost analysis, Economic evaluation


The Close Link between Anxiety and Cluster Symptoms in Lung Cancer Patients during First-Line Chemotherapy
Authors: Carnio S1, Galetta D2, Pilotto S3, Scotti V4, Cortionovis DL5, Antonuzzo A6, Pisconti S7, Rossi A8, Martelli O9, Cecere FL10, Lunghi A11, Del Conte A12, Montrone M2, Topulli J4, Canova S5, Rapetti SG1, Gianetta M1, Pacchiana MV1, Capelletto E1, Pegoraro V13, Cataldo N13, Bria E3 and Novello S1
Affiliations: 1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy 2 Clinical Cancer Center “Giovanni Paolo II”, Bari, Italy 3 U.O.C. Oncology, Department of Medicine, University of Verona, Italy 4 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 5 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 6 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 7 Department of Onco-Ematology Medical Oncology, SG Moscati Hospital, Taranto, Italy 8 Division of Medical Oncology, IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo (FG) 9 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 10 Medical Oncology 1, Regina Elena National Cancer Institute, Roma, Italy 11 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 12 IRCCS - Oncological Reference Center (CRO) - U.O. Oncology, Pordenone-S. Vito, Italy 13 IQVIA, Milan, Italy
Publications: J Cancer Sci Ther 2018, 10:9
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Survey research


Use of subcutaneous and intravenous trastuzumab: real-world experience from three hospitals in Sweden.
Authors: Valachis A, Sundqvist M, Carlsson L, Li B, Chiesa F, Uhde M, Sanglier T
Affiliations: Department of Oncology, Faculty of Medicine & Health, ?rebro University, SE 70182 ?rebro, Sweden (Valachis) AND Real World & Analytic Solutions (RWAS), IQVIA, Stockholm, Sweden (Milica Uhde)
Publications: Future Oncol. 2019 Aug;15(23):2733-2741. doi: 10.2217/fon-2019-0160. Epub 2019 Jul 15.
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31306041
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: hospital, Epidemiological study, Retrospective cohort analysis


An Exploratory Analysis of Real-World Endpoints for Assessing Outcomes Among Immunotherapy-Treated Patients with Advanced Non-Small Cell Lung Cancer.
Authors: Stewart M, Norden AD, Dreyer N, Henk HJ, Abernethy AP, Chrischilles E, Kushi L, Mansfield AS, Khozin S, Sharon E, Arunajadai S, Carnahan R, Christian JB, Miksad RA, Sakoda LC, Torres AZ, Valice E, Allen J.
Affiliations:
Publications: JCO Clinical Care Informatics 2019. 3:1-15.
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2019	English


Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Authors: LindstrÃ¶m V, Hakkarainen KM, MehtÃ¤lÃ¤ J, Klement R, Leval A, JÃ¤rvinen TM
Affiliations: VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag.
Publications: Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273.
Document Types: , Article
Countries: , Finland, Nordic
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis


A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on DarzalexÂ® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu RosÃ©, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: Presented at ISPEâ€™s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24â€“28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition	Year	Language	Analysis type
, Hematology, Oncology	2019	English	, Public Health, Survey research


Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study.
Authors: Meers S1, Bailly B2, Vande Broek I3, Malfait B4, Van Hoorenbeeck S4, Geers J4, Braakman J5, Van Kouwenhove M6, Doyle M7, Diels J8, Caekelbergh K9, Chevalier P9, Dierickx D10.
Affiliations: 1 Department Oncology, AZ Klina , Brasschaat , Belgium. 2 Department Haematology, Groupe Jolimont , Haine Saint-Paul , Belgium. 3 Department Oncology, AZ Nikolaas , Haematology, Sint Niklaas , Belgium. 4 Department Market Access, Janssen-Cilag NV , Beerse , Belgium. 5 Department Market Access, Janssen-Cilag BV , Breda , The Netherlands. 6 Department Medical, Janssen-Cilag BV , Breda , The Netherlands. 7 Department Medical, Janssen Ireland , Dublin 24 , Ireland. 8 Department Statistics and Modelling, Janssen Pharmaceutica NV , Beerse , Belgium. 9 Department Real-World Solutions, IQVIA , Zaventem , Belgium. 10 Department Haematology, UZ Leuven , Leuven , BelgiumDepartment Haematology.
Publications:
Document Types: , Abstract
Countries: , Belgium
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31551014
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2019	English	, Retrospective database analysis


Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC)
Authors: Amonkar M1, Gomez-Ulloa D2, Smita Kothari1, Cheung WY3, Chau I4, Zalcberg JR5, Lara N2, Falcone A6
Affiliations: 1 Merck & Co., Inc., Kenilworth, NJ, USA 2 IQVIA, Barcelona, Spain 3 British Columbia Cancer Agency, Vancouver, BC, Canada 4 Royal Marsden Hospital, London, UK 5 Alfred Health, Melbourne, Australia 6 University of Pisa, Pisa, Italy
Publications: BMC Gastroenterology volume 20, Article number: 133 (2020)
Document Types: , Poster
Countries: , Australia, Canada, Italy, UK
Condition	Year	Language	Analysis type
, Oncology	2019	English	, Retrospective cohort analysis


Cost-offsets in relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice
Authors: Ripellino C, Pegoraro V, Heiman F
Affiliations: Ripellino C: HEOR Consultant Freelance, Milan, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: CLINICO ECONOMICS ITALIAN ARTICLES ON OUTCOMES RESEARCH / VOL 14 / YEAR 2019 / PAG. 55-64
Document Types: , Article
Countries: , Italy
Abstract: http://www.clinicoeconomics.eu/articles/flipbook/14_2019_55-64/
Condition	Year	Language	Analysis type
, Health economics, Oncology	2019	Italian	, Cost analysis


Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries
Authors: Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy
Affiliations: Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA);
Publications: Radiology
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29869958
Condition	Year	Language	Analysis type
, Health policy, Oncology	2018	English	, Observational study, Population Based Study, Public Health, Retrospective cohort analysis


A HEALTH STATE UTILITY MODEL ESTIMATING THE IMPACT OF IVOSIDENIB ON QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Authors: Wehler EA, Storm M, Kowal S, Campbell C, Boscoe A
Affiliations: IQVIA
Publications: European Hematology Association
Document Types: , Poster
Countries: , USA
Abstract: https://learningcenter.ehaweb.org/eha/2018/stockholm/215730/michael.storm.a.health.state.utility.model.estimating.the.impact.of.ivosidenib.html?f=ce_id=1346ot_id=19069media=3*speaker=664497
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Utility analysis


Real-World Study of Comorbidities and Complications in Relapsed/Refractory Acute Myeloid Leukemia Patients Identified Using a Claims-based Algorithm
Authors: Shahed Iqbal, Aimee Near, Neil Dhopeshwarkar, Huan Huang, Maribel Salas, Kathy Lang
Affiliations: Huan Huang and Aimee Near are IQVIA authors
Publications: ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management)
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Population Based Study, Retrospective database analysis


Real-world Treatment Patterns for Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) Treated with Immuno-oncology Therapy
Authors: Huan Huang, Rahul Shenolikar, Brian Seal, Jenny Tse, Chakkarin Burudpakdee
Affiliations: Huan Huang, Jenny Tse and Chakkarin Burudpakdee are IQVIA authors
Publications: ISPOR
Document Types: , Poster
Countries: , USA
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(18)30588-6/fulltext
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Population Based Study, Retrospective database analysis


Contemporary real-world evidences on ALK+ NSCLC patients in Italy
Authors: Tucci C1, Trimarchi C1, Urbinati D1, Demma F2, Fico M2, Fioravanti L2
Affiliations: 1 IQVIA, RWI, Milan, Italy 2 Takeda, Italy
Publications: ISPOR 21th Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Database Study, Real World Data, Real World Evidence


Emerging trends in the management of NSCLC PD-L1+ patients in Italy
Authors: Trimarchi C1, Arenga A1, De Santo E1, Urbinati D1
Affiliations: 1 IQVIA, RWI, Milan, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Database Study, Real World Data, Real World Evidence


Cost-offsets associated with the new triplets available for the treatment of relapsed/refractory multiple myeloma and resource consumption derived from Italian real practice
Authors: Ripellino C1, Peduto I2, Heiman F2, Fioravanti L3, Rea M3, Demma F3
Affiliations: 1 HEOR Consultant Freelance, Milan, Italy 2 IQVIA, RWI, Milan, Italy 3 Takeda Italia S.p.a., Rome, Italy
Publications: ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Cost analysis, Economic evaluation


Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition	Year	Language	Analysis type
, Oncology	2018	English


Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


COMPARING THE ROLE OF DIFFERENT SPECIALITIES IN THE MANAGEMENT OF PROSTATE CANCER IN FRANCE AND ITALY: INSIGHTS FROM A REAL-WORLD STUDY
Authors: Mpima S , Nasuti P , Casey V
Affiliations: IQVIA London , UK
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Italy
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: Primary care


Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition	Year	Language	Analysis type
, Oncology	2018	English


EVALUATING NSCLC TREATMENT OPTIONS USING REAL WORLD DATA: FINDINGS FROM AN ONCOLOGY SURVEY ACROSS EIGHT COUNTRIES
Authors: Takeno S1, Tanaka S1, Saijo N1 Nasuti P2
Affiliations: 1IQVIA Solutions Japan K.K., Tokyo, Japan, 2IQVIA , London, UK
Publications: ISPOR 2018 APAC
Document Types: , Poster
Countries: , Asia Pacific, Europe
Condition	Year	Language	Analysis type
, Oncology	2018	English


Drug treatment in melanoma: a real-world analysis across Europe and Japan
Authors: Martinez de Pinillos, Anger C, Nasuti P
Affiliations: IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Treatment algorithm for multiple myeloma: real-world insights across five European countries
Authors: Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2
Affiliations: 1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries
Authors: Hoyer L, Schmidt N
Affiliations: IQVIA Frankfurt Germany
Publications: ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Authors: Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations: IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Authors: Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations: 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publications: ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4)
Authors: Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2
Affiliations: 1IQVIA Milan Italy , 2IQVIA London UK
Publications: CTOS 2018 Rome
Document Types: , Poster
Countries: , France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Oncology	2018	English


DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
Authors: Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2
Affiliations: 1 IQVIA London UK , 2IQVIA Madrid Spain
Publications: ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English


Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data
Authors: Maroun R1,2, Mitrofan L3, Benjamin L1 Nachbaur G1, Maunoury F4 Le Jeunne P3 Durand-Zaleski I2,5
Affiliations: 1GlaxoSmithKline, Health Economics and Outcomes Research,France 2INSERM, ECEVE, UMR 1123, Paris, France 3IQVIA, La DÃ©fense, France 4Statesia, Le Mans, France 5URC-ECO, APHP, Paris, France
Publications: BMC Cancer. 2018; 18: 214.
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822611/
Condition	Year	Language	Analysis type
, Oncology	2018	English


Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France
Authors: ClÃ©ment Le Dissez1, Pascal Paubel2, FrÃ©dÃ©ric Courbon3, RÃ©my Herve4, Mark Rance5, Marie-Aude Courteille6
Affiliations: 1IQVIA OpÃ©ration France, Paris, La DÃ©fense ; 2Inserm UMR S 1145, Institut Droit et SantÃ©, facultÃ© de pharmacie de Paris, UniversitÃ© Paris Descartes, Sorbonne Paris CitÃ©, 4 avenue de lâ€™observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France
Publications:
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Clinical practice, Health economics, Oncology	2018	English	, Budget impact, Literature Review, Public Health


Neue Krebstherapeutika: Personalisierte Medizin erÃ¶ffnet neuartige Therapieoptionen
Authors: Hoyer L , Schmidt L
Affiliations: IQVIA Frankfurt Germany
Publications: Pharmamind
Document Types: , Article
Countries: , Europe
Condition	Year	Language	Analysis type
, Oncology	2018	German


CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD
Authors: Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R
Affiliations: Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel
Publications: ISPOR Europe 2018
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy
Condition	Year	Language	Analysis type
, Nutritional Disorders, Oncology	2018	English	, Clinical setting: Home care, Epidemiological study


The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to Â§35A SGB V in Germany Oncological and Metabolic Diseases
Authors: Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D
Affiliations: IQVIA Commercial GmbH & Co. OHG, Munich, Germany
Publications:
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement	2018	English	, Cost analysis, Pricing & Reimbursement


Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices
Authors: Muigai J, Jacob L, Klostev K, Kalder M
Affiliations:
Publications: ONCOTARGET. 2018 JAN 3;9(9):8725-8730
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2018	English


Impact of Tobacco Smoking on the Risk of Developing 25 Different Cancers in the UK: A Retrospective Study of 422,010 Patients Followed for up to 30 Years
Authors: Jacob L, Freyn M, Kalder M, Dinas K, Kostev k
Affiliations:
Publications: ONCOTARGET. 2018 APR 3;9(25):17420-17429
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Retrospective cohort analysis


Association of Laryngeal Cancer with Vocal Cord Leukoplakia and related Risk Factors in 1,184 Patients Diagnosed in Otorhinolaryngology Practices in Germany
Authors: Kostev K, Jacob L, Kalder M, Sesterhenn AM, MDD, Seidel DU
Affiliations:
Publications: MOL CLIN ONCOLOGY 2018; 8: 689-693, 2018
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


The Impact of Non-Persistence in the Direct and Indirect Costs in Patients Treated with Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Germany
Authors: Ziegelbauer K, Kostev K, HÃ¼binger M, Dombrowski S, Friedrichs M, Friedel H, Kachroo S
Affiliations:
Publications: RHEUMATOLOGY (OXFORD). 2018 APR 12
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


Diagnoses of Suspected Cancer in Otolaryngology Practices in Germany
Authors: Kostev K, Lasrich M, SchÃ¼ller L, Diogo I, Sesterhenn A, Jacob L
Affiliations:
Publications: MOL CLIN ONCOLOGY
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2018	English


Association Between Sleep Disorders and the Presence of Breast Cancer Metastases in Gynecological Practices in Germany: A Case-Control Study of 11,412 Women
Authors: Jacob L, Schloten PC, Kostev K, Kalder M
Affiliations:
Publications: BREAST CANCER RES TREAT. 2018 MAY 29.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2018	English


Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe
Authors: Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA
Affiliations: Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA
Publications: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , Denmark, Finland, Germany, Norway, Sweden, UK
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods	2018	English	, Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review


Measuring Colorectal Cancer Screening Rates in a US Administrative Claims Database
Authors: Carrington CM, Johnson KE, Fedwa S, Wiatrek S, Lombardo J, Pirolli M, Oliveria SA
Affiliations: Carrington CM: IQVIA; Johnson KE: IMPAQ International; Fedwa S: American Cancer Society, Atlanta GA; Wiatrek S: American Cancer Society, Austin TX; Lombardo J: American Cancer Society Philadelphia PA; Pirolli M: American Cancer Society Philadelphia PA; Oliveria SA: IQVIA
Publications: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology	2018	English	, Database Study, Epidemiological study, Retrospective database analysis


Identification of Incident Pancreatic Cancer in Administrative Health Data: A Validation Study by the Canadian Network for Observational Drug Effect Studies
Authors: Wu JW, Axzoulay L, Huang A, Paterson M, Wu F, Secrest MH, Filion K
Affiliations: Wu JW: Analysis Group; Secrest MH: IQVIA
Publications: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , Canada
Condition	Year	Language	Analysis type
, Database Validity and methodology, Diabetes, Oncology	2018	English	, Database Study, Retrospective cohort analysis, Retrospective database analysis


#2811 Initial treatment in patients (pts) diagnosed with non-small cell lung cancer (NSCLC) in Denmark from 2005-2015: The SCAN-LEAF study
Authors: Jens Benn SÃ¸rensen, Simon Ekman, Pia Horvat, Deborah Layton, Joseph Kim, Mats Rosenlund, Ariadna Juarezâ€Garcia, Melinda Daumont, Hazel C. Jacobs, Laure Lacoin, Odd Terje Brustugun, Maria Planck
Affiliations: Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Karolinska University Hospital-Solna, Stockholm, Sweden; Real-World Evidence Solutions, IQVIA, London, UK; Data Science, IQVIA, London, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Uxbridge, UK; Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Braine-L?Alleud, Belgium; Department of Oncology, Radiumhospitalet, Oslo, Norway; Division of Oncology and Pathology, Skane University Hospital-Lund, Lund, Sweden
Publications:
Document Types: , Poster
Countries: , England, Nordic, UK
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Retrospective cohort analysis


Feasibility Analysis and Data Visualization to Identify a Complex Group of Cancer in the Simulacrum
Authors: ALI ABBASI1,2, Shubham Tayal3, Deborah Layton1 and Toby Gosden1
Affiliations: 1IQVIA, LONDON, United Kingdom2University Medical Centre Groningen, Groningen, Netherlands3IQVIA, Gurgaon, India
Publications:
Document Types: , Poster
Countries: , England
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Epidemiological study


Clinical Characteristics and Overall Survival of Patients Diagnosed With Non-Small Cell Lung Cancer (2006-2017) in Routine Clinical Practice: A Retrospective Analysis of a UK Hospital Database
Authors: Michael Snee, Sue Cheeseman, Matthew Thompson, Paul Godden, Will Sopwith, Carlos Chaib, Ariadna Juarez-Garcia, Laure Lacoin, John R Penrod, Geoff Hall
Affiliations: The Leeds Teaching Hospitals NHS Trust, Leeds, UK; IQVIA, London, UK; Bristol-Myers Squibb, Princeton, NJ, USA
Publications:
Document Types: , Abstract
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Retrospective database analysis


Treatment patterns in patients with stage IIIB-IV NSCLC in clinical practice: Retrospective analysis of a UK trust database
Authors: Michael Snee, Sue Cheeseman, Matthew Thompson, Laure Lacoin, Will Sopwith, Paul Godden, Carlos Chaib, Melinda Daumont, John R. Penrod, John Oâ€™Donnell & Geoff Hall
Affiliations: The Leeds Teaching Hospitals NHS Trust, Leeds/United Kingdom; IQVIA, London/United Kingdom; Bristol-Myers Squibb, Braine Lâ€™Alleud/Belgium; Bristol-Myers Squibb, Madrid/Spain; Bristol-Myers Squibb, Princeton, New Jersey/United States of America
Publications:
Document Types: , Poster
Countries: , England
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Retrospective database analysis


Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Authors: LÃ³pez N1, TornÃ© A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations: 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital ClÃnic-Institut d'Investigacions BiomÃ¨diques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital ClÃnic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publications: Infect Agent Cancer. 2018 May 2;13:15.
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937
Condition	Year	Language	Analysis type
, Health economics, Immunology and Vaccination, Infectious disease, Oncology	2018	English	, Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research


Real World Data y Real World Evidence como fuentes de evidencia en oncologÃa. Estado actual y perspectivas de futuro
Authors: Daniel Callejo y Anna de Prado
Affiliations: IQVIA Spain
Publications: New Medical Economics nÂº 79;22-24
Document Types: , Article
Countries: , Spain
Abstract: https://issuu.com/raizpublicidad/docs/nme_num79/22
Condition	Year	Language	Analysis type
, Oncology	2018	Spanish	, Clinical setting: hospital, Review


A real-world data study regarding hospital resources use and costs associated with melanoma cancer in Spain
Authors: Carmen Barrull, Ãngel Baltasar, Daniel Callejo, Vanessa GÃ³mez, Neus Canal, Miriam Solozabal
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPORÂ EuropeÂ 2018. 10-14 NovemberÂ 2018Â \| Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-melanoma-cancer-in.pdf?la=en&hash=8C1394471FDDA3956BBF8788628C6443F1E3D5B6
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A real-world data study regarding hospital resources use and costs associated with colorectal cancer in Spain
Authors: Laura Planellas, MÃriam Solozabal, Carmen Barrull, Anna de Prado, Neus Canal, Vanessa GÃ³mez
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPORÂ EuropeÂ 2018. 10-14 NovemberÂ 2018Â \| Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-colorectal-cancer.pdf?la=en&hash=FE374C80DDC224B135913C13D65857DAE36D0007
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


Hospital resources use and costs associated with 6 prevalent cancer in Spain, a Real World Data study
Authors: Daniel Callejo , Laura Planellas, MÃriam Solozabal, Carmen Barrull, Neus Canal, Anna de Prado
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPOR Europe, Barcelona, Spain, 10-14 November 2018
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/hospital-resources-use-and-costs-associated-with-6-prevalent-cancers-in-spain-a-real-world-data-stud.pdf?la=en&hash=C28017910D9722573D7A318AB3782530D5F50054
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A real-world data study regarding hospital resources use and costs associated with breast cancer in Spain
Authors: Daniel Callejo , Vanessa GÃ³mez, MÃriam Solozabal, Laura Planellas, Ãgata CarreÃ±o, Ãngel Baltasar
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPOR Europe, Barcelona, Spain, 10-14 November 2018
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-breast-cancer-in-s.pdf?la=en&hash=8547AD20386AF0B3E1DA95EDA710A7EEF6E40C68
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A real-world data study regarding hospital resources use and costs associated with bladder cancer in Spain
Authors: Anna de Prado, Ãngel Baltasar, Vanessa GÃ³mez, Carme Barrull, Ã€gata CarreÃ±o, Laura Planellas
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPORÂ EuropeÂ 2018. 10-14 NovemberÂ 2018Â \| Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-bladder-cancer-in.pdf?la=en&hash=9A2EA74E7E8AEC14E41A2D6DACD80911C716853F
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A real-world data study regarding hospital resources use and costs associated with lung cancer in Spain
Authors: Anna de Prado, Daniel Callejo, Vanessa GÃ³mez, Angel Baltasar, Neus Canal, Carme Barrull
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPORÂ EuropeÂ 2018. 10-14 NovemberÂ 2018Â \| Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-lung-cancer-in-spa.pdf?la=en&hash=8F884E874C670E07BCA72315DC3B6E042F558F23
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A real-world data study regarding hospital resources use and costs associated with prostate cancer in Spain
Authors: MÃriam Solozabal, Anna de Prado, Laura Planellas, Ãngel Baltasar, Ã€gata CarreÃ±o, Daniel Callejo
Affiliations: HEOR-RWI, IQVIA Spain
Publications: ISPORÂ EuropeÂ 2018. 10-14 NovemberÂ 2018Â \| Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-prostate-cancer-in.pdf?la=en&hash=1DA52D1BC0EDBFCE32B1DB5C46308CE4E06D318F
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Clinical setting: hospital, Cost analysis, Retrospective database analysis


A comparison of patient-reported outcomes (PRO) study between Japan and the United States in oncology research: a systematic literature review
Authors: Krishant Chand 1, Junko Morii 1, T Sato 1 (rwesheorj 1)
Affiliations: 1) IQVIA Solutions Japan K.K., Tokyo, Japan
Publications: ISPOR Asia Pacific 2018 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-asia-pacific-2018/a-comparison-of-patient-reported-outcomes-pro-study-between-japan-and-the-united-states-in-oncology-research-a-systematic-literature-review
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Literature Review


Predictors of Overall Survival for Multiple Myeloma Patients Depending on Transplant Status According to a Retrospective, Non-Interventional Study in Norway
Authors: Fredrik H. Schjesvold, MD PhD, Anderson Jenna, Jaak SÃµnajalg, Amy Leval, PhD, Anna LysÃ©n, MSc, Saeeda Rana, PÃ¤ivi Castren-Kortekangas, Fredrik Borgsten
Affiliations: Fredrik H. Schjesvold - Oslo University; Jenna Anderson - EPID Research (now part of IQVIA); Jaak SÃµnajalg - EPID Research (now part of IQVIA).
Publications: Blood (2018) 132 (Supplement 1): 5759.
Document Types: , Abstract
Countries: , Norway
Abstract: https://ashpublications.org/blood/article/132/Supplement%201/5759/263137/Predictors-of-Overall-Survival-for-Multiple
Condition	Year	Language	Analysis type
, Oncology	2018	English	, Observational study, Population Based Study


Evaluating the cost-effectiveness results of diagnostic strategies for hepatocellular carcinoma in Japan
Authors: M Uchida-Nakakoji 1, Akihiro Nishie 2, Graeme Ball 3, Eliza Kruger 4, Bruce Crawford 3, Hiroshi Honda 2
Affiliations: 1) Bayer Yakuhin Ltd., Tokyo, Japan 2) Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan 3) QuintilesIMS, Tokyo, Japan 4) QuintilesIMS, San Francisco, CA, USA
Publications: ISPOR 2017 Conference
Document Types: , Abstract
Countries: , Japan
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-22nd-annual-international-meeting/evaluating-the-cost-effectiveness-results-of-diagnostic-strategies-for-hepatocellular-carcinoma-in-japan
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Cost effectiveness


A Budget Impact Model of Third-Line or Later Trifluridine/Tipiracil Treatment of Metastatic Colorectal Cancer.
Authors: Ferrufino C, Wiseman F, Wert TD, Barghout V
Affiliations: QuintilesIMS Health, Falls Church, VA; Taiho Oncology, Priceton, NJ; Taiho Oncology, Inc, Princeton, NJ; VEB Healthcare, Morristown, NJ
Publications: ASCO
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Budget impact


Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Authors: Wehler EA, Zhao Z, Bilir S Pinar, Munakata J, Barber B
Affiliations:
Publications: Eur J Health Econ. 2017; 18: 49-58
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26721505
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Cost analysis


Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6.
Affiliations: Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom.
Publications: Breast. 2017 Apr;32:247-255.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648
Condition	Year	Language	Analysis type
, Oncology	2017	English	, clinical setting: Secondary care, Retrospective database analysis


THE ECONOMIC IMPACT OF DELAYING BRAIN METASTASES IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN THE COMMERCIALLY INSURED US POPULATION
Authors: Wong W1, Burudpakdee C2, Seetasith A2, Corvino F3, Yeh D1, Gubens M4
Affiliations: 1Genentech, Inc., South San Francisco, CA, USA, 2QuintilesIMS, Fairfax, VA, USA, 3Genesis Research, Hoboken, NJ, USA, 4University of California, San Francisco, San Francisco, CA, USA
Publications: ISPOR 22nd Annual International Meeting, Boston, 2017
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Budget impact, Retrospective database analysis


Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib.
Authors: Chen CC1, Parikh K2, Abouzaid S2, Purnomo L2, McGuiness C1B, Hussein M2, Wade RL1
Affiliations: 1QuintilesIMS, Plymouth Meeting, Pennsylvania. 2Celgene, Summit, New Jersey
Publications: J Manag Care Spec Pharm. 2017 Feb;23(2):236-246
Document Types: , Article
Countries: , USA
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2017.23.2.236
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Budget impact, Retrospective database analysis


Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan
Authors: Akihiro Nishie 1, Satoshi Goshima 2, Hiroki Haradome 3, Etsuro Hatano 4, Yasuharu Imai 5, Masatoshi Kudo 6, Masanori Matsuda 7, Utaroh Motosugi 7, Satoshi Saitoh 8, Kengo Yoshimitsu 9, Bruce Crawford 10, Eliza Kruger 10, Graeme Ball 10, Hiroshi Honda 11
Affiliations: 1) Kyushu University, Fukuoka, Japan 2) Gifu University Hospital, Gifu, Japan 3) Nihon University Hospital, Tokyo, Japan 4) Hyogo University Hospital, Hyogo, Japan 5) Ikeda Municipal Hospital, Osaka, Japan 6) Kindai University Hospital, Osaka, Japan 7) Yamanashi University, Yamanashi, Japan 8) Toranomon Hospital, Tokyo, Japan 9) Fukuoka University Hospital, Fukuoka, Japan 10) Quintiles IMS, Tokyo, Japan 11) Kyushu University, Fukuoka, Japan"
Publications: Clinical Therapeutics
Document Types: , Article
Countries: , Japan
Abstract: https://www.sciencedirect.com/science/article/pii/S0149291817301807?via%3Dihub
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Cost analysis


Do characteristics of patients influencing the choice of pain treatment by GPs differ in osteoarthritis and cancer? â€“ An Italian real world data study
Authors: Heiman F1, Pegoraro V1, Moretti R1
Affiliations: 1 QuintilesIMS, Milan, Italy
Publications: ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Oncology, Pain	2017	English	, Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective database analysis


The close link between anxiety and cluster symptoms in lung cancer patients during first-line chemotherapy: further data from a dedicated WALCE (Women Against Lung Cancer in Europe) survey
Authors: Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Cecere FL9, Lunghi A9, Del Conte A10, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG1, Gianetta M1, Pacchiana MV1, Pegoraro V11, Cataldo N11, Bria E12, Novello S1
Affiliations: 1 Thoracic Oncology Unit at San Luigi Hospital (Orbassano), University of Turin, Italy 2 Clinical Cancer Center â€œGiovanni Paolo IIâ€ Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Department of Medical Oncology , Azienda per lâ€™Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy 11 QuintilesIMS, Milan, Italy 12 Medical Oncology , Department of Medicine, Verona, Italy
Publications: XIX AIOM National Congress, Rome, Italy
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Survey research


Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
Authors: Jacob L, Kostev K, Hadji P
Affiliations:
Publications: Int J Clin Pharmacol Ther. 2017 May;55(5):394-39
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Epidemiological study


Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders -A retrospective analysis of subsequent pregnancy outcomes-
Authors: Jacob L, Kalder M, Arabin B, Kostev K
Affiliations:
Publications: J Cancer Res Clin Oncol. 2017 Feb 20. doi: 10.1007/s00432-017-2352-3. [Epub ahead of print]
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology, Surgery, Womens Health	2017	English	, Retrospective cohort analysis


Association of Dipeptidyl Peptidase 4 Inhibitors with Risk of Metastases in Patients with Type 2 Diabetes and Breast, Prostate or Digestive System Cancer
Authors: Rathmann W, Kostev K
Affiliations:
Publications: J Diabetes Complications. 2017 Jan 26. pii: S1056-8727(16)31034-0. doi: 10.1016/j.jdiacomp.2017.01.012. [Epub ahead of print]
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2017	English


Real-world treatment patterns and outcomes for mNSCLC patients receiving second- and third-line therapy in Germany
Authors: Yu N1, Rivera I2, Hipp J3, Zou M4, Pillai N4, Hammerschmidt S5
Affiliations: 1 Roche Products Ltd, Welwyn, UK 2 F. Hoffmann-La Roche, Basel, Switzerland 3 Roche Pharma AG, Grenzach-Wyhlen, Germany 4 QuintilesIMS, Basel, Switzerland 5 Klinikum Chemnitz gGmbH, Chemnitz, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Abstract: https://academic.oup.com/annonc/article/28/suppl_2/mdx091.052/3799717/132PReal-world-treatment-patterns-and-outcomes-for
Condition	Year	Language	Analysis type
, Clinical practice, Health status & patient reported outcomes, Oncology	2017	English	, clinical setting: Secondary care, Patient questionnaire, Quality of life


Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine.
Authors: LÃ³pez N1, TornÃ© A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4
Affiliations: 1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital ClÃnic-Institut dâ€²Investigacions BiomÃ¨diques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital ClÃnic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: HPV2017 31st International papillomavirus conference, 2017, February 28 â€“ March 4, Cape Town, South Africa
Document Types: , Poster
Countries: , Spain
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf
Condition	Year	Language	Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology	2017	English	, Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research


Impacto econÃ³mico de las enfermedades asociadas al VPH en EspaÃ±a: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine].
Authors: LÃ³pez N1, TornÃ© A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4
Affiliations: 1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital ClÃnic-Institut dâ€²Investigacions BiomÃ¨diques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital ClÃnic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: XXXVII Jornadas de EconomÃa de la Salud, 2017, 6 - 8 de septiembre, Barcelona, EspaÃ±a
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition	Year	Language	Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology	2017	Spanish	, Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research


EstimaciÃ³n de la carga epidemiolÃ³gica de patologÃas asociadas a 9 genotipos del virus del papiloma humano en EspaÃ±a: revisiÃ³n de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: Vacunas. 2017;18(2):36-42
Document Types: , Article
Countries: , Spain
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador
Condition	Year	Language	Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology	2017	Spanish	, Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review


Carga epidemiolÃ³gica y econÃ³mica de las patologÃas asociadas al virus del papiloma humano en espaÃ±a: revisiÃ³n de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: XXXVII Jornadas de EconomÃa de la Salud, 2017, 6 - 8 de septiembre, Barcelona, EspaÃ±a
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition	Year	Language	Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology	2017	Spanish	, Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review


Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story
Authors: Mpima S1, Moehler T2, Kanter S3, Mitrofan L4
Affiliations: 1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA
Publications: ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016.
Authors: Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3
Affiliations: 1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom
Publications: ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016.
Authors: Hoyer L, Schmidt N
Affiliations: QuintilesIMS Global Oncology, Central, East & South Europe
Publications: ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Measuring Breast Cancer Screening Rates in a US Administrative Claims Database
Authors: Karin E. Johnson, Stacey Fedewa, Dawn Wiatrek, Jennifer Lomardo, Melissa Pirolli, Susan A. Oliveria
Affiliations: QuintilesIMS
Publications: 33rd International Conference on Pharmacoepidemioligy, Montreal, Canada; August 2017
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology, Patient Registries & Real-World Study Methods	2017	English	, Retrospective cohort analysis, Retrospective database analysis


Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis.
Authors: Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Knopf KB., Lanasa MC.
Affiliations: AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M
Publications: J Comp Eff Res.
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28485619
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


FINANCIAL IMPACT OF INTRODUCING SC TRASTUZUMAB (HERCEPTIN) VERSUS CURRENTLY USED IV TRASTUZUMAB (HERCEPTIN) ON THE BUDGETS OF DIFFERENT HOSPITALS ACROSS KINGDOM OF SAUDI ARABIA (KSA)
Authors: AL-Tweigeri T1, Al-Shihri A2, Abdelhafeez N2, Ali A3, Zekri J4, Al Mansour M5, Al-gahmi A6, Ansari J7, Elbahaei A8, F Husseiny8, Awad N9, Safwat M9, Goyal R10
Affiliations: 1King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia (KSA), 2King Fahad National Guard Hospital, Riyadh, Saudi Arabia and 9QuintilesIMS, Dubai; 10QuintilesIMS, India
Publications: ISPOR 20th European conference, 4-8 November, 2017
Document Types: , Abstract
Countries: , Saudi Arabia
Abstract: https://ispor.confex.com/ispor/euro20/research/papers/index.cgi?username=78109&password=956822
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Budget impact, Clinical setting: hospital, Survey research


Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States
Authors: Qiufei Ma1, Yaozhu Juliette Chen, Dionne M Hines2, Julie Munakata2, Nicolas Batty1, Beth Louise Barber1, Zhongyun Zhao1
Affiliations: 1Amgen, 2QuintilesIMS
Publications: J Dermatolog Treat. 2017 Sep;28(6):549-553 Journal of Dermatological Treatment
Document Types: , Article
Countries: , USA
Abstract: http://www.tandfonline.com/doi/full/10.1080/09546634.2016.1277176
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Healthcare Resource Utilization and Costs of Skeletal-Related Events in Patients with Multiple Myeloma
Authors: Debajyoti Bhowmik1, Dionne M. Hines2, Michele Intorcia1, Catherine B. McGuiness2, Rolin L. Wade2
Affiliations: 1Amgen, 2QuintilesIMS
Publications: ISPOR
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and A Retrospective Real-World Study of Incident Comorbidities and Complications Among Acute Myeloid Leukemia Patients and Non-Cancer Comparison Patients in the US
Authors: Aimee Near, Shahed Iqbal, Huan Huang, Neil Dhopeshwarkar, Kathy Lang, Nicola Wallis
Affiliations: QuintilesIMS
Publications: American Society of Hematology 2017
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Burden of illness, Retrospective database analysis


Real-World Adherence and Its Determinants in Patients With Multiple Myeloma Treated With Pomalidomide and Carfilzomib
Authors: Chi-Chang Chen, PhD, MsPharm; KejalParikh, B. Pharm, MS; RolinL. Wade, RPh, MS; Catherine B. McGuiness, MA, MSc; Ali
Affiliations: QuintilesIMS, Plymouth Meeting, PA Celgene Corporation
Publications: Annual Conference of the Hematology/Oncology Pharmacy Association (HOPA); March 29-April 1, 2017; Anaheim, CA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective cohort analysis


The economic impact of delaying brain metastases in ALK-positive non-small cell lung cancer in the commercially insured US population
Authors: William Wong, Chakkarin Burudpakdee, Arpamas Seetasith, Frank A Corvino, Wei-Shi Yeh, Matthew Gubens
Affiliations: Genentech, Inc.; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA
Publications: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 22nd Annual International Meeting
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Cost of illness, Retrospective cohort analysis


Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey
Authors: Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Cecere FL9, Lunghi A9, Del Conte A10, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG11, Gianetta M11, Pacchiana MV11, Pegoraro V12, Cataldo N12, Bria E13, Novello S11.
Affiliations: 1 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 2 Clinical Cancer Center "Giovanni Paolo II", Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology, SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Rome, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Department of Medical Oncology, Azienda per l'Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy 11 Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Regione Gonzole 10, Orbassano, Turin, Italy 12 IQVIA, RWI, Milan, Italy 13 Medical Oncology, Department of Medicine, Verona, Italy
Publications: Support Care Cancer. 2018 Jun;26(6):1841-1849
Document Types: , Article
Countries: , Italy
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/?term=Chemotherapy-induced+nausea+and+vomiting+(CINV)+in+patients+with+advanced+lung+cancer+during+the+first-line+treatment%3A+assessment+by+physicians%2C+nurses%2C+and+patients+from+an+Italian+multicenter+survey
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Survey research


Evaluating Renal Cell Carcinoma treatment options using real world data: findings from an oncology survey across seven countries
Authors: S. Mpima, S. Menon, P. Nasuti, H. Mistry
Affiliations: IQVIA London UK
Publications: ESMO - ImmunoOncology
Document Types: , Poster
Countries: , Asia Pacific, Europe
Condition	Year	Language	Analysis type
, Oncology	2017	English


Real World analysis for immune related side effects in 3000 patients
Authors: Mitrofan L 1, Moehler T 2, Ruiz M 3
Affiliations: 1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain
Publications: ESMO - ImmunoOncology
Document Types: , Poster
Countries: , Europe, France, Germany, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2017	English


I-O Optimise: Developing a Unique Multinational Real-World Evidence-Based Research Platform in Oncology
Authors: Isabelle Durand-Zaleski, Melinda Manley-Daumont, Paul Baas, Carlos Chaib, David Chao, Christos Chouaid, Simon Ekman, Timothy dâ€™EstrubÃ©, Frank Griesinger, Ariadna Juarez-Garcia, Masha Khovratovich, Deborah Layton, Aoife McNamara, John C Oâ€™Donnell, John R Penrod, Marta Pereira, Henrik Toft SÃ¸rensen
Affiliations: URC Eco IdF, UnitÃ© de Recherche Clinique en Ã‰conomie de la SantÃ© dâ€™Ile de France, AP-HP Paris, Paris, France; Bristol-Myers Squibb, Rueil-Malmaison, France; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Bristol-Myers Squibb, Madrid, Spain; Department of Oncology, Royal Free Hospital, London, UK; Pneumology Unit, Centre Hospitalier Intercommunal de CrÃ©teil, CrÃ©teil, France; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; QuintilesIMS, London, UK; Department of Haematology and Oncology, University Division Internal Medicine-Oncology, Pius-Hospital Oldenburg, Oldenburg, Germany; Bristol-Myers Squibb, Mexico City, Mexico; Irish Cancer Society, Dublin, Ireland; Bristol-Myers Squibb, Princeton, NJ, USA; Bristol-Myers Squibb, Uxbridge, UK; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Publications:
Document Types: , Abstract
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


I-O Optimise: Developing a Unique Multinational Real-World Evidence-Based Research Platform in Oncology
Authors: Isabelle Durand-Zaleski, Melinda Manley-Daumont, Paul Baas, Carlos Chaib, David Chao, Christos Chouaid, Simon Ekman, Timothy dâ€™EstrubÃ©, Frank Griesinger, Ariadna Juarez-Garcia, Masha Khovratovich, Deborah Layton, Aoife McNamara, John C Oâ€™Donnell, John R Penrod, Marta Pereira, Henrik Toft SÃ¸rensen
Affiliations: URC Eco IdF, UnitÃ© de Recherche Clinique en Ã‰conomie de la SantÃ© dâ€™Ile de France, AP-HP Paris, Paris, France; Bristol-Myers Squibb, Rueil-Malmaison, France; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Bristol-Myers Squibb, Madrid, Spain; Department of Oncology, Royal Free Hospital, London, UK; Pneumology Unit, Centre Hospitalier Intercommunal de CrÃ©teil, CrÃ©teil, France; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; QuintilesIMS, London, UK; Department of Haematology and Oncology, University Division Internal Medicine-Oncology, Pius-Hospital Oldenburg, Oldenburg, Germany; Bristol-Myers Squibb, Mexico City, Mexico; Irish Cancer Society, Dublin, Ireland; Bristol-Myers Squibb, Princeton, NJ, USA; Bristol-Myers Squibb, Uxbridge, UK; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Publications:
Document Types: , Abstract
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


Pioglitazone Use and Risk of Bladder Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies
Authors: Hoti F, MehtÃ¤lÃ¤ J, Khanfir H, Christopher S, Bennett D, Ye Y, Korhonen P
Affiliations: EPID Research, Espoo, Finland
Publications: Pharmacoepidemiology and Drug Safety (2017);26 (S2): 3-636
Document Types: , Abstract
Countries: , Finland
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4275
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Literature Review, Meta analysis


Impact of locally advanced or metastatic prostate cancer on the quality of life
Authors: LÃ³pez-Calderero I, LÃ³pez-Fando L, RÃos-GonzÃ¡lez E, Maisonobe P, HernÃ¡ndez-Yuste E, Sarmiento-JordÃ¡n M
Affiliations: LÃ³pez-Calderero I: Hospital Can Misses, Ibiza, EspaÃ±a Sarmiento M: QuintilesIMS, Barcelona, EspaÃ±a
Publications: Actas UrolÃ³gicas EspaÃ±olas 2017;41(6):368-75
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28256271
Condition	Year	Language	Analysis type
, Oncology, Urology	2017	English	, Quality of life


Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States.
Authors: Ma Q1, Chen YJ2, Hines DM2, Munakata J3, Batty N4, Barber BL1, Zhao Z1.
Affiliations: 1 a Department of Global Health Economics , Amgen Inc , Thousand Oaks , CA , USA. 2 b Health Economics & Outcomes Research, IMS Health , Fairfax , VA , USA. 3 c Real World Evidence Solutions, IMS Health , San Francisco , CA , USA. 4 d Department of Medical Affairs , Amgen Inc , Thousand Oaks , CA , USA.
Publications: J Dermatolog Treat. 2017 Sep;28(6):549-553
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2017	English	, Retrospective database analysis


UTILIZATION OF RADIUM-223 DICHLORIDE (RA-223) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN CANADA: A REAL-WORLD RETROSPECTIVE STUDY
Authors: Lapierre M, Fraelic A
Affiliations: IMS Health, Kirkland, QC, Canada, IMS Health, Canada, Kanata, QC, Canada
Publications: ISPOR 21st, May 21-25 - 2016 Washington DC USA Value in Health, 2016, 19(3): A162
Document Types: , Poster
Countries: , Canada
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)01560-6/abstract
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


REAL-WORLD COMPARISON OF METASTATIC MELANOMA TREATMENTS BETWEEN ACADEMIC AND COMMUNITY HOSPITALS IN CANADA: A RETROSPECTIVE STUDY
Authors: Lapierre M
Affiliations: IMS Health, Kirkland, QC, Canada
Publications: ISPOR 21st, May 21-25 - 2016 Washingtown DC USA
Document Types: , Poster
Countries: , Canada
Abstract: http://www.imsbrogancapabilities.com/pdf/rwe/metastatic-melanoma-ispor-poster-2016.pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES
Authors: Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2
Affiliations: 1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain
Publications: ISPOR 21st, May 2016 Washington, USA
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Authors: Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publications: Clinical Epidemiology
Document Types: , Article
Countries: , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Literature Review


Population-based study of giant cell tumor of bone in Sweden (1983-2011).
Authors: Amelio JM1, Rockberg J2, Hernandez RK3, Sobocki P4, Stryker S5, Bach BA3, Engellau J6, Liede A5
Affiliations: 1Amgen Ltd. Uxbridge, UK. Electronic address: justyna.amelio@amgen.com. 2Pygargus/IMS Health, Stockholm, Sweden. 3Amgen Inc. Thousand Oaks, CA, USA. 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden. 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden.
Publications: Cancer Epidemiol
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(16)30039-X/abstract
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Real World Evidence


Italian electronic health records mapping: is clinical data collection getting in line with the real world evidence era?
Authors: Avitabile A, Caputo A, Gilardelli G, Golotta C, La Grasta L, Heiman F1, Porrello N.
Affiliations: 1 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publications: ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Health policy, Neurological disorders, Oncology	2016	English	, Clinical setting: hospital, Real World Data, Real World Evidence


Hospitalization cost and length of stay associated with HPV-related diseases.
Authors: Tsakeu E1, Petit C2, Chevalier P1
Affiliations: 1 QuintilesIMS, Zaventem, Belgium 2 Sanofi-Pasteur MSD, Diegem, Belgium
Publications: 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Cost analysis


Description of first-line treatments in patients with non-resectable colorectal cancers in Belgium.
Authors: Chevalier P, van Gils C, Lamotte M
Affiliations: QuintilesIMS, Zaventem, Belgium
Publications: 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2016	English


In-hospital mortality and complications following surgical resection of glioblastoma.
Authors: Chevalier P, van Gils C, Lamotte M
Affiliations: QuintilesIMS, Zaventem, Belgium
Publications: 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2016	English


Costs of HPV-related cancers in The Netherlands.
Authors: Ahmed Salem1, Shahbaz Pervaiz1, Vidya Breeveld-dwarkasing2, Dhont Patrick3, Slierendregt Bas2, Chantal van Gils1
Affiliations: 1 QuintilesIMS, Zaventem, Belgium 2 Sanofi-Pasteur MSD, Hoofddorp, The Netherlands 3 Sanofi-Pasteur MSD, Diegem, Belgium
Publications: 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Netherlands
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Real World Data


COSTS EVOLUTION OF CANCER THERAPIES IN EUROPE FROM 2004 TO 2014
Authors: Tetafort A, Aubert JM, Perrot D, Brigot G, Kolahi C, Ansolabehere X
Affiliations: IMS Health France
Publications: 19th ISPOR Congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN82.pdf
Condition	Year	Language	Analysis type
, Oncology, Pricing and reimbursement	2016	English	, Clinical setting: hospital, Cost analysis, Pricing & Reimbursement, Retrospective database analysis


USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA
Authors: Jubert H, Kolahi C, Karusisi N, Mitrofan L
Affiliations: IMS Health France
Publications: 19th ISPOR congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition	Year	Language	Analysis type
, Health economics, Oncology	2016	English	, Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis


Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence.
Authors: Rockberg J1, Amelio JM2, Taylor A2, JÃ¶rgensen L1, Ragnhammar P3, Hansson J4.
Affiliations: 1Pygargus AB/IMS Health Sweden AB, PyramidvÃ¤gen 7, Solna, Sweden 169 56. 2Amgen Inc, Uxbridge Business Park, Uxbridge, UK UB8 1DH. 3Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. 4Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden 171 76. johan.hansson@ki.se.
Publications: Int J Cancer
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27563839
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Epidemiological study, Real World Evidence


Overall survival and intermediate outcomes among Scandinavian non-small cell lung cancer patients: the SCAN-LEAF study
Authors: Simon Ekman (MD, PhD)1, Jens Benn SÃ¸rensen (MD, DMSc, MPA)2, Julia Rockberg (MSc, PhD)3, Martin Sandelin (MD, PhD)4, Melinda Manley Daumont (PhD)5, Patrik Sobocki (PhD)3, Peter Klint (PhD)6, Han-Yao Huang (PhD)7, Jenny SvÃ¤rd (MSc, PhD)3, Oana Cristina Chirita (MPharm, MSc)8, Leif JÃ¶rgensen (MSc)3, Maria Planck (MD, PhD)9
Affiliations: 1. Karolinska University Hospital, Stockholm, Sweden 2. Rigshospitalet, Copenhagen, Denmark 3. Pygargus/IMS Health, Solna, Sweden 4. Uppsala University, Uppsala, Sweden 5. Bristol-Myers Squibb, Paris, France 6. Bristol-Myers Squibb, Solna, Sweden 7. Bristol-Myers Squibb, Pennington, NJ, USA 8. Bristol-Myers Squibb, Uxbridge, UK 9. Lund University, Lund, Sweden
Publications: IASLC 17th World Conference on Lung Cancer, Vienna 2016
Document Types: , Abstract
Countries: , Sweden
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Epidemiological study, Real World Evidence


Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7.
Affiliations: 1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com.
Publications: Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Real world data: use of novel treatments and biomarkers in malignant melanoma in European countries
Authors: von Bredow D1, Kolb N1, Schmidt N2, Eheberg D1
Affiliations: 1 QuintilesIMS, Munich, Germany 2 QuintilesIMS, Frankfurt, Germany
Publications:
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Real World Data


Second-line drug regimens in metastatic melanoma patients based on BRAF mutation status: A Canadian real-world retrospective study
Authors: Bremner S1, Lapierre M2, Fraelic A1, Stewart D1
Affiliations: 1 IMS Health, Kanata, ON, Canada 2 IMS Health, Kirkland, QC, Canada
Publications: 2016 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/168312-176
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice
Authors: Cea Soriano L, Soriano-GabarrÃ³ M, GarcÃa RodrÃguez LA
Affiliations: Spanish Centre for Pharmacoepidemiological Research (CEIFE); Epidemiology, Bayer Pharma AG
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom
Authors: Cea Soriano L, Soriano-GabarrÃ³ M, GarcÃa RodrÃguez LA
Affiliations: Spanish Centre for Pharmacoepidemiologic Research (CEIFE); Global Epidemiology, Bayer Pharma AG
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network
Authors: Chiesa Fuxench ZC, Shin DB, Ogdie Beatty A, Gelfand JM
Affiliations: Departments of Dermatology, University of Pennsylvania; Epidemiology and Biostatistics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Dermatology, Miscellaneous, Oncology	2016	English	, Retrospective database analysis


Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study.
Authors: Mamtani R, Lewis JD, Scott FI, Ahmad T, Goldberg DS, Datta J, Yang YX, Boursi B
Affiliations: Division of Hematology/Oncology, University of Pennsylvania; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania; Division of Gastroenterology, University of Pennsylvania; Section of Cardiovascular Medicine, Yale School of Medicine; Department of Surgery, University of Pennsylvania; Tel-Aviv University
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort Study
Authors: Sampson EL, Lodwick R, Rait G, Candy B, Low J, King M, Petersen I
Affiliations: Marie Curie Palliative Care Research Department, Division of Psychiatry University College London; Research Department of Primary Care and Population Health, University College London
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Miscellaneous, Neurological disorders, Oncology, Respiratory disease	2016	English	, Retrospective database analysis


Chemotherapy-induced nausea and vomiting (CINV) in Italian lung cancer patients: assessment by physician, nurse and patient
Authors: Carnio S1, Galetta D2, Scotti V3, Cortinovis DL4, Antonuzzo A5, Pisconti S6, Rossi A7, Martelli O8, Lunghi A9, Pilotto S10, Del Conte A11, Pegoraro V12, Montagna ES2, Topulli J3, Pelizzoni D4, Rapetti SG1, Gianetta M1, Pacchiana MV1, Novello S1
Affiliations: 1 Thoracic Oncology Unit at San Luigi Hospital (Orbassano), University of Turin, Italy 2 Clinical Cancer Center â€œGiovanni Paolo IIâ€ Bari, Italy 3 Department of Oncology Radiation Therapy Unit, Careggi University Hospital, Florence, Italy 4 Medical Oncology Unit, San Gerardo Hospital, Monza, Italy 5 5Division of Medical Oncology Department of Oncology, S. Chiara University Hospital, Pisa, Italy 6 Department of OncoEmatology Medical Oncology, SG Moscati Hospital, Taranto, Italy 7 Division of Medical Oncology SG Moscati Hospital, Avellino, Italy 8 Medical Oncology Unit, San Giovanni Addolorata Hospital, Roma, Italy 9 Department of Oncology, Medical Oncology Unit, Careggi University Hospital, Florence, Italy 10 Medical Oncology , Department of Medicine, Verona, Italy 11 Department of Medical Oncology , Azienda per lâ€™Assistenza Sanitaria No.5, Friuli Occidentale, Presidio Ospedaliero di Pordenone, Pordenone, Italy, QuintilesIMS, Milan, Italy 13
Publications:
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Survey research


Impact of Metformin on Metastases in Patients with Breast Cancer and Type 2 Diabetes
Authors: Jacob L, Kostev K, Rathmann W, Kalder M
Affiliations:
Publications: J Diabetes Complications. 2016 Aug;30(6):1056-9
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2016	English


Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany
Authors: Jacob L, Hadji P, Kostev K
Affiliations:
Publications: J Geriatr Oncol. 2016 Apr 16. pii: S1879-4068(16)30019-4
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2016	English


Age-related differences in persistence with bisphosphonates in women with metastatic breast cancer.
Authors: Jacob L, Hadji P, Kostev K
Affiliations:
Publications: J Bone Oncol. 2016 Mar 2;5(2):63-6
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology, Womens Health	2016	English


Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Brain metastasis in NSCLC in the era of precision Medicine.
Authors: Mpima S, Anger C, Mitrofan L
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Observational study


17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5).
Authors: Bermudez F, Karanais Y, Mistry H, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data.
Authors: Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I
Affiliations: GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France
Publications: ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Longitudinal study


Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK.
Authors: Mpima S, Casey V, Nasuti P
Affiliations: QuintilesIMS, London, United Kingdom
Publications: IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Observational study


Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma.
Authors: Jubert H, Karusisi N, Kolahi C, Mitrofan L
Affiliations: QuintilesIMS, La Defense, France
Publications: IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition	Year	Language	Analysis type
, Oncology	2016	English


Increasing economic burden of tyrosine kinase inhibitor treatment failure by line of therapy in chronic myeloid leukemia.
Authors: McGarry LJ., Chen YJ., Divino V., Pokras S., Taylor CR., Munakata J., Nieset CC., Huang H., Jabbour E., Malone DC.
Affiliations: ARIAD. IMS authors: Divino V, Munakata J
Publications: Curr Med Res Opin. Curr Med Res Opin. 2016;32(2):289-99
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26566171
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Burden of illness


GENERIC DRUG VOLUME AND COST SAVINGS IN ONCOLOGY: A 2005-2014 MIDAS ANALYSIS
Authors: Divino V., Coyle K., Kleinrock M., Wade RL., DeKoven M., Kaura S.
Affiliations: Celgene. IMS authors: Divino V, Coyle K, Kleinrock M, Wade RL, DeKoven M
Publications: ISPOR 19th Annual European Congress
Document Types: , Poster
Countries: , USA
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/68602?pdfid=47233
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


New and emerging novel therapy combinations for relapsed and refractory multiple myeloma (RRMM)
Authors: Victoria Divino, Kejal Parikh, Mitch DeKoven, Katharine Coyle, Safiya Abouzaid
Affiliations: Celgene, IMS authors: Divino V, DeKoven M, Katharine Coyle
Publications: 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting
Document Types: , Poster
Countries: , USA
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2016.22.4.S1
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Literature Review


Mortality and Vascular Events among Elderly Patients with Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data
Authors: Lang K, McGarry L, Huang H, Dorer D, Kaufman E, Knopf K
Affiliations: Huan Huang is IQVIA author
Publications: Clin Lymphoma Myeloma Leuk
Document Types: , Article
Countries: , USA
Abstract: https://www.sciencedirect.com/science/article/pii/S2152265016000525?via%3Dihub
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Population Based Study, Retrospective database analysis


Guidelines for Breast Cancer Gene Mutation Testing in Healthy Individuals and Patients Diagnosed with Breast Cancer
Authors: Casso D, Telford C, Oliveria SA, Saggar JK, Tyczynski JE.
Affiliations: Casso D: IQVIA; Telford C: AstraZeneca; Oliveria SA: IQVIA; Tyczynski JE: AstraZeneca
Publications: 6th International Symposium on Hereditary Breast and Ovarian Cancer, Montreal, Canada
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Literature Review, Review


Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study
Authors: Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O
Affiliations: Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland
Publications: Menopause (2016);23(11):1199-1203
Document Types: , Article
Countries: , Finland
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27465718
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Epidemiological study, Population Based Study, Retrospective database analysis


Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study
Authors: Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.
Affiliations: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Publications: Menopause (2016) 23(11): 1199-1203
Document Types: , Article
Countries: , Finland
Abstract: https://journals.lww.com/menopausejournal/Abstract/2016/11000/Reduced_risk_of_breast_cancer_mortality_in_women.8.aspx
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Population Based Study, Prospective study


Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
Authors: MacLean E, Cisar L, Mehle K, Eremina D, Quigley JM
Affiliations: Outcomes and Evidence, Global Health and Value, New York, New York. US Medical Affairs, Oncology, Pfizer, New York, New York. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania. Statistical Methodology, IMS Health, Plymouth Meeting, Pennsylvania. Commercial Effectiveness Services, IMS Health, Plymouth Meeting, Pennsylvania.
Publications: J Manag Care Spec Pharm. 2016 Jun;22(6):723-732u
Document Types: , Abstract
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27231799
Condition	Year	Language	Analysis type
, Oncology	2016	English	, Retrospective database analysis


THERAPY OF DEPRESSION IN CANCER AND NON-CANCER PATIENTS IN GERMAN NEUROPSYCHIATRIC PRACTICES
Authors: Ziegelbauer K, Engelhard J, Kostev K
Affiliations: IMS Health, Frankfurt am Main, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2015	English


Axitinib as Subsequent Therapy in Renal Cell Carcinoma: Real-World Treatment Patterns in the United States
Authors: MacLean E1, Mehle K2, Eremina D2, Quigley J2
Affiliations: 1 Pfizer, New York, US, 2 IMS Health, Plymouth Meeting, US
Publications: American Society of Clinical Oncology, 2014 JMCP; 2015; 21(4):S15
Document Types: , Abstract
Countries: , USA
Abstract: http://www.amcp.org/mwg-internal/ogf7f4h09szyk7/progress?id=WFRYx0FI68JadqynyZ9ANLnilO3lKxogo0_mDztGEXc,&dl
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Cost-effectiveness of Radium-223 Dichloride (Radium-223) in Alsympca: A Cost-effectiveness analysis of Radium-223+Best standard of care (BSOC) compared with placebo+BSOC in treatment of Castration-Resistant Prostate Cancer (CRPC) and symptomatic bone metastases in Canada
Authors: Henricks P1, Cislo P2, Zhan L2, Beaudet A3, Grabbi E4, Lloyd A4, Fleshner N5, Chin W6
Affiliations: 1Bayer Inc, Toronto, ON, Canada, 2Bayer HealthCare, Whippany, NJ, USA, 3IMS Health, Basel, Switzerland, 4IMS Health, London, UK, 5Princess Margaret Hospital, University Health Network, Toronto, ON, Canada, 6ILEX Consulting, Toronto, ON, Canada
Publications: ISPOR 20th Annual International Meeting, Philadelphia, PA, USA, May 16-20 2015
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN74.pdf
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Cost effectiveness


NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrettâ€™s oesophagus: a populationbased caseâ€“control study
Authors: Masclee GM1, Coloma PM2, Spaander MC3, Kuipers EJ3, Sturkenboom MC4.
Affiliations: 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands
Publications: BMJ Open. 2015 Jan 29;5(1):e006640.
Document Types: , Article
Countries: , Netherlands, UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/pdf/bmjopen-2014-006640.pdf
Condition	Year	Language	Analysis type
, Gastrointestinal disorders, Oncology	2015	English	, Epidemiological study, Retrospective database analysis


Real-world treatment with abiraterone acetate (ZytigaÂ®) in metastatic castration-resistant prostate cancer (mCRPC) patients in the post-chemotherapy setting in Europe
Authors: L Dearden, P Musingarimi, N Shalet, T Maher, D Demuth, L Garcia-Alvarez, A Muthutantri, A Venerus, R Lasry, M Hankins
Affiliations:
Publications:
Document Types: , Conference
Countries: , Europe
Condition	Year	Language	Analysis type
, Methodology, Oncology	2015	English	, Real World Data, Real World Evidence


Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data.
Authors: Hess L, Michael D,Mytelka D, Beyrer J, Liepa1 A and Nicol S
Affiliations: Lilly Oncology
Publications: Gastric Cancer
Document Types: , Article
Countries: , USA
Abstract: http://scholar.google.com/scholar_url?url=http://link.springer.com/article/10.1007/s10120-015-0486-z/fulltext.html&hl=en&sa=X&scisig=AAGBfm3--GVI9iCpWS5h2bj0yC44jPhJVQ&nossl=1&oi=scholaralrt
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Axitinib as subsequent therapy in renal cell carcinoma: real world treatment patterns in the United States
Authors: MacLean E, Mehle K, Eremina D, Quigley J
Affiliations: Pfizer Global Health & Value, New York, NY
Publications:
Document Types: , Poster
Countries: , USA
Abstract: http://congress-download.pfizer.com/public/download.aspx?docID=my4%2fLzgcvl8%3d
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective cohort analysis


Increased Treatment Cost Associated with Mantle Cell Lymphoma Disease Progression
Authors: Wade R1, Hu X2, Chen Y3, Mahmoud D4, Le Gouill S3
Affiliations: IMS Health Global Market Access, Celgene, Summit, NJ, USA, Haematology Department, CHU Nantes and UMR892 INSERM, Nantes, France
Publications: EHA 2015, Congress of the European Hematology Association, June 2015
Document Types: , Abstract, Poster
Countries: , France, USA
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Cost analysis


Costs Associated with Routine Management of Febrile Neutropenia/Leukopenia in Three Tumour Types in German Hospitals - A Cost Study Update
Authors: Ihbe-Heffinger A1, Shlaen M5, Jacobs V3, Von Schilling C4, Paessens B1, Berger K6, Kiechle M3, Bernard R1, Peschel C2
Affiliations: 1 Hospital Pharmacy Unit, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 2 Third Medical Dept., Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 3 Dept. of Gynecology, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Third Medical Dept., Klinikum Freising, Freising, Germany 5 IMS Health GmbH, Munich, Germany 6 Medizinische Klinik III, HÃ¤matologie, Onkologie, Klinikum der UniversitÃ¤t, Munich, Germany
Publications: MASCC/ISOO Annual Meeting on Supportive Care in Cancer, 2015, February 15th, Copenhagen, Denmark
Document Types: , Abstract, Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2015	English


Evaluation of Pharmaceutical Transaction Data for Potential Augmentation of SEER Treatment Data
Authors: Cronin, K., Barrett, M., Warren, J., Tran, Q., Annett, D., Pressman, E., Wu, X., Hsieh, M., Pirolli, M., Penberthy, L.
Affiliations:
Publications: SEER
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Prevalence of bone loss among nonmetastatic breast cancer patients treated with aromatase inhibitors in the United States
Authors: Pirolli M, Hernandez R, Reich A, Liede A
Affiliations: Amgen
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Epidemiological study


Estimating the Budget Impact of Switching from Bortezomib Intravenous (IV) to Bortezomib Subcutaneous (SQ) in the Treatment of Relapsed/Refractory Multiple Myeloma (MM) in Mexico
Authors: Wehler EA1, Kowal S2, Hernandez-Garduno A3, Danese de los Santos L3, De Anda, Anaya P5, Munakata J6, Gonzalez-Michaca L7
Affiliations: 1IMS Health, Plymouth Meeting, PA, USA 2IMS Health, Seattle, WA, USA 3Janssen, Mexico City, Mexico 4IMS Health, Mexico City, Mexico 5IMS Health, Mexico, D.F., Mexico 6IMS Heath, San Francisco, CA, USA 7Janssen, Raritan, NJ, USA
Publications: Value Health, 2015, 18(7); A818
Document Types: , Poster
Countries: , Mexico, USA
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Cost analysis


An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Authors: Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2.
Affiliations: 1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy.
Publications: Drugs Context. 28;4:212285.
Document Types: , Article
Countries: , France, Germany, Italy
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf
Condition	Year	Language	Analysis type
, Health economics, Oncology	2015	English	, Survey research


Parentsâ€™ expressed emotion and mood, rather than their physical disability are associated with adolescent adjustment: A longitudinal study of families with a parent with multiple sclerosis
Authors: A Bogosian 1, J Hadwin 2, M Hankins 3, R Moss-Morris 4
Affiliations: 1 Psychology Department, City University, UK 2 Psychology Department, Southampton University, UK 3 Real-World Evidence Solutions, IMS Health, UK 4 Institute of Psychiatry, Psychology and Neuroscience, Kingâ€™s College London,
Publications: Clin Rehabil. 2015 Apr 14
Document Types: , Article
Countries: , England, Europe
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25872520
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Neurological disorders, Oncology	2015	English	, Longitudinal study


Development and psychometric evaluation of a new patient-reported outcome measure for stroke self-management: The Southampton Stroke Self-Management Questionnaire (SSSMQ)
Authors: Boger EJ1, Hankins M2, Demain SH3, Latter SM4.
Affiliations: 1Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK. 2Real-World Evidence Solutions, IMS Health, London, N1 9JY, UK. 3Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ, UK.4Faculty of Health Sciences, University of Southampton
Publications: Health and Quality of Life Outcomes
Document Types: , Article
Countries: , England
Condition	Year	Language	Analysis type
, Cardiovascular disease, Methodology, Oncology, Pain	2015	English	, Database Study, Quality of life


Real-world Assessment of Renal Involvement in Tuberous Sclerosis Complex (TSC) Patients in the United Kingdom (UK): A Retrospective Cohort Study in the Clinical Practice Research Datalink (CPRD)
Authors: Kingswood, Chris1, Nasuti, Paola2, Demuth, Dirk2, Patel, Keyur2, Myland, Melissa2, Erhard, Clement3, Gray, Elizabeth4, Pinnegar, Alun4, Magestro, Matthew5
Affiliations: The Royal Sussex County Hospital, Brighton, England 2 IMS Health, London, UK 3 CE Analytics, Cambridge, UK 4 Novartis Pharmaceuticals UK Ltd, Frimley, UK 5 Novartis Pharmaceuticals Corporation, East Hanover NJ, USA
Publications: International TSC Research Conference (Windsor, 11th Sept 2015).
Document Types: , Poster
Countries: , England
Condition	Year	Language	Analysis type
, Oncology, Pediatrics, Rare disease	2015	English	, Retrospective cohort analysis


Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study)
Authors: Benjamin L1, Maroun R, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1GlaxoSmithKline, Health Economics and Outcomes Research , Marly-le-Roi , France;2 IMS Health, La defense, Paris
Publications: Curr Med Res Opin. 2015 Feb;31(2):323-32
Document Types: , Article
Countries: , France
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26005879
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Database Study


PREVALENCE OF DEPRESSION AND ANXIETY AND THEIR RISK FACTORS IN WOMEN WITH BREAST CANCER IN GERMAN PRIMARY CARE
Authors: Engelhard J1, Bleicher L2, Kostev K1
Affiliations: 1IMS Health, Frankfurt am Main, Germany, 2University Clinic of Marburg, Marburg, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Mental health, Oncology	2015	English


A DESCRIPTION OF REAL-WORLD TREATMENT WITH ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN THE POST-CHEMOTHERAPY SETTING IN FRANCE AND THE NETHERLANDS
Authors: Dearden L1, Musingarimi P2, Shalet N3, Demuth D4, Garcia Alvarez L4, Muthutantri A4, Venerus A4, Lasry R4, Hankins M4, Maher T3
Affiliations: 1Janssen EMEA HEMAR, High Wycombe, UK, 2Janssen-Cilag Ltd., High Wycombe, UK, 3Janssen, High Wycombe, UK, 4IMS Health, London, UK
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , France, Netherlands
Condition	Year	Language	Analysis type
, Oncology	2015	English


THE ANALYSIS OF INPATIENTS COST OF BREAST CANCER IN CHINA, 2011
Authors: Song S, Wang Z, Zhang M
Affiliations: IMS consulting group, Shanghai, China
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , China
Condition	Year	Language	Analysis type
, Mental health, Oncology	2015	English


ESTIMATION OF DIRECT MEDICAL COSTS ASSOCIATED WITH TREATMENT OF METASTATIC MELANOMA IN SWITZERLAND
Authors: Christoffersen P1, Khan N1, Lucas J1, Christodoulopoulou A2, Del Ponte A2, Gutzwiller F2
Affiliations: 1IMS Health, Basel, Switzerland, 2Amgen Switzerland AG, Zug, Switzerland
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Switzerland
Condition	Year	Language	Analysis type
, Oncology	2015	English


4+ YEARS OF AMNOG â€“ CLINICAL DRIVERS FOR SUCCESSFUL DOSSIER SUBMISSIONS IN ONCOLOGY
Authors: Dehnen J, Goldhagen K, Petry D
Affiliations: IMS Consulting Group, Muenchen, Germany
Publications: ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2015	English


UTILIZATION AND COST OF SUPPORTIVE CARE AMONG PATIENTS RECEIVING NAB-PACLITAXEL + GEMCITABINE VERSUS FOLFIRINOX FOR METATSTATIC PANCREATIC CANCER
Authors: Patel M1, Parisi M1, Hill JW2, De AP2, Wade RL2
Affiliations: Celgene Corporation, Summit, NJ, USA, 2IMS Health, Plymouth Meeting, PA, USA
Publications: ISPOR 21th, May 2016 Washington, DC USA
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Cost analysis


Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Authors: Rockberg J1, Bach BA2, Amelio J3, Hernandez RK4, Sobocki P1, Engellau J5, Bauer HC6, Liede A7.
Affiliations: 1IMS Health (Pygargus), SveavÃ¤gen 155, SE-113 46, Stockholm, Sweden. 2Amgen Inc., One Amgen Center Drive, MS 38-2-B, Thousand Oaks, CA 91320-1799. 3Amgen Ltd, 1 Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, England. 4Amgen Inc., One Amgen Center Drive, MS 24-2-A, Thousand Oaks, CA 93120-1799. 5Lund University, SE-221 85 Lund, Sweden. 6Karolinska Universitetssjukhuset, Solna, A2:07,171 76 Stockholm, Sweden. 7Center for Observational Research, Amgen, Inc., 1120 Veterans Boulevard, ASF3, South San Francisco, CA 94080. E-mail address: aliede@amgen.com.
Publications:
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://jbjs.org/content/97/21/1756.long
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Real World Evidence


Recurrence/progression and surgery of malignant melanoma in a retrospective Swedish cohort
Authors: Hansson J.*, Rockberg J., Taylor A., JÃ¶rgensen L., Linder R., Ragnhammar P., Amelio J
Affiliations:
Publications: European Association of Dermato Oncology (EADO) Congress
Document Types: , Abstract
Countries: , Sweden
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Real World Evidence


Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis.
Authors: Mack CD1, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, StÃ¼rmer T.
Affiliations: Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
Publications: Epidemiology. 2015 Sep;26(5):690-9.
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Oncology	2015	English	, Retrospective database analysis


Metastatic Melanoma Patient Characteristics as a Determining Factor for Braf Gene Mutation Testing and Treatment in Canada â€“ a retrospective cohort study
Authors: Djokic S1, Lapierre M2
Affiliations: 1 IMS Health, Ottawa, ON, Canada 2 IMS Health, Kirkland, QC, Canada
Publications: ISPOR 20th Annual International Meeting
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/ScientificPresentationsDatabase/Presentation/55700
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective cohort analysis


Evolution of BRAF gene mutation testing and treatment options in BRAF mutation carriers in Canada
Authors: Djokic S
Affiliations: IMS Brogan, Kanata, ON, Canada
Publications: 2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/152450-156
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Comparison of Public Reimbursement for Oncology versus Non-oncology Drugs in Canada
Authors: Bosnic N, Donepudi K, Goodfield J, Zhang Y
Affiliations: 1 IMS Brogan, Kanata, ON, Canada 2 IMS Brogan, Mississauga, ON, Canada
Publications: 2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/153179-156
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada
Authors: Marc Lapierre
Affiliations: IMS Brogan, Kirkland, QC, Canada
Publications: 2015 ASCO Annual Meeting
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/content/152361-156
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective cohort analysis


New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
Authors: Lu Y, GarcÃa RodrÃguez LA, Malgerud L, GonzÃ¡lez-PÃ©rez A, MartÃn-PÃ©rez M, Lagergren J, Bexelius TS
Affiliations: Department of Molecular Medicine and Surgery, Karolinska Institutet; 2Department of Epidemiology and Biostatistics, Imperial College London; 3Centro EspanËœ ol de InvestigacioÂ´ n FarmacoepidemioloÂ´ gica; 4Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet; 5Division of Cancer Studies, KingÂ´ s College London; 6Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Diabetes, Miscellaneous, Oncology	2015	English	, Retrospective database analysis


What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
Authors: O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB
Affiliations: Division of Public Health and Epidemiology, University of Nottingham; Department of Respiratory Medicine, Nottingham City Hospital
Publications:
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Metastatic Melanoma Patient Characteristics as a determining Factor for BRAF Gene Mutation Testing and treatment in Canada.
Authors: Djokic S, Lapierre M
Affiliations: IMS Health Canada
Publications: IPSOR 2015 Annual Meeting
Document Types: , Poster
Countries: , Canada
Abstract: https://www.ispor.org/research_pdfs/49/pdffiles/PCN137.pdf
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Comparison of patient characteristics and chromosomal abnormalities by first-line treatment in chronic lymphoid leukemia (CLL) patients in Canada.
Authors: Lapierre M
Affiliations: IMS Health Canada
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/record/112933/abstract
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Evolution of BRAF gene mutation testing and treatment options in BRAF Mutation carriers in Canada.
Authors: Djokic S
Affiliations: IMS Health Canada
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , Canada
Abstract: http://meetinglibrary.asco.org/record/114023/abstract
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Observational study, Retrospective cohort analysis


Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed?
Authors: Charnock J, Bruce A, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581
Condition	Year	Language	Analysis type
, Oncology	2015	English


Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5).
Authors: Bruce A, Anger C, Gajeperia C
Affiliations: IMS Health, London, United Kingdom
Publications: ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK).
Authors: Bruce A, Hurlock J
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Stratification of high risk HER2-/HR+ patients following AI therapy.
Authors: Mitrofan L, Gajperia C, Charnock J, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia.
Authors: Knopf KB., Divino V., McGarry L., Chen YJ., Pokras S., Munakata J., Taylor C., Ng D., Nieset C., Huang H.
Affiliations: ARIAD. IMS authors: Divino V, Munakata J
Publications: Clin Lymphoma Myeloma Leuk
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26411541
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Burden of illness


Real-World Treatment Patterns and Outcomes Among Patients with Hairy Cell Leukemia
Authors: Karve S., Divino V., Gaughan A., DeKoven M., Gao G., Lanasa MC.
Affiliations: AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M
Publications: 57th ASH Annual Meeting and Exposition
Document Types: , Poster
Countries: , USA
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84903.html
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database
Authors: Divino V., Karve S., Gaughan A., DeKoven M., Gao G., Lanasa MC.
Affiliations: AstraZeneca, MedImmune. IMS authors: Divino V, DeKoven M
Publications: 57th ASH Annual Meeting and Exposition
Document Types: , Poster
Countries: , USA
Abstract: https://ash.confex.com/ash/2015/webprogramscheduler/Paper84933.html
Condition	Year	Language	Analysis type
, Oncology	2015	English	, Retrospective database analysis


Comparative Effectiveness Research (CER) of Treatments for Advanced Melanoma in Europe Using Existing Real-World Data Sources: A Feasibility Assessment
Authors: Daumont MM, Juuti R, Hoeller C, Zagorska A, Mertano E, Korhonen P
Affiliations: Worldwide Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France
Publications: Pigment Cell & Melanoma Research (2015) 28 (6), pp. 753-826
Document Types: , Abstract
Countries: , Europe
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1111/pcmr.12419
Condition	Year	Language	Analysis type
, Comparative Effectiveness & Health Technology Assessment, Oncology	2015	English	, Literature Review, Review


Physicians influence on breast cancer patient compliance.
Authors: Kostev K1, Waehlert L2, Jockwig A2, Jockwig B2, Hadji P3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany
Publications: GMS Ger Med Sci., 2014, 12:Doc03 doi: 10.3205/000188, http://www.egms.de/static/en/journals/gms/2014-12/000188.shtml
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895867/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Compliance


Gender differences in persistency to bisphosphonates in patients with metastatic breast and prostate cancer.
Authors: Hadji P1, Kyvernitakis J1, Albert U, Jockwig J2, Kostev K3
Affiliations: 1 Phillips-University of Marburg, Marburg, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany 3 IMS Health, Frankfurt, Germany
Publications: Int J Clin Pharmacol Ther., 2014, Apr 2. [Epub ahead of print]
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gender+differences+in+persistency+to+bisphosphonates+in+patients+with+metastatic+breast+and+prostate+cancer
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Increasing burden of tyrosine kinase inhibitor (TKI) treatment failure with later lines of therapy in chronic myeloid leukemia: a real world retrospective database analysis.
Authors: Chen Y1, Huang H2, Divino V1, Pokras S1, Hallinan S1, Munakata J1, Taylor C2, McGarry L2, Malone D3
Affiliations: IMS Health, USA 2 Ariad Pharmaceuticals, Inc, Cambridge, USA 3 University of Arizona College of Pharmacy, Phoenix, USA
Publications: Academy of Managed Care Pharmacy 26th Annual Meeting & Expo, 2014, April, Tampa, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Building a real world non-small cell lung cancer cohort by linking a claims database to oncology electronic medical records.
Authors: Chen C1, Wade R2, Khan N1, Pokras S3, Semonelli C1, Zeng S1, Marcus M1
Affiliations: 1 IMS Health, Plymouth Meeting, USA 2 IMS Health, Parsippany, USA, 3 IMS Health, Alexandria, USA
Publications: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 19th Annual International Meeting, 2014, May, Montreal, Canada
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Evidence around criteria for selecting ovarian cancer patients for BRCA mutation testing - findings from the literature and guidelines review.
Authors: Garcia E1,Eccles E2,Balmana J3,Ehlken B4,Schroeder C4,Clune J5,Hirst C6,Potter D7,Tyczynski J
Affiliations: 1 Maastricht UMC,Maastricht, Netherlands 2 University of Southampton, Southampton, United Kingdom 3 Familial Cancer Program,Barcelona,Spain 4IMS Health,Munich,Germany 5 AstraZeneca,Melbourne,United Kingdom 6 Hoggmann-La Roche Ltd,Basel,Switzerland 7 AstraZeneca,Gaitherburg,USA
Publications:
Document Types: , Abstract
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Literature Review


Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review
Authors: Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6
Affiliations: 1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, MÃ¼nchen, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA
Publications: Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22â€“24 September, 2014 (Poster)
Document Types: , Abstract
Countries: , Germany, Netherlands, Spain, UK, USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Literature Review


Population-based study of giant cell tumour of the bone in Sweden
Authors: Amelio J1, Sandberg J2, Hernandez RK4, Sobocki P2,Stryker S4, Engellau J3, Bach BA4, Liede A4
Affiliations: 1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of oncology, Lund University Hospital, 221 00 - Lund/SE
Publications: ESMO 2014 CTOS 19th Annual Meeting, October 15- 18, 2014 at the InterContinental Hotel in Berlin, Germany
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Database Study


Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis.
Authors: Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7
Affiliations: 1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del RocÃo, US, CSIC), Seville, Spain.
Publications: Lung Cancer. 2014 Aug;85(2):230-8
Document Types: , Article
Countries: , China, Germany, Hong Kong, Spain, Taiwan, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Meta analysis


Association of diabetes and cancer diagnosis in primary care practices in France
Authors: Grandfils N, Ricarte C, Solomiac A
Affiliations: IMS Health, Paris La DÃ©fense, France
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Abstract, Poster
Countries: , France
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2014	English	, Retrospective database analysis


Clinical utility of the collect scale to assess comorbidities in patients with chronic lymphocytic leukemia
Authors: De La Serna J1, Carbonell F2, Giraldo P3, Lopez A4, GonzÃ¡lez I5, GarcÃa C5, Orofino J5, Roset M6, Perulero N6, Rios E
Affiliations: 1Hospital Universitario 12 de Octubre, Madrid, Spain, 2Consorci Hospital General Universitari Valencia, Valencia, Spain, 3Hospital Universitario Miguel Servet, Zaragoza, Spain, 4Hospital Universitari Valle d'Hebron, Barcelona, Spain, 5Roche Pharma, Madrid, Spain, 6IMS Health, Barcelona, Spain, 7Hospital Virgen de Valme, Sevilla, Spain
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Utility analysis


A guideline-based estimate of healthcare resource use and cost of metastatic unresectable osteosarcoma
Authors: Cornelio N, Burudpakdee C
Affiliations:
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Cost consequence


Cost-effectiveness of ipilimumab in previously untreated patients for advanced melanoma in Sweden
Authors: Barzey V1, Asukai Y1, Gueron B2, Holmberg C3, Kotapati S4
Affiliations: 1IMS Health, London, UK, 2Bristol-Myers Squibb, Rueil Malmasion, France, 3Bristol-Myers Squibb, Bromma, Sweden, 4Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Nordic, Sweden
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Cost effectiveness


Treatment patterns and costs of neoadjuvant systemic therapies (NAT) for early breast cancer (EBC): A retrospective claims analysis
Authors: Chen YJ, Santos E, Schabert V, Antao VP, De AP, Portera CC, Wang Y, Kamath T
Affiliations:
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Oncology products in the AMNOG process â€“ learnings for a successful dossier submission
Authors: Dehnen J1, Goldhagen K2
Affiliations: 1 IMS Health, Cambridge, UK 2 IMS Health, Munich, Germany
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Willingness to pay


Current guidance for BRCA mutation testing in ovarian cancer patients
Authors: Ehlken B1, Driedger J2, Hofmann-Xu L1, Paulus G2, Berger K1, de Moor C3, Schroeder C1, Clune J4, Tyczynski J5
Affiliations: 1IMS Health Germany, Munich, Germany, 2IMS Health, Munich, Germany, 3IMS Health US, Alexandria, VA, USA, 4AstraZeneca, London, UK, 5AstraZeneca, Gaithersburg, MD, USA
Publications: ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Database Study


Envisioning oncology coverage decision framework: how do current and future trends in Asia-Pacific affect the accessibility?
Authors: Leartsakulpanitch J1, Chiu C-F2, Bae SJ3, Tan SC4
Affiliations: 1 Johnson & Johnson, Bangkok, Thailand 2 China Medical University Hospital, Taipei, Taiwan 3 Ewha Womans University, Seoul, South Korea 4 IMS Asia Pacific, Singapore, Singapore
Publications: ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014
Document Types: , Symposium
Countries: , Asia Pacific
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Methodology


Understanding treatment in metastatic castrate-resistant prostate cancer: Implications of variance between UK and Asia
Authors: King C
Affiliations: IMS Health Asia-Pac & China, Singapore
Publications: AccessPoint, 2014, May; 4(8): 36-39
Document Types: , Article
Countries: , Asia Pacific, UK
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Drug utilization in oncology: Current topics and challenges
Authors: Ehlken B1, Keja J1, Kallich J2
Affiliations: 1 IMS Health, Munich, Germany 2 Big Health Data, Los Angeles, California, USA
Publications: AccessPoint, 2014, May; 4(8): 51-55
Document Types: , Article
Countries:
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Clinical practice, Oncology	2014	English	, Real World Data


Evidence-based insights in oncology: The journey is only just beginning
Authors: Ghai C
Affiliations: RWE Solutions & HEOR, IMS Health, New York, USA
Publications: AccessPoint, 2014, May; 4(8): 14-20
Document Types: , Article
Countries: , USA
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Health economics, Oncology	2014	English	, Real World Evidence


Innovation in cancer care: Implications for global healthcare systems
Authors: Johnson K
Affiliations: Global Oncology, IMS Health, Plymouth Meeting, USA
Publications: AccessPoint, 2014, May; 4(8): 8-13
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Health policy, Oncology	2014	English	, Real World Evidence


Future access to innovative oncology drugs in the EU: Evolution and proactive application of real-world evidence
Authors: McDonell A1, Opel M1, Berger K2
Affiliations: 1 IMS Health, London, UK 2 IMS Health, Munich, Germany
Publications: AccessPoint, 2014, May; 4(8): 32-35
Document Types: , Article
Countries: , Europe
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Health policy, Oncology	2014	English	, Real World Evidence


Transforming oncology outcomes research through data linkage in Sweden: A unique real-world lens on the entire patient journey
Authors: Sobocki P
Affiliations: IMS Health, Stockholm, Sweden
Publications: AccessPoint, 2014, May; 4(8): 21-25
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Methodology, Oncology	2014	English	, Real World Evidence


Research question-driven data selection: A comparison of real-world insights in non-small cell lung cancer
Authors: Chen CC, Pokras S, Wade R
Affiliations: IMS Health, Parsippany, USA
Publications: AccessPoint, 2014, May; 4(8): 40-45
Document Types: , Article
Countries:
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Methodology, Oncology	2014	English	, Real World Evidence


Payment by use: Achieving a new value paradigm for oncology
Authors: Woolmore A, Simpson D
Affiliations: RWE Solutions, IMS Health, London, UK
Publications: AccessPoint, 2014, May; 4(8): 26-31
Document Types: , Article
Countries:
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Oncology, Pricing and reimbursement	2014	English	, Real World Evidence


High-value oncology targeted therapies: Opportunities and challenges in emerging Asia Pacific markets
Authors: Afable A, Caputo J
Affiliations: IMS Health, Asia-Pac, Singapore, Singapore
Publications: AccessPoint, 2014, May; 4(8): 46-50
Document Types: , Article
Countries: , Asia Pacific
Abstract: http://issuu.com/ims_heor_publications/docs/ims_rwe_accesspoint_8_-_250514f_iss
Condition	Year	Language	Analysis type
, Oncology, Pricing and reimbursement	2014	English	, Real World Evidence


A caseâ€“control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer
Authors: Keane MG, Horsfall L, Rait G & Pereira SP
Affiliations: UCL Institute for Liver and Digestive Health
Publications: BMJ Open2014 Nov 19;4(11):e005720.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244441/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study
Authors: Selle F1, Wittnebel S2, Biron P3, Gravis G4, Roubaud G5, Bui BN5, Delva R6, Bay JO7, FlÃ©chon A3, Geoffrois L8, Caty A9, Soares DG10, de Revel T11, Fizazi K2, Gligorov J12, MiclÃ©a JM13, Dubot C10, Provent S10, Temby I10, Gaulet M14, Horn E15, Brindel I16, Lotz JP12
Affiliations: 1Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En CancÃ©rologie), HÃ´pital Tenon (HÃ´pitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne UniversitÃ©s, UniversitÃ© Pierre et Marie Curie (UPMC Univ Paris 06), Paris frederic.selle@tnn.aphp.fr. 2Department of Medicine, Institut Gustave Roussy, Villejuif. 3Department of Medical Oncology, Centre LÃ©on BÃ©rard, Lyon. 4Department of Medical Oncology, Institut Paoli Calmette, Marseille. 5Department of Medicine, Institut BergoniÃ©, Bordeaux. 6Department of Chemotherapy, Centre Paul Papin, Angers. 7Department of Medicine, Centre Hospitalier Universitaire, Clermont-Ferrand. 8Department of Medicine, Centre Alexis Vautrin, Nancy. 9Department of Medicine, Centre Oscar Lambret, Lille. 10Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En CancÃ©rologie), HÃ´pital Tenon (HÃ´pitaux Universitaires de l'Est-Parisien, AP-HP), Paris. 11Department of Hematology, HÃ´pital D'Instruction des ArmÃ©es Percy, Clamart. 12Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En CancÃ©rologie), HÃ´pital Tenon (HÃ´pitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne UniversitÃ©s, UniversitÃ© Pierre et Marie Curie (UPMC Univ Paris 06), Paris. 13Cytapheresis and Cell Therapy Unit, HÃ´pital St Louis (AP-HP), Paris. 14Statistic, 3ES-Cegedim Strategic Data, Boulogne, France. 15Department of Internal Medicine, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA. 16Department of Clinical Research, HÃ´pital St Louis (AP-HP), Paris, France
Publications: Ann Oncol. 2014 Sep;25(9):1775-82.
Document Types: , Article
Countries: , France
Abstract: http://annonc.oxfordjournals.org/content/25/9/1775.full.pdf+html
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Prospective study


Diagnosis of pernicious anemia and the risk of pancreatic cancer.
Authors: Shah P, Rhim AD, Haynes K, Hwang WT & Yang YX
Affiliations: Memorial Sloan Kettering Cancer Center Department of Medicine, Gastroenterology and Nutrition Service
Publications: Pancreas. 2014 Apr;43(3):422-6. doi: 10.1097/MPA.0000000000000054
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015141/
Condition	Year	Language	Analysis type
, Hematology, Oncology	2014	English	, Retrospective database analysis


Digoxin use and the risk for colorectal cancer.
Authors: Boursi B, Haynes K, Mamtani R & Yang YX
Affiliations: University of Pennsylvania Division of Gastroenterology
Publications: Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1147-53. doi: 10.1002/pds.3717. Epub 2014 Sep 29
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525471/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practices
Authors: Fett N, Haynes K, Propert KJ & Margolis DJ
Affiliations: Philadelphia Department of Veterans Affairs Medical Center
Publications: J Am Acad Dermatol. 2014 Apr;70(4):651-8. doi: 10.1016/j.jaad.2013.11.045. Epub 2014 Jan 28
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959616/
Condition	Year	Language	Analysis type
, Dermatology, Oncology	2014	English	, Retrospective database analysis


Real World Data in Oncology: Third- and Fourth-Line Treatments administered in Metastatic Colon-Rectal Cancer (mCRC)
Authors: Heiman F, Ripellino C ,Visentin E
Affiliations: CSD Medical Research, Milan, Italy
Publications: ISPOR 17th Annual European Congress Amsterdam, The Netherlands November, 2014
Document Types: , Poster
Countries: , Italy
Abstract: http://www.ispor.org/ScientificPresentationsDatabase/Presentation/51939
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Data


Sociodemographic Trends in the Incidence of Pancreatic and Biliary Tract Cancer in UK Primary Care.
Authors: Keane MG, Horsfall LJ Rait G2 & Pereira SP Keane MG1, Horsfall LJ2, Rait G2, Pereira SP1.
Affiliations: UCL Institute for Liver and Digestive Health 1Institute for Liver and Digestive Health, University College London, London, United Kingdom. 2Research Department of Primary Care and Population Health, University College London, London, United Kingdom.
Publications: 30;9(9):e108498 PLoS One DOI: 10.1371/journal.pone.0108498
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182488/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.
Authors: Masclee GMC, Coloma PM, de Wilde M, Kuipers EJ & Sturkenboom M
Affiliations: Erasmus University Medical Center Department of Medical Informatics
Publications: Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30. doi: 10.1111/apt.12759. Epub 2014 Apr 16
Document Types: , Article
Countries: , Netherlands, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24738722
Condition	Year	Language	Analysis type
, Gastrointestinal disorders, Oncology	2014	English	, Retrospective database analysis


Validation of a coding algorithm to identify bladder cancer and distinguish stage in an electronic medical records database.
Authors: Mamtani R, Haynes K, Boursi B, Scott F, Goldberg DS, Keefe SM, Vaughn DJ, Malkowicz SB & Lewis JD
Affiliations: University of Pennsylvania Abramson Cancer Center
Publications: Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):303-7. doi: 10.1158/1055-9965.EPI-14-0677. Epub 2014 Nov 11
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294969/
Condition	Year	Language	Analysis type
, Database Validity and methodology, Oncology	2014	English	, Retrospective database analysis


Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal).
Authors: Collins GS & Altman DG
Affiliations: Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
Publications: Br J Cancer. 2012 Jul 10 Br J Cancer. 2012 Jul 10; 107(2): 260â€“265.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394989/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


HERPES ZOSTER-RELATED HEALTHCARE RESOURCE USE IN CANCER PATIENTS IN FIVE EUROPEAN COUNTRIES
Authors: Berhanu Gebremeskel, MD, MPH, MSCE(c.)1a, Lorena Lopez-Gonzalez, PhD2 ,Pallavi Patwardhan, PhD, BSPharm1b, Jiyoung Chin, PhD3,Marie-Sophie Schwalm, MS4, Camilo Acosta, MD, PhD1a, Jay Margolis, PharmD5
Affiliations: 1Merck & Co. Inc., (aWest Point, PA, bCokesbury, NJ) Whitehouse Station, NJ, USA;2Truven Health Analytics, Austen, TX, USA; 3Cegedim Strategic Data, Jersey City, NJ, USA; 4Cegedim Strategic Data, Paris, France; 5Truven Health Analytics, Bethesda, MD, USA
Publications: ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Europe
Abstract: http://www.ispor.org/event/ProgramList/2014Amsterdam?type=Poster&sess=V&acode=PIN
Condition	Year	Language	Analysis type
, Infectious disease, Oncology	2014	English	, Retrospective database analysis


Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas.
Authors: Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ & Lewis JD
Affiliations: University of Pennsylvania Abramson Cancer Center
Publications: Diabetes Care. 2014 Jul;37(7):1910-7. doi: 10.2337/dc13-1489. Epub 2014 Feb 4
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24496803
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2014	English	, Retrospective database analysis


Demographic and Comorbidity Characteristics of Newly Diagnosed Multiple Myeloma Patients in the United States: A Real World Data Analysis
Authors: Chen Y, De A, Cong Z, Aggarwal S, Wade R
Affiliations: Onyx Pharmaceuticals, Inc
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Characterization of HER2 Testing and Treatment Patterns among Gastric Cancer Patients in the United States using the Oncology Services Comprehensive Electronic Records (OSCER) Database
Authors: Lowe K1, Reich A2, Bobiak S2, Chau D1, Quigley J2, Kelsh M1
Affiliations: 1 Amgen, Inc. 2 IMS Health
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Review


Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding
Authors: Dood RL, Gracia CR, Sammel MD, Haynes K, Senapati S, Strom BL
Affiliations: University of Pennsylvania Center for Clinical Epidemiology and Biostatistics
Publications: J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):744-52. doi: 10.1016/j.jmig.2014.02.012. Epub 2014 Feb 28
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470903/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Risk factors for the development of oesophageal adenocarcinoma in Barrettâ€™s oesophagus: a UK primary care retrospective nested caseâ€“control study
Authors: Cooper S, Menon S, Nightingale P & Trudgill N
Affiliations: Sandwell and West Birmingham Hospitals NHS Trust Department of Gastroenterology
Publications: United European Gastroenterol J. 2014 Apr; 2(2): 91â€“98
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040819/
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Validation of Bone Metastases Coding in an Oncology Electronic Medical Records Database and a Commercial Claims Database
Authors: Hernandez, R1, Quach, D2, Wade, S3, Pirolli, M2, Reich, A2, Quigley, J2, Liede, A1
Affiliations: 1. Center for Observational Research, Amgen Inc., CA 2. IMS Health, Plymouth Meeting, PA 3. Wade Outcomes Research and Consulting, Salt Lake City, UT
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Prevalence of Renal Impairment (RI) and Use of Nephrotoxic Agents Among Patients with Bone Metastases From Solid Tumors in the United States
Authors: Pirolli, M, Quach, D, Quigley, J
Affiliations:
Publications: Cancer Medicine
Document Types: , Manuscript in preparation
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study)
Authors: L. Benjamin 1, R. Maroun 1, F. Maurel 2, I. Bardoulat 2, C. Ricarte 2
Affiliations: 1. GlaxoSmithKline, Health Economics and Outcomes Research, Marly-le-Roi, France; 2. IMS Health, La DÃ©fense, France
Publications: Current Medical Research & Opinion 2014
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Market impact, Retrospective database analysis


Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States.
Authors: Hernandez RK1, Quach D, Wade SW, Pirolli M, Quigley J, Narod SA, Liede A.
Affiliations: 1Center for Observational Research, Amgen Inc, IMS Health Plymouth,
Publications: Breast Cancer Res Treat. 2014 Aug;146(3):637-46
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Survival and clinical metastases among prostate cancer patients treated with androgen deprivation therapy in Sweden
Authors: Banefelt J1, Liede A2, Mesterton J3, StÃ¥lhammar J4, Hernandez RK5, Sobocki P6, Persson BE7.
Affiliations: 1Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden. 2Amgen Inc., Center for Observational Research, South San Francisco, CA, United States. 3Quantify Research, Hantverkargatan 8, 112 21 Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institute, 171 77 Stockholm, Sweden. 4Department of Public Health and Caring Sciences, Uppsala University, 751 22 Uppsala, Sweden. 5Amgen Inc., Center for Observational Research, One Amgen Center Drive 24-2-A, Thousand Oaks, CA 91320, United States. 6IMS Health/Pygargus, SveavÃ¤gen 155, 113 46 Stockholm, Sweden; LIME/Medical Management Centre, Karolinska Institute, 171 77 Stockholm, Sweden. 7Uppsala University, 751 05 Uppsala, Sweden. Electronic address: Bo-Eric.Persson@ferring.com.
Publications: Cancer Epidemiol
Document Types: , Article
Countries: , Nordic, Sweden
Abstract: http://www.cancerepidemiology.net/article/S1877-7821(14)00089-7/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Population-based study of giant cell tumour of the bone in Sweden.
Authors: Amelio J.1, Sandberg J.2, Hernandez R.H.3, Sobocki P.4, Stryker S.5, Engellau J.6, Bach B.A.3, Liede A.5
Affiliations: 1Amgen Ltd. Uxbridge, UK 2Pygargus/IMS Health, Stockholm, Sweden 3Amgen Inc. Thousand Oaks, CA, USA 4Pygargus/IMS Health, Stockholm, Sweden; Karolinska Institutet, Stockholm, Sweden 5Amgen Inc. South San Francisco, CA, USA. 6Lund University, Lund, Sweden.
Publications: The Connective Tissue Oncology Society (CTOS) Annual Meeting 2014 October 15â€“18, Berlin Germany
Document Types: , Oral presentation
Countries: , Sweden
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Population-based study of giant cell tumour of the bone in Sweden
Authors: J. Amelio1, J. Sandberg2, R.K. Hernandez3, P. Sobocki2, S. Stryker3, J. Engellau4, B. Bach3, A. Liede3
Affiliations: 1Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Inc., Thousand Oaks/US 4Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE
Publications: European Society for Medical Oncology Meeting 2014, 29 Sept 2014, Madrid Spain
Document Types: , Abstract
Countries: , Sweden
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Population-based-study-of-giant-cell-tumour-of-the-bone-in-Sweden
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Trends in giant cell tumour of the bone and osteosarcoma incidence in the Sweden (1958-2011.
Authors: A. Liede1, J. Sandberg2, J. Amelio3, R.K. Hernandez4, P. Sobocki2, H.C..F. Bauer5, B. Bach6, J. Engellau7
Affiliations: 1Center For Observational Research, Amgen Inc., 94080 - South San Francisco/US 2., IMS Health, 113 46 - Stockholm/SE 3Center For Oberservational Research, Amgen Ltd., UB8 1DH - Uxbridge/UK 4Center For Observational Research, Amgen Inc., 91320 - Thousand Oaks/US 5Molecular Medicine And Surgery, Karolinska Institute, Stockholm/SE 6Clinical Development, Amgen Inc., Thousand Oaks/US 7Department Of Oncology, Lund University Hospital, 221 00 - Lund/SE
Publications: European Society for Medical Oncology (ESMO) Meeting 2014, Madrid Spain, 29 September
Document Types: , Abstract
Countries: , Nordic, Sweden
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Sarcoma/Trends-in-Giant-Cell-Tumour-of-the-Bone-and-Osteosarcoma-Incidence-in-the-Sweden-1958-2011
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Real World Evidence


Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study
Authors: Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, SuZ, Mun Y, Sloan JA, Kaufman PA
Affiliations:
Publications: Breast 2014; Sep 2. pii: S0960-9776(14)00140-4. doi: 10.1016/j.breast.2014.08.004
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2014	English	, RWLPR (Real-World Late Phase Research-quintiles


Description of GCSF usage in oncology in 5 European countries.
Authors: Anger C1, Schmidt N2, Ricarte C3
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://meetinglibrary.asco.org/record/97923/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Observational study


Association of diabetes and cancer diagnoses in primary care practices in Germany.
Authors: Schmidt N, Kostev K, Ziller V, Kowall B, Rathmann W
Affiliations: 1 IMS Health GmBH & Co. OHG, Frankfurt/Main, 2 Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Poster
Countries: , Germany
Abstract: http://meetinglibrary.asco.org/record/96337/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English


Importance of durational hormone therapy in breast cancer patients in Germany: Retrospective database analysis.
Authors: Schmidt N, Haas G, Kostev K, Peyman H
Affiliations: 1IMS Health GmBH & Co. OHG, Frankfurt/Main, 2Department of Gynecology Endocrinology and Oncology, Phillips University of Marburg, Germany, 3 Institute of Biometrics and Epidemiology, German Diabetic Center, Duesseldorf, Germany
Publications: ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Poster
Countries: , Germany
Abstract: http://meetinglibrary.asco.org/record/96376/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries.
Authors: Schmidt N, Ricarte C, Haas G
Affiliations: 1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Analysis of treatment patterns of patients with Advanced Gastrointestinal Stromal Tumors (GIST) in EU5.
Authors: Jehle K, Rabiller M, Grippon S, Haas G, Ngai C, Mohamed A, Chang J
Affiliations: 1 IMS Health Global Oncology, Plymouth Meeting, PA, USA, and Frankfurt, Germany; 2 IMS Health CE Consulting, Frankfurt, Germany; 3 Bayer Healthcare Pharmaceuticals, Whippany NJ, USA
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries:
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv499/2242114/1427PANALYSIS-OF-TREATMENT-PATTERNS-OF-PATIENTS
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US.
Authors: Charnock J, Bruce A, Murch L, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK.
Authors: Khanna R, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Association of diabetes and cancer diagnosis in primary care practices in France.
Authors: Grandfils N, Ricarte C, Solomiac A
Affiliations: 1IMS Health, La Defense, France
Publications: ISPOR 2014 Annual Meeting
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


Population-based study of Giant Cell Tumor of the bone in Sweden
Authors: Amelio J, Sandberg J, Hernandez R, Sobocki P, Stryker S, Engellau J, Bach B, Liede A
Affiliations: Center for Oberservational Research, Amgen Ltd., Uxbridge, UK\|IMS Health, Stockholm Sweden
Publications: Annals of Oncology (2014) 25(suppl 4):iv509-iv510
Document Types: , Poster
Countries: , Nordic, Sweden
Abstract: https://academic.oup.com/annonc/article/25/suppl_4/iv509/2242151
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Epidemiological study, Population Based Study, Retrospective database analysis


Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries
Authors: Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5
Affiliations:
Publications: VALUE IN HEALTH 17 ; A684
Document Types: , Abstract
Countries: , Belgium, France, Germany, Italy, Spain
Condition	Year	Language	Analysis type
, Health economics, Immunology and Vaccination, Oncology	2014	English	, Cost of illness, Retrospective database analysis


Economic burden of tyrosine kinase inhibitor (TKI) treatment failure in patients with chronic myeloid leukemia (CML).
Authors: Yaozhu J Chen, Hui Huang, Victoria Divino, Shibani Pokras, Shawn Hallinan, Julie Munakata, Catherine Taylor, Lisa McGarry, Daniel Ng, Christopher Nieset, Kevin B. Knopf
Affiliations: ARIAD; IMS authors: Victoria Divino, Julie Munakata
Publications: 2014 ASCO Annual Meeting
Document Types: , Poster
Countries: , USA
Abstract: http://meetinglibrary.asco.org/record/92488/abstract
Condition	Year	Language	Analysis type
, Oncology	2014	English	, Retrospective database analysis


The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium.
Authors: Body JJ1, Chevalier P2, Gunther O3, Hechmati G4, Lamotte M2
Affiliations: 1 CHU Brugmann, UniversitÃ© Libre de Bruxelles, Brussels, Belgium 2 IMS Health, Vilvoorde, Belgium 3 Centre for Observational Research, Amgen Ltd, Uxbridge, UK 4 Health Economics, Amgen (Europe) GmbH, Zug, Switzerland
Publications: J Med Econ., 2013, 16(4): 539-46
Document Types: , Article, Manuscript in preparation
Countries: , Belgium
Condition	Year	Language	Analysis type
, Musculoskeletal disease, Oncology	2013	English	, Burden of illness


Comparative Analysis of Radium-223 Dichloride in Symptomatic Metastatic Castration Resistant Prostate Cancer versus Best Supportive Care on Skeletal-Related Events Outcomes
Authors: Seal B1, Pawar V1, Valderrama A1, Grabbi E2, Lloyd A2, Beaudet A3
Affiliations: 1Bayer Healthcare Pharmaceuticals, Montville, NJ, USA, 2IMS Health, London, United Kingdom, 3IMS Health, Basel, Switzerland
Publications: ISPOR US 2013
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost analysis, Quality of life


Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
Authors: Hess G1, Barlev A2, Chung K2, Hill JW1, Fonseca E1
Affiliations: 1 IMS Health, Plymouth Meeting, USA 2 Amgen Inc, Thousand Oaks, USA
Publications: Radiation Oncology. 2012, 7:168. Impact Factor: 2.3. Published October 12, 2012
Document Types: , Article
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561237/
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost analysis


The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care â€” an observational analysis on non-small-cell lung cancer patients.
Authors: Ihbe-Heffinger A13, Paessens B1, Berger K24, Shlaen M2, Bernard R1, von Schilling C56, Peschel C5
Affiliations: 1 Hospital Pharmacy Department Klinikum rechts der Isar Technische UniversitÃ¤t Munich, Germany 2 IMS Health, Munich, Germany 3 Department of Gynaecology Klinikum rechts der Isar Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Department of Transfusion Medicine and Haemostaseology, Klinikum der UniversitÃ¤t MÃ¼nchen, Munich, Germany 5 Third Medical Department, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 6 Department of Internal Medicine III Klinikum Freising, Freising, Germany
Publications: Support Care Cancer, 2013, 21: 1665â€“1675
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost consequence, Observational study


COST/BENEFIT ANALYSIS OF FIRST LINE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENTS IN MEXICO
Authors: Munakata J1, Leyva V1, Wehler E1, Bertwistle D1, Valencia A2, HernÃ¡ndez A2, Torre L2, Gonzalez-Michaca L2
Affiliations: 1IMS Health, 2Janssen de Mexico
Publications: ISPOR 4th Latin America Conference, 2013
Document Types: , Poster
Countries: , Mexico
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost analysis, Cost benefit


Burden of actinic keratosis in germany-results of a literature research
Authors: Pfiffner C1, Macheleidt O2, Batscheider A1, Ehlken B1, Greiner RA1, Schroeder C1, Hutt HJ2
Affiliations: 1 IMS Health, Munich, Germany 2 LEO Pharma GmbH, Neu Isenburg, Germany
Publications: ISPOR 16th annual european congress, 2013, November 2-6, Dublin, Ireland
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Dermatology, Oncology	2013	English	, Burden of illness


Oncology real-world data in Europe
Authors: Noibi S1, Bertwistle D1, Berger K2
Affiliations: 1IMS Health, London, UK, 2IMS Health, Munich, Germany
Publications: AccessPoint, May 2013; Vol 3(6); 24-29
Document Types: , Article
Countries:
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Real World Data


Identification and qualitative assessment of real world data sources: example of lymphoma and multiple myeloma in Europe
Authors: Noibi S1, Bertwistle D1, MacDougall F1, Berger K2, Mehta J3, Trask P3
Affiliations: 1IMS Health, London, UK, 2IMS Health, Munich, Germany, 3Sanofi, Cambridge, MA, USA
Publications: ISPOR 16th Annual European Congress, 2013. PRM48.
Document Types: , Abstract, Poster
Countries: , Europe
Abstract: http://www.ispor.org/Events/Posters.aspx?eventId=42&sess=V
Condition	Year	Language	Analysis type
, Hematology, Oncology	2013	English	, Real World Data


Cost-effectiveness of bendamustine versus fludarabine for first-line treatment of chronic lymphocytic leukemia (cll) in Colombia
Authors: Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Ariza JG5, Zambrano C5, Gonzalez L6
Affiliations: 1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen Cilag, BogotÃ¡, Colombia, 6Janssen, Raritan, NJ, USA
Publications: ISPOR 16th Annual European Congress, 2013. PCN119.
Document Types: , Abstract, Poster
Countries: , Colombia
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost effectiveness


The cost-effectiveness of bendamustine versus fludarabine for the first-line treatment of chronic lymphocytic leukemia (cll) in Mexico.
Authors: Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Valencia A5, Hernandez A5, de la Torre L5, Gonzalez L6
Affiliations: 1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen, Mexico City, Mexico, 6Janssen, Raritan, NJ, USA
Publications: ISPOR 16th Annual European Congress, 2013. PCN99.
Document Types: , Abstract, Poster
Countries: , Mexico
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost effectiveness


TREATMENTS FOR EGFR MUTATION POSITIVE NSCLC â€“ A NETWORK META-ANALYSIS
Authors: Fonseca T1;Lungershausen J2;Wallenstein G3;Stammberger U3;Bertwistle D1, Griebsch I2
Affiliations: 1IMS Health, London, United Kingdom, 2Boehringer Ingelheim Pharma GmbH, Ingelheim am Rhein, Germany, 3Boehringer Ingelheim Pharma GmbH & Co.KG, Ingelheim, Germany
Publications: ISPOR 16th Annual European Congress, 2013. PCN24.
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Meta analysis


Validating an indolent non-hodgkin's lymphoma (nhl) cost-effectiveness analysis model using two software tools: key implementation considerations and results
Authors: Wehler EA1;Bilir SP2;Bertwistle D3;Leyva V4, Munakata J2
Affiliations: 1IMS Health, Alexandria, VA, USA, 2IMS Health, San Francisco, CA, USA, 3IMS Health, London, United Kingdom, 4IMS Health, Mexico City, Mexico
Publications: ISPOR 16th Annual European Congress, 2013. PRM82
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost effectiveness


The cost-effectiveness of bendamustine-rituximab versus fludarabine-rituximab for patients with indolent non-hodgkin's lymphoma (inhl) who have progressed following treatment with rituximab or a rituximab-containing regimen in Mexico
Authors: Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Valencia A5, Hernandez A5, de la Torre L5, Gonzalez L6
Affiliations: 1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen, Mexico City, Mexico, 6Janssen, Raritan, NJ, USA
Publications: ISPOR 16th Annual European Congress, 2013. PCN110.
Document Types: , Abstract, Poster
Countries: , Mexico
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost effectiveness


The cost-effectiveness of bendamustine-rituximab versus fludarabine-rituximab for patients with indolent non-hodgkin's lymphoma (inhl) who have progressed following treatment with rituximab or a rituximab-containing regimen in Colombia
Authors: Bertwistle D1, Munakata J2, Wehler E3, Leyva V4, Ariza JG5, Zambrano C5, Gonzalez L6
Affiliations: 1IMS Health, London, United Kingdom, 2IMS Health, San Francisco, CA, USA, 3IMS Health, Alexandria, VA, USA, 4IMS Health, Mexico City, Mexico, 5Janssen Cilag, BogotÃ¡, Colombia, 6Janssen, Raritan, NJ, USA
Publications: ISPOR 16th Annual European Congress, 2013. PCN94.
Document Types: , Abstract, Poster
Countries: , Colombia
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Cost effectiveness


Synchronization of administrations of chemotherapy and erythropoiesis-stimulating agents and frequency of associated healthcare visits
Authors: Hill J1, Shreay S2, McGarvey N3, Hess GP4, Corey-Lisle P2
Affiliations: 1 IMS Health, PA, USA 2 Amgen Inc., CA, USA 3 University of California, CA, USA 4 Leonard Davis Institute UPenn, PA, USA
Publications:
Document Types: , Article
Countries: , USA
Abstract: http://link.springer.com/article/10.1007/s00520-013-1830-7
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective cohort analysis


Current situation of oral anticancer treatments use in france: the actor study (analysis of cancer treatments given orally)
Authors: Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2
Affiliations: 1. GlaxoSmithKline, Marly-leRoi, France; 2. IMS Health, La DÃ©fense, France
Publications: ISPOR 16th anual European congress - 2013 Value Health November 2013 Volume 16, Issue 7, Page A425
Document Types: , Abstract, Poster
Countries: , France
Abstract: www.ispor.org/Events/Posters.asp
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Real World Data, Retrospective database analysis


Management costs of the first five years after diagnosis in breast cancer by stage in France made with the french National Cancer Institute
Authors: Atsou K1, Bardoulat I2, Colin X1, Lemasson H1, Ricarte C1, Maurel F1, Ajjouri R2, LanÃ§on F2
Affiliations: 1.IMS Health, La DÃ©fense, France; 2. Institut national du Cancer, Boulogne-Billancourt, France
Publications: ISPOR 16th annual congress Value Health November 2013 Volume 16, Issue 7, Page A403
Document Types: , Abstract, Poster
Countries: , France
Abstract: www.ispor.org/Events/Posters.asp
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Economic evaluation, Retrospective database analysis


Evolution of oral anticancer treatments use in France from 2004-2012 : RE-ACTOR study (retrospective analysis of cancer treatments given orally)
Authors: Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2
Affiliations: 1. GlaxoSmithKline, Marly-le-Roi, France; 2. IMS Health, La DÃ©fense, France
Publications: Ispor 16th annual European congress - Nov2013 Value Health November 2013 Volume 16, Issue 7, Page A425
Document Types: , Abstract, Poster
Countries: , France
Abstract: www.ispor.org/Events/Posters.asp
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis.
Authors: Hadji P1, Ziller V1, Kyvernitakis J1, Bauer M1, Haas G2, Schmidt N2, Kostev K2
Affiliations: 1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany
Publications: Breast Cancer Res Treat., 2013, Feb;138(1):185-91
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23334803
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Persistence with bisphosphonates in patients with metastatic breast cancer: A retrospective database analysis.
Authors: Hadji P1, Ziller V1, Kyvernitakis J1, Schmidt N2, Kostev K2
Affiliations: 1 Philipps - University of Marburg, Marburg, Germany 2 IMS Health, Frankfurt, Germany
Publications: J Cancer Res Clin Oncol., 2013, Jul;139(7):1149-55
Document Types: , Article
Countries: , Germany
Abstract: http://link.springer.com/article/10.1007%2Fs00432-013-1427-z
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Adherence in tamoxifen therapy after conversion to a rebate pharmaceutical in breast cancer patients in Germany.
Authors: Kostev K1, May U2, Hog D2, Eisel J2, Kremmers T2, Kosteic M2, Waehlert L2, Hadji P3
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Hochschule Fresenius, Idstein, Germany 3 Phillips-University of Marburg, Marburg, Germany
Publications: Int J Clin Pharmacol Ther., 2013, Dec;51(12):969-75
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Adherence+in+tamoxifen+therapy+after+conversion+to+a+rebate+pharmaceutical+in+breast+cancer+patients+in+Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


(Analysis of the influence of the physician on the compliance of breast cancer patients) Analyse des Einflusses des Arztes auf die Compliance von Brustkrebs-Patientinnen.
Authors: Kostev K1, Oschmann L2, Schneider DM2, GrÃ¶ger S2, Karsten T2, Waehlert L2
Affiliations: 1 IMS Health, Frankfurt, Germany 2 Fresenius University of Applied Sciences, Idstein, Germany
Publications: Monitor Versorgungsforschung, 2013, Mar. (01): 29-34.
Document Types: , Article
Countries: , Germany
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/Analyse_Einfluss_Arzt_auf_Compliance_Brustkrebs-Patientinnen
Condition	Year	Language	Analysis type
, Oncology	2013	German	, Compliance


(Significantly shortened survival time of patients with prostate cancer in the occurrence of bone metastases) Deutlich verkÃ¼rzte Ãœberlebenszeit von Patienten mit Prostatakarzinom beim Auftreten von Knochenmetastasen.
Authors: Haas G1, Kostev K1
Affiliations: 1 IMS Health, Frankfurt, Germany
Publications: Monitor Versorgungsforschung, 2013, May. (04): 27-31
Document Types: , Article
Countries: , Germany
Abstract: http://www.monitor-versorgungsforschung.de/kurzfassungen/kurzfassungen-2013/copy_of_Arzneimittelentwicklung-in-der-Onkologie
Condition	Year	Language	Analysis type
, Oncology	2013	German	, Burden of illness, Quality of life


Prevalence of renal impairment among cancer patients with bone metastases in the United States.
Authors: Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2
Affiliations: 1 Univ of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc, Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA
Publications: American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM).
Authors: Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3
Affiliations: 1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA
Publications: 2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508)
Document Types: , Abstract
Countries: , USA
Abstract: http://meetinglibrary.asco.org/content/112069-132
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Prevalence of hypercalcemia of malignancy in the United States.
Authors: Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1
Affiliations: 1 Amgen, USA 2 IMS, Plymouth Meeting, USA
Publications: Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy.
Authors: Colombo R1, Pellucchi F1, Rocchini L1, Maccagnano C1, Katz P2, Pegoraro V2
Affiliations: 1 Department of Urology, University Vita-Salute, San Raffaele Hospital, Milan, Italy 2 CSD Medical Research S.r.l. Milan, Italy
Publications: farmeconomia Vol 14, No 1 (2013) > Colombo
Document Types: , Article
Countries: , Italy
Abstract: http://journals.edizioniseed.it/index.php/FE/article/view/635
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Economic evaluation


Identifying patients with undetected gastro-oesophageal cancer in primary care: External validation of QCancerÂ® (Gastro-Oesophageal).
Authors: Collin GS, Altman DG
Affiliations:
Publications: Eur J Cancer. 2013 Mar;49(5):1040-8. doi: 10.1016/j.ejca.2012.10.023. Epub 2012 Nov 15.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23159533
Condition	Year	Language	Analysis type
, Oncology	2013	English


Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(Â®) (Pancreas).
Authors: Collins GS & Altman DG
Affiliations:
Publications: Br J Gen Pract. 2013 Sep;63(614):e636-42. doi: 10.3399/bjgp13X671623
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23998844
Condition	Year	Language	Analysis type
, Oncology	2013	English


Identifying patients with undetected renal tract cancer in primary care: an independent and external validation of QCancerÂ® (Renal) prediction model.
Authors: Collins GS & Altman DG
Affiliations: University of Oxford Centre for Statistics in Medicine
Publications: Cancer Epidemiol. 2013 Apr;37(2):115-20. doi: 10.1016/j.canep.2012.11.005. Epub 2012 Dec 29
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23280341
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Identifying women with undetected ovarian cancer: independent and external validation of QCancer(Â®) (Ovarian) prediction model.
Authors: Collins GS & Altman DG
Affiliations:
Publications: Eur J Cancer Care (Engl). 2013 Jul;22(4):423-9. doi: 10.1111/ecc.12015. Epub 2012 Nov 1
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23121234
Condition	Year	Language	Analysis type
, Oncology	2013	English


Regional variations of basal cell carcinoma incidence in the U.K. using The Health Improvement Network database (2004-10).
Authors: Musah A, Gibson JE, Leonardi-Bee J, Cave MR, Ander EL & Bath-Hextall F.
Affiliations: University of Nottingham Division of Epidemiology and Public Health
Publications: Br J Dermatol. 2013 Nov;169(5):1093-9. doi: 10.1111/bjd.12446.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701520
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Epidemiological study, Retrospective database analysis


The association between smoking quantity and lung cancer in men and women.
Authors: Powell HA, Iyen-Omofoman B, Hubbard RB, Baldwin DR & Tata LJ.
Affiliations: University of Nottingham Nottingham Respiratory Research Unit
Publications: Chest. 2013 Jan;143(1):123-9.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22797799
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study.
Authors: Hwang A, Narayan V & Yang YX
Affiliations: University of Pennsylvania Department of Gastroenterology
Publications: Cancer. 2013 Jan 15;119(2):404-10. doi: 10.1002/cncr.27731. Epub 2012 Aug 1.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23292900
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2013	English	, Retrospective database analysis


Utility and Willingness to Pay for Lung Cancer Treatments: Patient Versus General Population Values in Thailand.
Authors: Thongprasert S, Permsuwan U, Sakulbumrungsil R, Chaiyakunapruk N, Crawford B, Petcharapiruch S1, Leartsakulpanitch J.
Affiliations: 1Outcomes Resarch, Medical Department, Pfizer (Thailand) Limited, Thailand
Publications: HTAi (June 17 â€“ 19, 2013, Seoul Korea).
Document Types: , Poster
Countries: , Thailand
Abstract: http://www.novelhealthstrategies.com/KoreaHTAiSchedule.pdf
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Economic evaluation


Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates
Authors: Quach D1, Liede A2, Byekwaso S1, Eremina D1, Kossar B1, Zhou L1, Quigley J1, Kallich J2, Adams J3, Smith P1
Affiliations: 1 Oncology Marketing Analytics and Services, IMS Health, Plymouth Meeting, PA, United States 2 Center for Observational Research, Amgen Inc., Thousand Oaks, CA, United States 3 Kaiser Permanente, Pasadena, CA, United States
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Review


Prevalence of Hypercalcemia of Malignancy in the United States
Authors: Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1
Affiliations: 1 Amgen Inc., Thousand Oaks, CA 2 IMS Health, Plymouth Meeting, PA
Publications:
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Real World Data


Patterns of Treatment (tx) with Bone-Modifying Agents (BMA) in Patients with Bone Metastases (mets)
Authors: Quigley J1, Hernandez R2, Cetin K2, Pirolli M1, Quach D1, Liede A3
Affiliations: 1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA
Publications: 2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e20690)
Document Types: , Abstract
Countries: , USA
Abstract: http://meetinglibrary.asco.org/content/115636-132
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Prevalence of Renal Insufficiency (RI) in Cancer (Ca) Patients (pts) with Bone Metastases (BM)
Authors: Chen K1, Hernandez R1, Quigley J2, Pirolli M2, Quach D2, Liede A3, Arellano J3
Affiliations: 1 Amgen Inc., Thousand Oaks, USA 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., South San Francisco, USA
Publications: 2013 ASCO Annual Meeting; Citation: J Clin Oncol 31, 2013 (suppl; abstr e12508)
Document Types: , Abstract
Countries: , USA
Abstract: http://meetinglibrary.asco.org/content/112069-132
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Estimating Prevalence of Stage II-III Breast Cancer in the United States by Treatment and Biologic Subtypes Using Oncology Clinic Data
Authors: Quigley J1, Hernandez R2, Pirolli M1, Quach D1, Liede A3
Affiliations: 1 IMS Health, Plymouth Meeting, USA 2 Amgen, Inc., Thousand Oaks, USA 3 Amgen, Inc., South San Francisco, USA
Publications: San Antonio Breast Cancer Symposium, 2013, December 10-14, San Antonio, USA
Document Types: , Abstract
Countries: , USA
Abstract: http://sabcs.org/
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Prevalence of Renal Impairment among Cancer Patients with Bone Metastases in the United States
Authors: Shahinian V1, Chen K2, Hernandez R2, Quigley J3, Pirolli M3, Quach D3, Liede A2, Arellano J2
Affiliations: 1 University of Michigan Medical School, Ann Arbor, USA 2 Amgen, Inc., Thousand Oaks, USA 3 IMS Health, Plymouth Meeting, USA
Publications: American Society of Nephrology Kidney Week, 2013, November 5-10, Atlanta, USA (abstr TH-PO295, 171-A)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Prevalence of Hypercalcemia of Malignancy in the United States
Authors: Gastanaga V1, Jain R1, Pirolli M2, Quach D2, Quigley J2, Stryker S1, Liede A1
Affiliations: 1 Amgen, USA 2 IMS, Plymouth Meeting, USA
Publications: Thirty-Fifth Annual Meeting of the American Society for Bone and Mineral Research, 2013, October 4-7, Baltimore, USA (abstr MO0172, S384)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Patterns of Treatment with Bone-Modifying Agents in Patients with Bone Metastases in the US
Authors: Quigley, J., Hernandez, R., Cetin, K., Pirolli, M., Quach, D., Arellano, J., Liede, A.
Affiliations:
Publications: MASCC/ISOO International Symposium on Supportive Care in Cancer, 2013, June 27-29, Berlin, Germany
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Projection Methods Using Oncology Electronic Health Records to Produce Nationally Representative Estimates
Authors: Quach, D., Liede, A., Byekwaso, S., Eremina, D., Kossar, B., Zhou, L., Quigley, J., Kallich, J., Adams, J., Smith, P.
Affiliations:
Publications: International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2013.
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Charateristics of Patients Included in the Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform
Authors: Hess, G1, Fonseca, E2, Lee, A3, Wang, H3, Dhawan, R3, Thompson, S4, Iqbal, S3, Redmond, S2
Affiliations: 1 Symphony Health Solutions, Horsham, PA 2 IMS Health, Plymouth Meeting, PA 3 Sanofi, Cambridge, MA 4 Sanofi, Bridgewater, NJ
Publications:
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Metformin and survival in pancreatic cancer: a retrospective cohort study
Authors: Hwang AL, Haynes K, Hwang WT, Yang YX
Affiliations:
Publications: Pancreas. 2013 Oct;42(7):1054-9. doi: 10.1097/MPA.0b013e3182965a3c.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779343/
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2013	English	, Retrospective database analysis


Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US.
Authors: Hernandez RK1, Quigley J, Pirolli M, Quach D, Chen KS, Arellano J, Liede A.
Affiliations: 1Center for Observational Research, Amgen, IMS Health, One IMS Drive, Global Health Economics, Amgen Inc
Publications: Support Care Cancer. 2014 Oct;22(10):2697-705
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2013	English


Dietary intake of vitamin d and calcium and breast cancer risk in the European prospective investigation into cancer and nutrition
Authors: Abbas S, Linseisen J, Rohrmann S, Chang-Claude J, Peeters PH, Engel P et al
Affiliations:
Publications: Nutr Cancer 2013; 65(2):178-87
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2013	English	, RWLPR (Real-World Late Phase Research-quintiles


Impact of oncology-related direct-to-consumer advertising
Authors: Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC
Affiliations: 1Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. gregory_abel@dfci.harvard.edu
Publications: Cancer 2013;119(5):1065-1072.
Document Types: , Article
Countries:
Abstract: http://onlinelibrary.wiley.com/doi/10.1002/cncr.27814/abstract;jsessionid=875CDEEE301260EAFDFA48F72D2B313F.f01t02
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Real World Evidence


Management costs of the first five years after diagosis in Breast Cancer by Stage in France.
Authors: Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F
Affiliations: 1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective cohort analysis


Evaluation of treatment persistence with Tamoxifene or aromatase inhibitors in breast cancer patients in Germany.
Authors: Schmidt N, Haas G, Mergenthaler U, Kostev K, Hadji P
Affiliations: 1 IMS Health, CES Oncology, Frankfurt, Germany, 2 IMS Health, CES Epidemiology, Frankfurt, Germany, 3 Department of Gynecology, Endocrinology and Oncology, Phillips-University of Marburg, Germany
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2013	English


Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition	Year	Language	Analysis type
, Oncology	2013	English


Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology).
Authors: Ricarte C, Bruce A, Anger C
Affiliations: 1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom
Publications: ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf
Condition	Year	Language	Analysis type
, Oncology	2013	English	, Retrospective database analysis


Cost effectiveness analysis of bendamustine as first line treatment for chronic lymphocytic leukaemia in the Netherlands.
Authors: Vandekerckhove S1, Holtzer-Goor K2, Van Den Steen D1, van Megen Y3, Huijgens P4, Lamotte M1, Uyl- de Groot C5
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 iMTA, Rotterdam, Zuid Holland, Netherlands 3 Mundipharma Pharmaceuticals, Hoevelaken, Netherlands 4 VU University Medical Center, Amsterdam, Netherlands 5 Erasmus University, Rotterdam, Netherlands
Publications: 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Netherlands
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost effectiveness, Cost utility


Cost utility analysis of bortezomib in a biomarker positive subgroup of relapsed and refractory folicular lymphoma
Authors: Vandekerckhove S1, Lamotte M1, Iannazzo S2, Chirita O3
Affiliations: 1 IMS HEOR, Brussels, Belgium 2 IMS HEOR, Milan, Italy 3 Janssen-Cilag Ltd., Buckinghamshire, United Kingdom
Publications: 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost effectiveness, Cost utility


NICE Technology Appraisals and the uptake of breast cancer drugs in the UK
Authors: Bertwistle D1, Anderson P2, Jofre-Bonet M3
Affiliations: 1 IMS Health, London, UK 2 Swansea Centre for Health Economics, Swansea University, Wales, UK 3 City University, London, UK
Publications: ESMO (European Society for Medical Oncology) 2012 Value Health November 2012 Volume 15, Issue 7, Page A434
Document Types: , Abstract, Poster
Countries: , UK
Abstract: www.ispor.org/congresses/berlin1112
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Economic evaluation


Blood component use and associated costs after standard dose chemotherapy-a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany
Authors: Paessens B, Ihbe-Heffinger A, von Schilling C, Shlaen R2, Bernard R, Peschel C, Schramm W, Berger K
Affiliations: Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Support Care Cancer, 2012, 20(5): 1011-1021
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21562801
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Prospective study


Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy â€“ retrospective analysis of changes over 3 yr in a German hospital
Authors: Boehme A1, Atta J1, Mousset S1, Ehlken B2, Shlaen M2, Bug G1, Serve H. 1, Hoelzer D. 1
Affiliations: 1 Department of Medicine, Hematology â„ Oncology, Goethe-University, Frankfurt â„ Main; 2 IMS Health, Munich, Germany
Publications: European Journal of Haematology, 2011, EPub Oct 13 European Journal of Haematology, 2012, 88(1): 68-77
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective cohort analysis


Major surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: J Gastrointest Cancer. 2012 Sep;43(3):456-61
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3
Affiliations: Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3
Publications: Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print]
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Patient out-of-pocket payments for oral oncolytic therapies: results from a U.S. claims data analysis.
Authors: Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1
Affiliations: 1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA
Publications: Am J Manag Care 2012;18(2 Spec No.):SP57-SP64
Document Types: , Manuscript in preparation
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis, Retrospective database analysis


Risk of treatment failure after first-line sunitinib therapy in patients with metastatic renal cell carcinoma
Authors: Chen CC1, Hess GP1, Liu Z2, Gesme DH3, Agarwala SS4, Garay CA4, Hill JW1, Guo MA4
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, PA 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA
Publications: Genitourinary Cancers Symposium 2012
Document Types: , Poster, Symposium
Countries: , USA
Condition	Year	Language	Analysis type
, Nephrology, Oncology	2012	English	, Retrospective database analysis


Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies.
Authors: Burudpakdee C1, Zhao Z2, Munakata J1, Gao S2, Trochlil K1, Barber B2
Affiliations: 1 IMS Health, Alexandria, VA, US 2 Amgen, Thousand Oaks, CA, US
Publications: J Med Econ, 2012, 15(2):371-7
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Feasibility of Efficiency Frontier Analysis (EFA) In Metastatic Breast Cancer (MBC) treatments: A UK perspective (PCN94)
Authors: Burudpakdee C1, Bertwistle D2
Affiliations: 1IMS Health, Alexandria , VA, USA, 2IMS Health, London, UK
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , UK
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx#top
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Assessing relative clinical value within three metastatic diseases
Authors: Karweit J1, Wolfe S1, Kotapati S2, Lees M3, Abernethy AP4
Affiliations: 1IMS Consulting Group, New York, NY, USA, 2Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA, 3Bristol-Myers Squibb, Rueil-Malmaison, France, 4Duke Clinical Research Institute and Duke Cancer Institute, Durham, NC, USA
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Cost of Erythropoiesis-stimulating Agents (ESAs) in the treatment of Chemotherapy-related Anaemia in Spain
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G6, Annemans L7
Affiliations: 1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Oblikue Consulting, Barcelona, Spain 5 Amgen S.A., Barcelona, Spain; 6 Independent Consultant, Barcelona, Spain 7 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost of illness


Preliminary validation of collect scale: a co-morbidity assessment tool for patients with Chronic Lymphocytic Leukaemia
Authors: Giraldo P1, Lopez A2, Rios E3, Gonzalez-Grande I4, Roset M5, Castro-Gomez A6, De La Serna J7, Carbonell F8
Affiliations: 1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitari Valle d'Hebron, Barcelona, Spain, 3Hospital Virgen de Valme, Sevilla, Spain, 4Roche Farma, S.A., Madrid, Spain, 5IMS Health, Barcelona, Spain, 6Roche, Madrid, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Consorci Hospital General Universitari Valencia, Valencia, Spain
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English


Cost-Effectiveness of Plerixafor plus GCSF for Mobilization of Peripheral blood Stem Cells in Patients with Myeloma and Lymphoma in Spain
Authors: Duarte RF1, PÃ©rez-SimÃ³n JA2, MartÃn G3, de la Rubia J4, MarÃn P5, Ãlvarez MA6, EspinÃ³s B7, Roset M7
Affiliations: 1Institut CatalÃ D'Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain, 2Hospital Universitario Virgen del RocÃo, Sevilla, Spain, 3Banc de Sang i Teixits, Barcelona, Spain, 4Hospital Universitario La Fe de Valencia, Valencia, Spain, 5Hospital ClÃnic, Barcelona, Spain, 6Hospital Reina SofÃa, CÃ³rdoba, Spain, 7IMS Health, Barcelona, Spain
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost effectiveness


Cost-Effectiveness Analysis of Erlotinib vs Plantinum based Chemotherapy as First-Line treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations
Authors: Garrido P1, LÃ³pez-Vivanco G2, Rosell R3, EspinÃ³s B4, Castro-Gomez A5
Affiliations: 1Hospital Universitario RamÃ³n y Cajal, Madrid, Spain, 2Hospital de Cruces, Barakaldo, Spain, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 4IMS Health, Barcelona, Spain, 5Roche, Madrid, Spain
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost effectiveness


Cancer Related Bisphosphonate Therapy In Different Treatment Facilities
Authors: Haas G1, Kostev K2
Affiliations: 1IMS Health, Frankfurt/Main, Germany, 2IMS Health, Frankfurt am Main, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany Value Health November 2012 Volume 15, Issue 7, Page A412
Document Types: , Abstract, Poster
Countries:
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Observational study


Persistence in patients with breast cancer treated with Tamoxifen or Aromatase Inhibitors: Results of a Retrospective Cohort Study
Authors: Kostev K1, Haas G2, Hadji P3
Affiliations: 1IMS Health, Frankfurt am Main, Germany, 2IMS Health, Frankfurt/Main, Germany, 3Universityhospital of Giessen and Marburg GmbH, Marburg, Hessen, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective cohort analysis


Persistence in first line treatment of Metastatic Renal Cell Carcinoma in routine care in Germany
Authors: Mergenthaler U1, Morawski E2, Wendschlag A1
Affiliations: 1IMS Health, Frankfurt, Germany, 2Pfizer GmbH, Berlin, Germany
Publications: ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Germany
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Burden of illness


Tumor hormone/HER2 receptor status and pharmacologic treatment of metastatic breast cancer in Western Europe
Authors: Gao S, Barber B, Schabert V, Ferrufino C.
Affiliations: 1,2Amgen, Thousand Oaks, CA, USA, 3IMS Health, Woodland Hills, CA, USA, 4IMS Health, Alexandria, VA, USA
Publications: Curr Med Res Opin
Document Types: , Manuscript in preparation
Countries: , Europe
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Treatment cost of invasive fungal disease (lfd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.
Authors: Rieger CT1, Cornely OA2, Hoppe-Tichy T3, Kiehl M4, Knoth H5, Thalheimer M3, Schuler U, Ullmann AJ6, Ehlken B7, Ostermann H1
Affiliations: 1 Department of Hematology / Oncology, University Hospital of Munich, Munich 2 Germany Department I for Internal Medicine and ZKS KÃ¶ln (BMBF 01KN0706), University of Cologne, Cologne 3 Germany Pharmacy Department, University Hospital of Heidelberg, Heidelberg 4 Germany Clinical Center Frankfurt/Oder 5 Germany University Hospital of Dresden, Dresden 6 Germany Department of Internal Medicine III, Johannes Gutenberg-University, Mainz, Germany 7 IMS Health, Munich, Germany
Publications: Mycoses, 2012, EPub April 3
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22471310
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Practice patterns in the management of prostate cancer in spain: results from a National Survey Among Radiation oncologists in 2009
Authors: Zapatero A, LÃ³pez-Torrecilla J, Herruzco I, Calvo FA.
Affiliations: Department of Radiation Oncology, Health Research Institute IP, Hospital University of Princess, Madrid.
Publications: Clin Transl Oncol. 2013 Mar;15(3):226-32
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Practice%20patterns%20in%20the%20management%20of%20prostate%20cancer%20in%20spain%3A%20results%20from%20a%20National%20Survey%20Among%20Radiation%20oncologists%20in%202009
Condition	Year	Language	Analysis type
, Oncology	2012	Spanish	, Survey research


Analisi dei costi associati agli agenti stimolanti lâ€™eritropoiesi nel trattamento dei pazienti con anemia indotta da chemioterapia in Italia (Costs analysis of erythropoiesis-stimulating agents in the treatment of chemotherapy- induced anemia)
Authors: Grabbi E1, Lucioni C2, Duran A1, Spaepen E3, Lamotte M4, Kutikova L5, Pujol B5, Gozzo M6, Iannazzo S7
Affiliations: 1 Health Economics and Outcomes Research, IMS Health, London, UK 2 Springer Healthcare Italia, Milan, Italy 3 SBD Analytics BVBA/SPRL, Belgium 4 Health Economics and Outcomes Research, IMS Health, Vilvoorde, Belgium 5 Amgen (Europe) GmbH, Zug, Switzerland 6 Amgen DompÃ© S.p.A., Milano, Italy 7 Health Economics and Outcomes Research, IMS Health, Milan, Italy
Publications: PharmacoEconomics Italian Research Articles, 2012; 14(2): 91-100
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Cost analysis


Oncology growth drives new evidence needs
Authors: Berger K1
Affiliations: 1IMS Health, Munich, Germany
Publications: AccessPoint, Nov 2012; Vol 3(5); 11-15
Document Types: , Article
Countries:
Abstract: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Services/Pharma%20Commercial%20Effectiveness/Health%20Economics%20_%20Outcomes%20Research/AccessPoint-5-281012%20F.pdf
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Budget impact, Real World Evidence


Access to cancer screening in people with learning disabilities in the UK: cohort study in the health improvement network, a primary care research database.
Authors: Osborn DP, Horsfall L, Hassiotis A, Petersen I, Walters K & Nazareth I
Affiliations: Mental Health Sciences Unit
Publications: PLOS ONE 7(8):e43841
Document Types: , Article
Countries: , UK
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0043841
Condition	Year	Language	Analysis type
, Mental health, Oncology	2012	English	, Retrospective database analysis


Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study.
Authors: Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K & Lewis JD.
Affiliations: Sherwood Forest Hospitals Foundation Trust University of Pennsylvania Department of Medicine
Publications: J Natl Cancer Inst. 2012 Sep 19;104(18):1411-21. Epub 2012 Aug 9.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529598/pdf/djs328.pdf
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2012	English	, Retrospective database analysis


First-line sunitinib in type I and II papillary renal cell carcinoma (PRCC): SUPAP, a phase II study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase trials (GEP).
Authors: Ravaud A1, Oudard S2, De Fromont M3, Chevreau C4, Gravis G5, Zanetta S6, Theodore C7, Jimenez M8, Sevin E9, Laguerre B10, Rolland F11, Ouali M12, Culine S13, Escudier B14.
Affiliations: 1Department of Medical Oncology, Bordeaux University Hospital, Bordeaux alain.ravaud@chu-bordeaux.fr. 2Department of Medical Oncology, Paris Rene Descartes University, Paris. 3Pathology Department, SCP Pathology, Marseille. 4Department of Medical Oncology, Institut Claudius RÃ©gaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 5Department of Medical Oncology, Institut Paoli Calmettes, Marseille. 6Department of Medical Oncology, Centre Georges-FranÃ§ois Leclerc, Dijon. 7Department of Medical Oncology, HÃ´pital Foch, Suresnes. 8Research and Development Department, Unicancer, Paris. 9Department of Medical Oncology, Centre FranÃ§ois Baclesse, Caen. 10Department of Medical Oncology, Centre EugÃ¨ne Marquis, Rennes. 11Department of Medical Oncology, Institut de CancÃ©rologie de L'Ouest, Nantes. 12Department of Biostatistics, Institut Claudius RÃ©gaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 13Medical Oncology, HÃ´pital Saint-Louis, Paris. 14Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Publications: 2009 ASCO Annual Meeting Abstract Number: 5146
Document Types: , Poster
Countries: , France
Abstract: http://meetinglibrary.asco.org/content/30779-65
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Prospective study


How commonly is gastric cancer missed at endoscopy (a UK primary care based study) ?
Authors: Menon S, Dhar A, Hoare J, Trudgill N
Affiliations: Sandwell Hospital
Publications: Digestive Disease Week conference San Diego
Document Types: , Abstract, Conference
Countries: , UK
Abstract: http://gut.bmj.com/content/61/Suppl_2/A43.1
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
Authors: Do-Youn OH 1, Bruce CRAWFORD6, Sung-Bae KIM 2, Hyun-Cheol CHUNG 3, Jeffrey MCDONALD 6, Sang Yoon LEE 4, Su-Kyoung KO4 andJungsil RO 5
Affiliations: 1 Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine 2 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine 3 Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University Health System 4 Pfizer Korea, Seoul 5 Center for Breast Cancer, National Cancer Center, Goyang, Korea 6 Adelphi Values, Tokyo, Japa
Publications: Asia Pac J Clin Oncol. 2012 Sep;8(3):282-91. doi: 10.1111/j.1743-7563.2012.01546.x. Epub 2012 May 21.
Document Types: , Article
Countries: , Korea
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22898238
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Burden of illness, Survey research


Prevalence of Non-Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors in the United States
Authors: Liede A1, Pirolli M2, Hernandez R1, Quigley J2, Quach D2
Affiliations: 1 Amgen, Inc., Thousand Oaks, USA 2 IMS Health, Plymouth Meeting, USA
Publications: San Antonio Breast Cancer Symposium, 2012, December 4-8, San Antonio, USA (abstr P2-13-03, 275s)
Document Types: , Abstract
Countries: , USA
Abstract: http://www.sabcs.org/UserPortal/Documents/SABCS_2012_Abstract_Book.pdf
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Castration Resistance and High-Risk Disease among Non-Metastatic (M0) Prostate Cancer (PC) Patients on Androgen Deprivation Therapy (ADT)
Authors: Pirolli M1, Hernandez R2, Cetin K2, Quigley J1, Grant-Huerta Y2, Stryker S2, Smith P1, Adams J3, Liede A2
Affiliations: 1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc, Thousand Oaks, USA 3 RAND Corporation, Santa Monica, USA
Publications: J Clin Oncol., 30, 2012 (suppl; abstr 1581)
Document Types: , Abstract
Countries: , USA
Abstract: http://meetinglibrary.asco.org/content/94833-114
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


FOLFIRINOX Treatment of Metastatic Pancreatic Cancer in an Electronic Health Records Warehouse in the US
Authors: Gastanaga, V., Lethen, J., Barlev, A., Wang, S., Kelsh, M.
Affiliations:
Publications: Annals of Oncology, vol. 23 s4, p. iv63, 2012
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Risk of Significant Hemoglobin (Hb) Declination in Chemotherapy Patients Prior To and After Policy Changes Affecting Use of Erythropoiesis -Stimulating Agents (Esa's): 2006-2009
Authors: Hill, J. W., Cong, Z., Hess, G. P., McGarvey, N., Nordyke, R. J.
Affiliations:
Publications: International Journal of Medical Research
Document Types: , Abstract
Countries: , USA
Abstract: http://www.medscape.com/medline/abstract/22971506
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
Authors: Renehan AG, Yeh HC, Johsnon JA, Wild SH, Gale EA, Moller H, Diabetes and Cancer Research Consortium
Affiliations: University of Manchester Department of Surgery, School of Cancer and Enabling Sciences
Publications: Diabetologia. 2012 Jun;55(6):1619-32. doi: 10.1007/s00125-012-2526-0. Epub 2012 Apr 4.
Document Types: , Article
Countries: , UK
Abstract: http://link.springer.com/article/10.1007/s00125-012-2526-0/fulltext.html
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2012	English	, Retrospective database analysis


Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.
Authors: Johnson JA1, Carstensen B2 3, Witte D2, Bowker SL1, Lipscombe L4 & Renehan AG5
Affiliations: 1 School of Public Health, University of Alberta, 2 Steno Diabetes Center, 3 2 Department of Biostatistics, University of Copenhagen 4 Womenâ€™s College Hospital, University of Toronto, 5 School of Cancer and Enabling Sciences, University of Manchester
Publications: Diabetologia. 2012 Jun;55(6):1607-18. doi: 10.1007/s00125-012-2525-1. Epub 2012 Apr 4.
Document Types: , Article
Countries: , Canada, UK
Abstract: http://link.springer.com/article/10.1007/s00125-012-2525-1/fulltext.html
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2012	English	, Retrospective cohort analysis, Retrospective database analysis


The association between smoking quantity and lung cancer in men and women
Authors: Iyen-Omofoman B, Hubbard RB, Baldwin DR & Tata LJ
Affiliations: University of Nottingham Nottingham Respiratory Research Unit
Publications: Chest 10.1378/chest.12-1068.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22797799
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Patient-reported outcomes in patients with metastatic breast cancer form the VIRGO observational cohort study
Authors: Kaufman PA, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Cleeland CS
Affiliations:
Publications: ASCO Breast Cancer Symposium, Sep 13 - 15, 2012, San Francisco, CA
Document Types: , Symposium
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: An interim analysis of the Asia-Pacific (AP) cohort
Authors: Chen PJ, Park JW, Chen M, Sherman M, Johnson P, Colombo M, Kudo M, Roberts L, Huang B, Wagner S
Affiliations:
Publications: Asian Pacific Association for the Study of Liver. Feb 2012. Taipei, Taiwan
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: First characterizations of the full study population
Authors: Park JW, Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Kudo M, Johnson P, Huang B, Orsini LS
Affiliations:
Publications: ASCO. 2012. Chicago, IL
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: Global comparison of outcomes by staging system
Authors: Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Huang B, Wagner S, Orsini LS
Affiliations:
Publications: American Society of Clinical Oncology. 2012. Chicago, IL
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Observed patterns of systemic therapy use in hepatocellular carcinoma (HCC) patients from the multinational HCC BRIDGE study: Results of a second interim analysis
Authors: Colombo M, Roberts L, Schwartz M, Degos F, Sherman M, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Huang B, Wagner S, Orsini LS
Affiliations:
Publications:
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC BRIDGE study: Second interim analysis of the european (EU) cohort
Authors: Izzo F, Colombo M, Leroy V, Blanc JF, Johnson P, Fenwick S, Stal P, Assenat E, Matilla A, Bartolome SP, Bourcier V, Degos F, Huang B, Wagner S, Orsini LS
Affiliations:
Publications: European Association for the Study of the Liver- International Liver Congress. 2012. Barcelona, Spain
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, RWLPR (Real-World Late Phase Research-quintiles


Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer
Authors: Connolly GC, Dalal M, Lin J, Khorana AA
Affiliations: University of Rochester Medical Center, Rochester
Publications: Lung Cancer 2012;78(3):253-258.
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Public Health


Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey.
Authors: DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria
Affiliations: IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA
Publications: ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570)
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570
Condition	Year	Language	Analysis type
, Oncology	2012	English	, Retrospective database analysis


Cost Analysis of Anaemia Treatment With Erythropoiesis-Stimulating Agents in Cancer Patients Receiving Chemotherapy
Authors: Duran A1, Spaepen E2, Lamotte M3, Walter E4, Kutikova L5, Pujol B5, Ribnicsek E6, Annemans L7
Affiliations: 1IMS Health, London, UK; 2SBD Analytics BVBA/SPRL, Belgium; 3IMS Health, Vilvoorde, Belgium; 4Institut fÃ¼r PharmaÃ¶konomische Forschung, Vienna, Austria; 5Amgen (Europe) GmbH, Zug, Switzerland; 6Amgen, Vienna, Austria; 7I-CHER Interuniversity Centre for Health Economics Research, UGent, VUB, Belgium
Publications: 16th Congress of the European Association of Hospital Pharmacists, 30 March - 1 April 2011.
Document Types: , Poster
Countries: , Austria, Belgium
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost analysis


Cost-effectiveness of cetuximab, bevacizumab, and panitumumab in first-line treatment of metastatic colorectal cancer (mCRC) for patients with KRAS wild-type (wt) tumors in the United Kingdom
Authors: Samyshkin Y1, Hertel N1, Griebsch I2
Affiliations: 1Health Economics and Outcomes Research, IMS Health, London, UK; 2Pricing & Health Economics, Merck KGaA, Darmstadt, Germany
Publications: The European Multidisciplinary Cancer Congress, Stockholm 23 â€“ 27 September 2011
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach.
Authors: Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9
Affiliations: 1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de InvestigaÃ§ao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publications: ISPOR 14th Annual European Congress 5-8 November 2011, Madrid, Spain
Document Types: , Poster
Countries: , Austria, Italy, Portugal, Spain
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost analysis


Management of febrile neutropenia - a german prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer
Authors: Ihbe-Heffinger A, Paessens BJ, von Schilling C, Shlaen M2, Gottschalk N, Berger K, Bernard R, Kiechle M, Peschel C, Jacobs VR
Affiliations: 1Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Onkologie 2011;34(5):241-6. Epub 2011 Apr 26
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2011	German	, Prospective study


Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients
Authors: Paessens BJ, von Schilling C, Berger K, Shlaen M2, MÃ¼ller-Thomas C, Bernard R, Peschel C, Ihbe-Heffinger A.
Affiliations: Krankenhausapotheke, Klinikum rechts der Isar (MRI) der Technischen UniversitÃ¤t MÃ¼nchen, MÃ¼nchen, Germany, 2Health Economics and Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Ann Oncol, 2011, 22(10): 2310-2319
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Prospective study


A comparative effectiveness analysis of trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees.
Authors: Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3
Affiliations: 1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consultin Group, Woodland Hills, CA, USA
Publications: 34th Annual San Antonio Breast Cancer Symposium, December 2011, San Antonio, TX, USA
Document Types: , Abstract, Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective cohort analysis, Retrospective database analysis


Are out-of-pocket payments for oral oncologic therapies too high? Updated results from a U.S. claims data analysis.
Authors: Raborn ML1, Pelletier EM2, Smith DB2, Reyes CM1
Affiliations: 1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA
Publications: International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Meeting, November 2011, Madrid, Spain
Document Types: , Abstract, Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost analysis, Retrospective database analysis


Trastuzumab persistence between two adjuvant breast cancer treatment regimens among US health plan enrollees: a comparative effectiveness analysis.
Authors: Lalla D1, Pelletier EM2, Goodman S2, Brammer M1, Schabert VF3
Affiliations: 1Genentech, Inc., South San Francisco, CA, USA, 2IMS Consulting Group, Watertown, MA, USA, 3IMS Consulting Group, Woodland Hills, CA, USA
Publications: 16th European Cancer Organisation (ECCO) â€“ 36th European Society for Medical Oncology (ESMO) Multidisciplinary Cancer Congress, September 2011, Stockholm, Sweden
Document Types: , Abstract, Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective cohort analysis, Retrospective database analysis


Extrapolation in Oncology Modelling: Novel Methods for Novel Compounds
Authors: Annemans L1, Asukai Y2, Barzey V2, Kotapati S3, Lees M4, Van Baardewijk M5, Wang Q4, Batty AJ6, Fisher D6
Affiliations: 1 Ghent University, Belgium, 2 IMS Health, London, UK, 3 Bristol-Myers Squibb Pharmaceuticals, Wallingford, CT, USA, 4 Bristol-Myers Squibb, Uxbridge, Middlesex, UK, 5 Bristol-Myers Squibb, Braine L'Alleud, Belgium, 6 BresMed Health Solutions, Sheffield, South Yorkshire, UK
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types:
Countries:
Abstract: http://www.ispor.org/congresses/Spain1111/Podiums.asp#session3
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective cohort analysis


Economic model of granulocyte-colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in Non-Hodgkin's Lymphoma (NHL) patients undergoing chemotherapy in France.
Authors: Perrier L1, Sebban C1, Leon N2, Maurel F2, Cohen-Nizard S3, De LiÃ¨ge F3
Affiliations: 1 Cancer Centre LÃ©on BÃ©rard, Lyon, France 2 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France
Publications: Abstract - Presentation PCN88 for the 14th European congress of Ispor 2011
Document Types: , Abstract
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


Cost-effectiveness of ganulocyte colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in patients with stages 2 and 3 breast cancer (BC) undergoing cytotoxic chemotherapy in France.
Authors: Perrier L1, Bachelot T2, Leon N3, Maurel F3, Cohen-Nizard S4, De LiÃ¨ge F4
Affiliations: 1 Cancer Centre LÃ©on BÃ©rard, Lyon, France 2 Centre LÃ©on BÃ©rard - Inserm U590, Lyon Cedex 08, France 3 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France
Publications: Abstract - Presentation PCN77 for the 14th European Congress of ISPOR 2011
Document Types: , Abstract
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


Correlation between quality of life and clinical outcomes in gastric cancer.
Authors: Goldberg E, DeKoven M, Su Y, Coyle K, Chapman R, Wagner S.
Affiliations: IMS Health, Bristol Myers Squibb
Publications: Annals of Oncology 2011; 22(Supplement 5): v34â€“v35. 13th World Congress on Gastrointestinal Cancer, Barcelona, Spain, June 22-25, 2011
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Literature Review


Cost-effectiveness of Cetuximab and Bevacizumab in the first-line treatment of metastatic colorectal cancer (MCRC) for patients with KRAS wild-type tumours in the United Kingdom
Authors: Samyshkin Y1, Hertel N1, Griebsch I2
Affiliations: 1IMS Health, London, UK, 2Merck KGaA, Darmstadt, Germany
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , UK
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN70
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


Modeling Early Pricing And Strategic Assessments Of Oncology Agents
Authors: Lloyd A1, Munakata J2, Tencer T3
Affiliations: 1 IMS Health, London, UK 2 IMS Consulting Group, Redwood City, CA, USA 3 Eisai, Inc., Woodcliff Lake, NJ, USA
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Workshop
Countries:
Abstract: http://www.ispor.org/congresses/spain1111/workshops.asp#sessioni W2
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


Cost Analysis: Treatment of Chemotherapy-induced Anaemia with Erythropoiesis-Stimulating Agents (ESAS) in Spain
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G5, Annemans L6
Affiliations: 1IMS Health, London, UK, 2SBD Analytics BVBA/SPRL, Bekkevoort, Belgium, 3IMS Consulting Group, Vilvoorde, Belgium, 4Oblikue Consulting, Barcelona, Spain, 5Amgen S.A., Barcelona, Spain, 6Ghent University, Ghent, Belgium
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost analysis


Cost analysis of anaemia treatment with erythropoiesis-stimulating agents (ESAs) in cancer patients receiving chemotherapy in Italy.
Authors: Duran A1, Spaepen E2, Lamotte M3, Lucioni C4, Kutikova L5, Pujol B5, Gozzo M6, Annemans L7
Affiliations: 1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Consulting Group, Vilvoorde, Belgium 4 Wolters Kluwer Health Italy Ltd., Milan, Italy 5 Amgen (Europe) GmbH, Zug, Switzerland 6 Amgen Dompe S.p.A., Milan, Italy 7 Ghent University, Ghent, Belgium
Publications: 14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain
Document Types: , Abstract, Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost analysis


The cost effectiveness of Cetuximab (Erbitux) in the third line treatment of metastatic colorectal cancer in the UK
Authors: Perard R1, Samyshkin Y2, Guillermin ALG2
Affiliations: 1Merck Serono Limited, Feltham, UK, 2IMS Health, London, UK
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


An epidemiological evaluation of chemotherapy used in the treatment of metastatic prostate cancer.
Authors: Chevalier P1, Moeremans K1
Affiliations: 1 IMS Health, Vilvoorde, Belgium
Publications: 14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Epidemiological study


Assessing relative clinical value across tumor types in metastatic disease
Authors: Karweit J1, Nanavati S1, Van Baardewijk M2, Wagner S3, Kotapati S4
Affiliations: 1IMS Consulting Group, New York, NY, USA, 2Bristol-Myers Squibb, Braine L'Alleud, Belgium, 3Bristol-Myers Squibb, Princeton, NJ, USA, 4Bristol-Myers Squibb, Wallingford, CT, USA
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PRM60
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Literature Review


Value of Progression-Free Survival (PFS) in refractory Non-Small Cell Lung Cancer (NSCLC): An exploratory modeling analysis
Authors: Ferrufino CP1, Foley D2, Trochlil K1, Munakata J3
Affiliations: 1IMS Consulting Group, Alexandria, VA, USA, 2Boehringer Ingelheim, Ridgefield, CT, USA, 3IMS Consulting Group, Redwood City, CA, USA
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN88
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness


The impact of advanced or metastasic Non-Small Cell Lung Cancer (NSCLC) symptoms on patient daily living and health related quality of life: final results
Authors: Artal A1, Oramas J2, Cobo M3, Domine M4, Barneto I5, RodrÃguez-Abreu D6, Menendez-UreÃ±a M7, Andrade J8, Guillot M9, Perulero N10, Castro-Gomez AJ11
Affiliations: 1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitario de Canarias, La Laguna, Santa Cruz de Te, Spain, 3Hospital Regional Universitario Carlos Haya, Malaga, Spain, 4FundaciÃ³n JimÃ©nez-DÃaz, Madrid, Spain, 5Hospital Universitario Reina SofÃa, CÃ³rdoba, Andalucia, Spain, 6Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain, 7Hospital Universitario de MÃ³stoles, Mostoles, Madrid, Spain, 8Complejo Hospitalario de Toledo-Hospital Virgen de la Salud, Toledo, Castilla La Manc, Spain, 9Hospital Universitari Son Espases, Palma de Mallorca, Spain, 10IMS Health, Barcelona, Spain, 11Roche Farma S.A., Madrid, Spain
Publications: ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PCN138
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Survey research


The incidence and outcome of febrile neutropenia in different chemotherapy regimens for cancer patients in Belgium.
Authors: Chevalier P1, Lamotte M1, Malfait M2, Marciniak A3
Affiliations: 1 IMS Health HEOR, Brussels, Belgium 2 Amgen nv, Brussels, Belgium 3 Amgen Ltd, Uxbridge, UK
Publications: The European Multidisciplinary Cancer Congress, 2011, September 23-27, Stockholm
Document Types: , Poster
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2011	English


The incidence and outcome of febrile neutropenia in different chemotherapy regimens for cancer patients in Belgium.
Authors: Chevalier P1, Lamotte M1, Malfait M2, Marciniak A3
Affiliations: 1 IMS Health HEOR, Vilvoorde, Belgium 2 Amgen sa/nv, Brussels, Belgium 3 Amgen Ltd, Uxbridge, UK
Publications: 14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain
Document Types: , Abstract
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2011	English


Surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Metastatic renal cell carcinoma: patient characteristics, treatment patterns, and schedule compliance in clinical practice
Authors: Hess GP1, Chen CC1, Hill JW1, Liu Z2, Gesme DH3, Agarwala SS4
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, PA; SDI, 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Minnesota Hem Onc, Minneapolis, MN 4 St. Luke's Hospital and Health Network, Bethlehem, PA
Publications: Kidney Cancer Journal 2011; 9(3)
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Clinical burden of illness in patients with neuroendocrine tumors
Authors: Hess GP1, Chen CC1, Liu Z2, Yao JC3, Phan AT3, Hill JW1.
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, US 2 Novartis Pharmaceuticals, East Hanover, NJ 3 Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX
Publications: Pancreas. 2012 Apr 17 In press
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Burden of illness


Metastatic renal cell carcinoma: patient characteristics and recent treatment patterns in real-world practice.
Authors: Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA
Publications: JMCP April 2011;17(3):232-272 (suppl: abstract)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Patient compliance with metastatic renal cell carcinoma treatments.
Authors: Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA
Publications: JMCP April 2011;17(3):232-272 (suppl: abstract)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Risk of treatment failure after first-line tyrosine kinase inhibitors (TKI) therapy in patients with metastatic renal cell carcinoma
Authors: Hess GP1, Chen CC1, Liu Z2, Gesme DH3, Agarwala SS4, Hill JW1
Affiliations: 1 IMS Health (formerly SDI), Plymouth Meeting, PA, USA 2 Novartis Pharmaceuticals, East Hanover, NJ, USA 3 Minnesota Hem Onc, Minneapolis, MN, USA 4 St. Luke's Hospital and Health Network, Bethlehem, PA, USA
Publications: J Clin Oncol 29: 2011 (suppl; abstr e15114)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Patient Compliance with Metastatic Renal Cell Carcinoma Treatments
Authors: Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS
Affiliations: IMS Health (formerly SDI Health),Plymouth Meeting, PA,USA
Publications: AMCP's 23rd Annual Meeting April 27-29, 2011.
Document Types: , Abstract
Countries: , USA
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Metastatic Renal Cell Carcinoma: Patient Characteristics and Recent Treatment Patterns in Real-World Practice
Authors: Hess GP, Chen C, Liu Z, Gesme DH, Agarwala SS
Affiliations: IMS Health (formerly SDI Health), Plymouth Meeting, PA, USA
Publications: AMCP's 23rd Annual Meeting April 27-29, 2011
Document Types: , Abstract
Countries: , USA
Abstract: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8975
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Health resource utilization and costs associated with gastric cancer: results from a US claims database.
Authors: Knopf K1, Smith D2, Doan J3, Munakata J4
Affiliations: 1 California Pacific Medical Center, San Francisco, CA, US 2 IMS Consulting Group, Watertown, MA, US 3 Genentech Inc., South San Francisco, CA, US 4 IMS Consulting Group, Redwood City, US
Publications: The European Multidisciplinary Cancer Congress, 2011, September 23-27, Stockholm
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Estimating the economic burden of gastric cancer.
Authors: Knopf KB1, Smith DB2, Doan JF3, Munakata J4
Affiliations: 1 California Pacific Medical Center, San Francisco, CA, US 2 IMS Consulting Group, Watertown, MA, US 3 Genentech Inc., South San Francisco, CA, US 4 IMS Consulting Group, Redwood City, CA, US
Publications: J Clini Oncol, 2011, 29:(suppl; abstr e16589)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


An epidemiological evaluation of chemotherapy used in the treatment of metastatic prostate cancer.
Authors: Chevalier P1, Moeremans K1
Affiliations: 1 IMS Consulting Group, Vilvoorde, Belgium
Publications: 14th ISPOR Annual European Congress, 2011, November 5-8, Madrid, Spain
Document Types: , Abstract, Poster
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2011	English


Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study.
Authors: Damery S, Ryan R, Wilson S, Ismail T, Hobbs R.
Affiliations:
Publications: Colorectal Dis. 2011 Apr;13(4):e53-60. doi: 10.1111/j.1463-1318.2010.02488.x.
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21054747
Condition	Year	Language	Analysis type
, Hematology, Oncology	2011	English


Linking cancer registry records to THIN - a UK general practice database.
Authors: Marshall T, Dattani H, Thompson M, Bourke A, Pinder L & Blak BT
Affiliations: Cegedim
Publications: 27th International conference on pharmacoepidemiology & therapeutic risk management (ICPE) Chicago, USA
Document Types: , Poster
Countries: , UK
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data.
Authors: 2Iyen OB, Hubbard RB, Smith CJ, Sparks E, Bradley E, 1Bourke A & Tata LJ
Affiliations: 1Cegedim 2Division of Epidemiology and Public health, University of Nottingham, Clinical Sciences Building, City Hospital, Nottingham, NG5 1PB, UK
Publications: BMC Public Health 2011, 11:857
Document Types: , Article
Countries: , UK
Abstract: http://www.biomedcentral.com/1471-2458/11/857
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


The Use of Large GPs Longitudinal Database in the Reasearch of Causal Associations Among Pathologies: The Case of Diabetes and Cancer Incidence.
Authors: Katz P, Ripellino C., Heiman F., Chatenoud F.
Affiliations:
Publications: Value in Health. 11/2011; 14(7). DOI: 10.1016/j.jval.2011.08.1293
Document Types: , Article
Countries:
Abstract: http://www.researchgate.net/publication/238509387_PCN194_The_Use_of_Large_GPs_Longitudinal_Database_in_the_Reasearch_of_Causal_Associations_Among_Pathologies_The_Case_of_Diabetes_and_Cancer_Incidence
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2011	English


Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Recieving CHOP+R
Authors: Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M.
Affiliations:
Publications: Blood, 2011
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research
Authors: Lau, E.C., Legg, J.C., Watson, H.N., Steffey, D.L., Mowat, F.S., Kelsh, M.A.
Affiliations:
Publications: ICPE, 2011
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data
Authors: Mowat, F.S., Lau, E.C., Kelsh, M.A., Legg, J.C., Engel-Nitz, N.M., Watson, H.N., Collins, H.L., Nordyke, R.J., Whyte, J.L.
Affiliations:
Publications: ICPE, 2011
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data
Authors: Whyte, J.L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J.
Affiliations:
Publications: Value in Health, 14(3):A6, 2011
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data
Authors: Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Enge-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L.
Affiliations:
Publications: Clinical Epidemiology
Document Types: , Abstract
Countries: , USA
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224632/
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Hemoglobin Trends and Anemia Treatment Due To Concomitant Chemotherapy in Community Oncology Clinics
Authors: Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J.
Affiliations:
Publications: Journal of Oncology Practice
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Chemotherapy Relative Dose Intensity Among Older (>65) and Younger (<65) Patients with Non-Hodgkin Lymphoma Receiving CHOP+/-R
Authors: Whittaker, S., Abella, S., Schwartzberg, L., Saleh, M.
Affiliations:
Publications: Blood
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Rate of Hemoglobin Decline in Patients Receiving Chemotherapy Without an Erythropoiesis-Stimulating Agent in the United States Community Setting
Authors: Pirolli, M., Collins, H., Quigley, J., Hulnick, S.
Affiliations:
Publications: European Journal of Cancer
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


The Problem of Missing Data: Using Imputation Methods to Facilitate Oncology Outcomes Research
Authors: Lau, E. C., Legg, J. C., Watson, H. N., Steffey, D. L., Mowat, F. S., Kelsh, M. A.
Affiliations:
Publications: ICPE
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data
Authors: Mowat, F. S., Lau, E. C., Kelsh, M. A., Legg, J. C., Engel-Nitz, N. M., Watson, H. N., Collins, H. L., Nordyke, R. J., Whyte, J. L.
Affiliations:
Publications: ICPE
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Rate of Hemoglobin Decline from <10 G/Dl to <9 G/Dl by Electronic Medical-Record (EMR) Evaluation in Community Oncology Patients Receiving Chemotherapy in the Absence of ESA Treatment
Authors: Pirolli, M., Collins, H., Quigley, J., Hulnick, S.
Affiliations:
Publications: ASCO
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Synchronization of Administrations of Chemotherapy and Erythropoiesis-Stimulating Agents and Frequency of Associated Health Care Visits
Authors: Hill, J., Shreay, S., McGarvey, N., De, A. P., Hess, G., Corey-Lisle, P.
Affiliations:
Publications: Value in Health, 14(3):A75
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Use of Electronic Medical Records (EMR) for Oncology Outcomes Research: Assessing the Comparability of EMR Information to Patient Registry and Health Claims Data
Authors: Lau, E. L., Mowat, F. S., Kelsh, M. A., Legg, J., Engel-Nitz, N. M., Watson, H. N., Collins, H., Nordyke, R. J., Whyte, J. L.
Affiliations:
Publications: Value in Health, 14(3):A178
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


A Validation Study of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data
Authors: Whyte, J. L., Engel-Nitz, N., Teitelbaum, A., Gomez-Rey, G., Kallich, J.
Affiliations:
Publications: Value in Health, 14(3):A6
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Development of Algorithms to Identify Metastatic Cancer in Claims Data, Using Oncology EMR Data
Authors: Nordstrom, B., Whyte, J., Kallich, J.
Affiliations:
Publications: AHRQ Symposium on Research Methods for Comparative Effectiveness and Patient-Centered Outcomes Research
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Retrospective database analysis


Analisi di budget impact sullâ€™utilizzo di pegfilgrastim nella profilassi della neutropenia febbrile in Italia.
Authors: Rosti G1, Lebboroni M1, Cerchiari A2, Katz P3.
Affiliations: 1 Oncologia Medica, Ospedale Regionale, Azienda UnitÃ Locale Socio Sanitaria nÂ°9 di Treviso, 2 Amgen DompÃ¨ SpA, Italia, 3 CSD Medical Research Srl, Italia
Publications: Farmeconomia e percorsi terapeutici. 12(3). 119-127.
Document Types: , Article
Countries: , Italy
Condition	Year	Language	Analysis type
, Health economics, Oncology	2011	Italian	, Budget impact


The use of large GPs longitudinal database in the research of causal associations among pathologies : the case of diabetes and cancer incidence
Authors: Katz P 1, Ripellino C 1, Heiman F 1, Chatenoud L. 2
Affiliations: 1 CSD Medical Research srl, Milan, Italy, 2 Istituto di Ricerche Farmacologiche, Milan, Italy
Publications: ISPOR Annual European Congress, Madrid, 2011
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2011	English	, Retrospective database analysis


Observations of hepatocellular carcinoma (HCC) management patterns from the multinational HCC BRIDGE study: First overall analysis of the North American cohort
Authors: Roberts L, Sherman M, Castel H, Schwartz M, Therneau T, Huang B, Orsini LS
Affiliations:
Publications: American Association for Study of Liver Diseases. Nov 2011. San Francisco, CA
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, RWLPR (Real-World Late Phase Research-quintiles


Observed patterns of systemic therapy use in hepatocellular carcinoma (HCC) patients from the multinational HCC BRIDGE study: An initial analysis
Authors: Roberts L, Colombo M, Schwartz M, Degos F, Sherman M, Chen PJ, Chen M, Park JW, Kudo M, Johnson O, Therneau T, Huang B, Orsini, LS
Affiliations:
Publications: International Liver Cancer Association. Sept 2011. Hong Kong
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, RWLPR (Real-World Late Phase Research-quintiles


Observations of hepatocellular carcinoma (HCC) management patterns from the multinational HCC BRIDGE study: An interim analysis
Authors: Sherman M, Colombo M, Roberts L, Schwartz M, Degos F, Chen PJ, Chen M, Park JW, Kudo M, Johnson P, Therneau T, Huang B, Orsini LS
Affiliations:
Publications: International Liver Cancer Association. Sept 2011. Hong Kong
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, RWLPR (Real-World Late Phase Research-quintiles


Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes
Authors: Campion FX, Larson LR, Kadlubek PJ, Earle CC, Neuss MN
Affiliations:
Publications: J Oncol Pract 2011; 7(3s):31s-35s
Document Types: , Article
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, RWLPR (Real-World Late Phase Research-quintiles


Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
Authors: Chen M1, Therneau T, Orsini LS, Qiao YL.
Affiliations: Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangdong Province, China
Publications: BMC Gastroenterol. 2011 May 12;11:53
Document Types: , Article
Countries: , China
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115904/
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Clinical setting: hospital, Retrospective cohort analysis


Oncology Market Research Provides a Feasible Index for Standardization of Colorectal Cancer Chemotherapy.
Authors: Inoue Y, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Kusunoki M
Affiliations: 1 Department of Gastrointestinal and Pediatric surgery,2 Division of reparative medicine, 3 Institute of Life Sciences,4Mie University Graduate school of Medicine, Mie, Japan, 4 IMS Health Oncology, Fairfield, CT, USA
Publications: Japanese journal of clinical oncology, 2011, 41(10):1203-1208
Document Types: , Book chapter
Countries:
Condition	Year	Language	Analysis type
, Oncology	2011	English	, Cost effectiveness, Database Study, Retrospective database analysis


Metagenes Associated with Survival in Non-Small Cell Lung Cancer
Authors: Urgard E, Vooder T,VÃµsa U, VÃ¤lk K, Liu M,Luo C, Hoti F, Roosipuu R, Annilo T, Laine J, Frenz CM, Zhang L, Metspalu A
Affiliations: Department of Information and Computer Science, Aalto University School of Science, Otakaari 1, FI-02150 Espoo, Finland
Publications: Stat Med
Document Types: , Article
Countries: , Estonia
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118451/
Condition	Year	Language	Analysis type
, Oncology	2011	English


Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population.
Authors: Asukai Y1, Valladares A2, Camps C3, Wood E1, Taipale K4, Arellano J4, Cassinello A2, Sacristan JA2, Dilla T2.
Affiliations: 1 IMS Health, London, UK 2 Eli Lilly SA, Madrid, Spain 3 Hospital General Universitario, Valencia, Spain 4 Eli Lilly, Windlesham, Surrey, UK
Publications: BMC Cancer. 2010 Jan 29;10:26
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20113499
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost effectiveness


Cost effectiveness of cetuximab in 1st-line treatment of metastatic colorectal cancer in the UK
Authors: Griebsch I1, Eggington S2, Garrell D3, Samyshkin Y2
Affiliations: 1 Merck KGaA, Darmstadt, Germany; 2 IMS Health, London, UK; 3 Merck Serono UK, Middlesex, UK
Publications: ASCO Gastrointestinal symposium, Orlando, Florida 22-24 January 2010
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost effectiveness


[Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for Germany]
Authors: Sehouli J1, Goertz A1, Steinle T1, Dubois R1, Plesnila-Frank C2, Lalla A1, von Minckwitz G1
Affiliations: 1 CharitÃ©/Campus Virchow-Klinikum, Klinik fÃ¼r GynÃ¤kologie, UniversitÃ¤tsmedizin Berlin, Berlin, Germany 2 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: Deutsche medizinische Wochenschrift 2010 Mar, 135(9): 385-9
Document Types: , Article
Countries: , Germany
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20180162
Condition	Year	Language	Analysis type
, Oncology	2010	German	, Cost effectiveness


Krebsinzidenz bei insulinpflichtigen Diabetikern in Deutschland â€“ eine Analyse der Publikation von Hemkens et al. anhand der STROBE-QualitÃ¤tskriterien [Cancer incidence for insulin-dependent diabetics in Germany - an analysis of the publication of Hemkens et al. based on the STROBE criteria]
Authors: Fuchs S1, Fricke F-U1,2, Pirk O1
Affiliations: 1 IMS Health GmbH & Co. OHG, Nuremberg, Germany 2 Georg Simon Ohm University, Nuremberg, Germany
Publications: Perfusion 2010; 23: 4-10
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2010	German	, Literature Review


Cost effectiveness of cetuximab in 1st-line treatment of metastatic colorectal cancer in the UK: A summary of the submission to NICE
Authors: Griebsch I1, Samyshkin Y2, Eggington S2, Garrell D3
Affiliations: 1 Merck Serono, Germany 2 IMS Health HEOR, London UK 3 Merck Serono, UK
Publications: 12th World Congress on Gastrointestinal Cancer, Barcelona 30 June - 3 July 2010
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost effectiveness


Cost-utility analysis of Dasatinib as a second-line treatment in the chronic phase of Chronic Myeloid Leukaemia in Russia
Authors: Kuznetzov SV1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4
Affiliations: 1 Haematology Research Centre, Russian Academy of Medical Sciences (RAMN), Moscow, Russia 2 IMS Health, London, UK 3 BMS Russia, Moscow, Russia 4 BMS Europe, Belgium
Publications: ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , Russian Federation
Abstract: http://www.ispor.org/Events/Index.aspx?eventId=33
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost utility


Outcomes and costs of Nanoparticle Albumin-bound(NAB) Paclitaxel compared to Docetaxel in women with pretreated metastatic breast cancer.
Authors: Donatti CM1, McLeod E1, Lloyd A1, PruniÃ¨ras FJ2
Affiliations: 1 Health Economics & Outcomes Research, IMS Health, London, UK 2 Pricing and Reimbursement, Abraxis Bioscience, Paris, France
Publications: International Society for Quality of Life Research, 17th Annual Conference, October 27-30, 2010, Hilton Metropole, London, England
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost benefit


Indirect comparison and UK cost-effectiveness analysis of paclitaxel albumin vs docetaxel for pretreated metastatic breast cancer
Authors: Prunieras F1, McLeod E2, Lloyd A2, Canney P3
Affiliations: 1Abraxis Bioscience, Paris, France 2 IMS Health, London, UK, 3 Glasgow, UK
Publications: 35th ESMO Congress, 8-12 October 2010, Milan, Italy
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost effectiveness


A UK Cost-Utility Analysis of Paclitaxel Albumin compared to solvent-based Paclitaxel Monotherapy and Docetaxel Monotherapy for pretreated Metastatic Breast Cancer (Mbc)
Authors: McLeod EJ1, Lloyd A1, Samyshkin Y1, PruniÃ¨ras F2, Canney P3
Affiliations: 1IMS Health, London, UK, 2Abraxis Bioscience, Paris, France, 3Beatson West of Scotland Cancer Centre, Glasgow, UK
Publications: ISPOR 13th Annual European Congress, 6-9 November 2010, Prague, Czech Republic
Document Types: , Poster
Countries: , UK
Abstract: http://www.ispor.org/congresses/Prague1110/posters1.aspx
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost utility


Quality of life, outcomes and costs in the Belgian population receiving 90Y-Zevalin for non-hodgkin lymphoma: a study for reimbursement revision.
Authors: Caekelbergh K, Moeremans K
Affiliations: IMS Health Consulting, Brussels, Belgium
Publications: ISPOR 13th Annual European Congress, 2010, November 6-9, Prague, Czech Republic
Document Types: , Abstract
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Quality of life


Change of antifungal tretment patterns and associated costs in patients with acute myelogenous leukemia (AML) after chemotherapy in a german hospital from 2004 to 2006
Authors: Boehme A1, Atta J1, Mousset S1, Steffen B1, Serve H1, Hoelzer D1, Shlaen R2, Ehlken B2, Bug G1
Affiliations: 1 Med Clinic II, J.W. Goethe-University, Frankfurt, Germany, 2 IMS Health GmbH & Co. OHG, Munich, Germany
Publications: ISPOR 13th Annual European Congress, 6-9 Nov., 2010, Prague, Czech Republic
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective cohort analysis


Cost-utility analysis of dasatinib as a second line treatment in the chronic phase of chronic myeloid leukaemia in Russia
Authors: Kuznetzov S1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4
Affiliations: 1 Haematology Research Centre, Moscow, Russia, 2 IMS Health, London, UK, 3 BMS, Moscow, Russia, 4 BMS, Braine Lâ€™Alleud, Belgium
Publications: ISPOR 13th Annual European Congress, 6-9 November 2010, Prague Congress Centre, Prague, Czech Republic.
Document Types: , Poster
Countries: , Russian Federation
Condition	Year	Language	Analysis type
, Hematology, Oncology	2010	English	, Cost utility


Real-Life Cost Analysis of Anemia Treatment with Erythropoiesis Stimulating Agents In Cancer Patients Receiving Chemotherapy
Authors: Duran A1, Spaepen E2, Lamotte M3, Walter E4, Kutikova L5, Pujol B5, Annemans L6
Affiliations: 1 IMS Health, London, UK; 2 SBD Analytics BVBA/SPRL, Belgium; 3 IMS Health, Brussels, Belgium; 4 Institut fuer Pharmacoekonomische Forschung, Vienna, Austria; 5 Amgen (Europe) GmbH, Zug, Switzerland; 6 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publications: American Society of Hematology. December 4-7, 2010 Orlando, FL. USA
Document Types: , Poster
Countries: , Austria
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost analysis


The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.
Authors: Gerlier L1, Lamotte M1, Awada A2, Bosly A3, Bries G4, Cocquyt V5, Focan C6, Henry S7,8, Lalami Y2, Machiels JP9, Mebis J10, Straetmans N11, Verhoeven D12, Somers L13
Affiliations: 1 IMS Health Consulting, Vilvoorde Belgium 2 Jules Bordet Institute, Brussels, Belgium 3 University Hospital of Mont-Godinne, Yvoir, Belgium 4 Virga Jesse Hospital, Hasselt, Belgium 5 University Hospital Ghent, Gent, Belgium 6 CHC-Saint-Joseph Clinic, LiÃ¨ge, Belgium 7 University Hospital of Mont-Godinne, Yvoir, Belgium 8 Sainte-Elisabeth Clinic, Namur, Belgium 9 UCL Saint-Luc University Hospital, Brussels, Belgium 10 Virga Jesse Hospital, Hasselt, Belgium 11 Jolimont Hospital, Haine-Saint-Paul, Belgium 12 AZ Klina, Brasschaat, Belgium 13 OncoLogX, Wuustwezel, Belgium
Publications: BMC Cancer, 2010, 10:642
Document Types: , Article
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Survey research


Cost Evaluation study of oral treatment with Xeloda and Tarceva compared to intravenous chemotheraphy from the perspective of a Spanish private insurance company
Authors: Benito A1, Caballo B2, Gomez J2, Moyano N3, Gimenez E4, Prior M4.
Affiliations: 1 Mapfre Familiar, 2 H. U.Madrid Sanchinarro, 3Hospital QuirÃ³nMadrid, 4 IMS Health, barcelona, Spain
Publications: Revista EspaÃ±ola EconomÃa de la Salud 2010;9(1):28-36
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2010	Spanish	, Economic evaluation


Clinical and economic burden of toxicities associated with monoclonal antibodies for metastatic colorectal cancer (MCRC).
Authors: Burudpakdee C, Zhao Z, Trochlil K, Gao S, Munakata J, Barber B
Affiliations:
Publications: The 35th ESMO Congress, 2010, October 8-12, Milan
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Cost analysis


Systematic Therapy for Metastatic Colorectal Cancer: Patterns of Chemotherapy and Biologic Therapy Use in US Medical Oncology Practice
Authors: Hess, G. P., Wang, P. F., Quach, D., Barber, B., Zhao, Z.
Affiliations:
Publications: Journal of Oncology Practice, 6(6):301-307
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Real-World Use of Granulocyte Colony-Stimulating Factor Support with CHOP+/-R Therapy for Non-Hodgkin's Lymphoma
Authors: Campomayor, C., Jurss, L.
Affiliations:
Publications: The Journal of Supportive Oncology, 8(5):A12
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Clinical Practice Use of Absolute Neutrophil Count Monitoring with Chemotherapy
Authors: Barron, R. L., Pirolli, M., Hess, G., Quach, D., Quigley, J. M., Hill, J.
Affiliations:
Publications: JMCP
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Hemoglobin Trends Among Patients with Anemia with Concomitant Chemotherapy in the Community Oncology Clinic Setting
Authors: Feinberg, B., Gilmore, A., Haislip, S., Gilmore, J., Jain, G., Whyte, J.
Affiliations:
Publications: Supportive Care in Cancer, 18:S138
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Trends in Erythropoiesis-Stimulating Agents (ESAs) Utilization and Hemoglobin (Hb) Levels Among Cancer Patients Undergoing Chemotherapy (2006-2008)
Authors: Hill, J., Cong, Z., Hess, G., Nordyke, R.
Affiliations:
Publications: Supportive Care in Cancer, 18:S138-9
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K.
Authors: Arana A, Wentworth CE, FernaÂ´ndez-Vidaurre C, Schlienger RG, Conde E & Arellano F
Affiliations: Risk Management Resources, Pharmacovigilance Services SL, Spain
Publications: Br J Dermatol. 2010 Nov;163(5):1036-43. doi: 10.1111/j.1365-2133.2010.09887.x.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20545690
Condition	Year	Language	Analysis type
, Dermatology, Oncology	2010	English	, Retrospective database analysis


Incidence rates of edema in solid tumor cancer patients in the THIN Database.
Authors: Gastanaga V, Wenstowrth C, Ganesh V, Hughes G, Xue F, Verma M, Dimery I & Zhao S
Affiliations: Amgen
Publications: Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf?
Condition	Year	Language	Analysis type
, Cardiovascular disease, Oncology	2010	English	, Retrospective database analysis


Incidence rates of retinal artery thrombosis in solid tumor cancer patients in the THIN Database
Authors: Gastanaga V, Wentworth C, Hughes G, Xue F, Ganesh V, Verma M, Dimery I & Zhao S
Affiliations: Amgen
Publications: Pharmacoepidemiol Drug Saf. 2010 Aug;19:S1-S347.
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf?
Condition	Year	Language	Analysis type
, Cardiovascular disease, Oncology, Ophthalmology	2010	English	, Retrospective database analysis


Lymphoma among patients with atopic dermatitis treated with topical corticosteroids and/or topical calcineurin inhibitors
Authors: Arana A, Wentworth CW, Rivero E, Plana E & Conde E
Affiliations: Risk MR Pharmacovigilance Services, Zaragoza, Spain
Publications: Journal of American academy of dermatology 2010
Document Types: , Abstract
Countries: , UK
Abstract: http://www.jaad.org/article/S0190-9622(10)01118-7/abstract
Condition	Year	Language	Analysis type
, Dermatology, Oncology	2010	English	, Retrospective database analysis


Explorative analysis about the potential of a large GPs longitudinal database on searching causal associations among pathologies
Authors: Katz P, Heiman F.
Affiliations: CSD Medical Research srl
Publications: ISPOR Annual European Congress, Prague, 2010
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Diabetes, Oncology	2010	English	, Retrospective database analysis


Capturing breast cancer patients experience beyond disease progression: Implementation of a patient-reported outcome (PRO) substudy in the VIRGO metastatic breast cancer observational cohort study
Authors: Kaufman PA, Dreyer NA, Mayer M, Sloan JA, Chung CY, Sing A, Yim YM, Yu E, Mathias SD, Cleeland CS
Affiliations:
Publications: ASCO. June, 2010
Document Types: , Abstract
Countries:
Condition	Year	Language	Analysis type
, Oncology	2010	English	, RWLPR (Real-World Late Phase Research-quintiles


NICE implementation uptake report: The diagnosis and treatment of lung cancer.
Authors:
Affiliations: IMS
Publications: NICE Guidance
Document Types: , Article
Countries: , UK
Abstract: http://www.nice.org.uk/media/8E2/8C/UptakeReportLungCancerFinal.pdf
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Reasons for discontinuation of hormonal therapy in breast cancer patients across five european countries.
Authors: Petrilla AA, Ferrufino
Affiliations: CPIMS Health, Falls Church, VA, USA
Publications: ISPOR 13th Annual European Congress
Document Types: , Poster
Countries:
Abstract: http://www.ispor.org/research_pdfs/36/pdffiles/PCN157.pdf
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Retrospective database analysis


Incidence of cancer and statin usageâ€”record linkage study
Authors: Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J
Affiliations: Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland
Publications: International Journal of Cancer (2010); 126(1):279-84
Document Types: , Article
Countries: , Finland
Abstract: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.24536
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Epidemiological study, Population Based Study, Retrospective cohort analysis


Incidence of cancer and antidepressant medication: Record linkage study
Authors: Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J
Affiliations: Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland
Publications: International Journal of Cancer (2010);126(1):285-96
Document Types: , Article
Countries: , Finland
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.24537
Condition	Year	Language	Analysis type
, Oncology	2010	English	, Epidemiological study, Population Based Study, Retrospective database analysis


Epidemiologic study to assess patients' involvement with adjuvant chemotherapy in breast cancer (PROSA study).
Authors: Tusquets I1, Espinosa Arranz E2, MÃ©ndez M3, JM Gil4, Guayar JL5, Perulero N6.
Affiliations: 1 Servicio de OncologÃa, Hospital de Mar, Barcelona, Spain 2 Servicio de OncologÃa, Hospital de la Paz, Madrid, Spain 3 Servicio de OncologÃa, Hospital de MÃ³stoles, Madrid, Spain 4 Institut CatalÃ de Oncologa- hospital Duran i Reynals, Lâ€™Hospitalet, Spain 5 Sanofi-Aventis, Barcelona, Spain 6 IMS Health, HEOR Barcelona, Spain
Publications: Clin Transl Oncol. 2009;11(4):221-7.
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19380299
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Epidemiological study


Cost-effectiveness of Rituximab combined with Fludarabine and Cyclophosphamide in previously untreated patients with Chronic Lymphocytic Leukemia in France
Authors: Roussel M1, Troussard X2, Delmer A3, Poinso M4, Miadi-Fargier H5
Affiliations: 1 Roche, Neuilly-sur-Seine, France 2 ClÃ©menceau Hospital, Haematology department, Caen, France 3 Robert DebrÃ© Hospital, Haematology department, Reims, France 4 IMS Health HEOR, Puteaux, France
Publications: ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009
Document Types: , Poster
Countries: , France
Abstract: http://www.ispor.org/congresses/paris1009/Posters1.aspx
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost effectiveness


Mobilization with chemotherapy compared to G-CSF alone: an analysis of resource use and cost in autologous stem cell transplant patients.
Authors: Pelletier EM1, Smith PJ1, Dembek CJ2.
Affiliations: 1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA
Publications: BMT Tandem Meeting, 2009, February 11-15, Tampa, FL, US
Document Types: , Abstract, Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost analysis


Cost effectiveness of Cetuximab in first line treatment of metastatic colorectal cancer: description of a NICE submission
Authors: Eggington SG1, Garrell D2, Griebsch I3, Samyshkin Y1
Affiliations: 1IMS Health, London, UK, 2Merck Serono UK, Feltham, UK, 3Merck KGaA, Darmstadt, Germany
Publications: ISPOR 12th Annual European Congress, Paris France, 24-27 October 2009
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost effectiveness


Cost-effectiveness analysis of Pemetrexed/Cisplatin in the first-line treatment of non-small cell lung cancer in Italy: results for the Adenocarcinoma histology sub-population
Authors: Guidi L1, Malik S2, Valle D1, Asukai Y2, Taipale K3
Affiliations: 1Eli Lilly Italia S.p.A., Firenze, Italy, 2IMS Health, London, UK, 3Eli Lilly and Company, Lilly Research Centre, Windlesham, UK
Publications: ISPOR 12th Annual European Congress, 24th â€“ 27th October 2009, Paris, France
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost effectiveness


Cost utility analysis of 90y-Ibritumomab Tiuxetan following first-line chemotherapy compared to no follow-up in patients with stage III or IV follicular lymphoma in Spain
Authors: Eggington S1, PiÃ±ol C2, Musi E3, Valderrama A4
Affiliations: 1IMS Health, London, Camden, UK, 2Bayer HealthCare, Barcelona, Spain, 3Bayer HealthCare, Sant Joan DespÃ (Barcelona), Catalonia, Spain, 4Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA
Publications: ISPOR 12th Annual European Congress, 24th â€“ 27th October 2009, Paris, France
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost utility


The bone metastases quality of life questionnaire (BOMET-QoL. In: Preedy VR and Watson RR. Handbook of Disease Burdens and Quality of Life Measures.
Authors: Badia X, Vieta A, Gilabert M.
Affiliations: Badia X1, Vieta A1, Gilabert M2. 1 IMS Health HEOR Spain 2 Novartis Oncology, Spain
Publications: New York: Springer 2009;Part 1:195-207
Document Types: , Book chapter
Countries:
Abstract: http://www.springerlink.com/content/r23j12761mm36354/
Condition	Year	Language	Analysis type
, Oncology	2009	English	, , Burden of illness, Quality of life


Cost-effectiveness analysis of Pemetrexed in the first-line treatment of non-small cell lung cancer in Italy: Results for the adenocarcinoma histology sub-population
Authors: Guidi L1, Malik S2, Valle D1, Asukai Y2, Taipale K3
Affiliations: 1Eli Lilly Italia S.p.A., 2IMS Health, London, UK, 3Eli Lilly and Company, Lilly Research Centre, UK
Publications: ISPOR 12th Annual European Congress, 24th - 27th October 2009, Paris, France
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost effectiveness


Custo do tratamento do cancro em Portugal. [Cost of cancer care in Portugal].
Authors: AraÃºjo A1, Barata F2, Barroso S3, Cortes P4, Damasceno M5, Parreira A6, EspÃrito Santo J7, Teixeira E8, Pereira R9.
Affiliations: 1 ServiÃ§o de Oncologia. Instituto PortuguÃªs de Oncologia. Porto 2 ServiÃ§o de Pneumologia. Centro Hospitalar de Coimbra. Coimbra 3 ServiÃ§o de Oncologia. Hospital do EspÃrito Santo. Ã‰vora 4 ServiÃ§o de Oncologia. Hospital de Santa Maria. Lisboa 5 ServiÃ§o de Oncologia. Hospital de SÃ£o JoÃ£o. Porto 6 Departamento de Hematologia. Instituto PortuguÃªs de Oncologia. Lisboa 7 ServiÃ§o de Oncologia. Hospital de Nossa Senhora do RosÃ¡rio. Barreiro 8 ServiÃ§o de Pneumologia, Hospital de Santa Maria. Lisboa 9 IMS Health Portugal, HEOR
Publications: Acta Med Port 2009; 22: 525-536.
Document Types: , Article, Manuscript in preparation
Countries: , Portugal
Condition	Year	Language	Analysis type
, Oncology	2009	Spanish	,


Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Authors: Mayordomo JI, LÃ³pez A, ViÃ±olas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, SÃ¡nchez J; ENIA Study Group.
Affiliations: 1 ClÃnico Lozano Blesa, Zaragoza, Spain 2 Vall dâ€™Hebron, Barcelona, Spain 3 ClÃnic i Provincial, Barcelona, Spain 4 Xeral-CÃes, Vigo, Spain 5 Institut CatalÃ dâ€™Oncologia, Lâ€™Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de CastellÃ³n, CastellÃ³n, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain
Publications: Curr Med Res Opin. 2009 Oct;25(10): 2533-42.
Document Types: , Article
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563
Condition	Year	Language	Analysis type
, Hematology, Oncology	2009	English	,


Patient out-of-pocket payments for second-line non-small-cell lung cancer oncologic therapies: results from a U.S. claims data analysis.
Authors: Pelletier EM1, Tierce J2, Reyes CM3
Affiliations: 1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA
Publications: International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer (WCLC), 2009, August, San Francisco, CA, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost of illness


Patient characteristics and patterns of therapy use among newly diagnosed patients with early breast cancer: results from a U.S. claims data analysis.
Authors: Pelletier EM1, Smith DB1, Kaura S2, Zelt S2, Battleman DS3
Affiliations: 1IMS Health, Watertown, MA, USA, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3IMS Health, Falls Church, VA, USA
Publications: 32nd Annual San Antonio Breast Cancer Symposium, 2009, December, San Antonio, TX, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


Patient out-of-pocket payments for oral oncologic therapies: updated results from a U.S. claims data analysis.
Authors: Pelletier EM1, Tierce J2, Yim YM3, Reyes C3
Affiliations: 1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genentech Inc., South San Francisco, CA, USA
Publications: American Society of Clinical Oncology (ASCO) 45th Annual Meeting, 2009, May, Orlando, FL, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Cost analysis


Health economic review of non-small cell lung cancer (NSCLC) treatment in the United States.
Authors: Munakata J1, Trochlil K1, Battleman D1, Foley D2
Affiliations: 1IMS Health, Falls Church, VA, USA, 2Boehringer Ingelheim Ltd, Ridgefield, CT, USA
Publications: ISPOR 12th Annual Europena Congress, Paris, France 24-27 October 2009 PCN145
Document Types: , Poster
Countries: , USA
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Literature Review


The Importance of Clinical Variables in Comparative Analyses Using Propensity Score Matching: the Case of ESA Costs for the Treatment for Chemotherapy-Induced Anemia
Authors: Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J.
Affiliations:
Publications: Pharmacoeconomics, 27(9):755-765
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


Review: Use of Electronic Medical Records for Health Outcomes Research: A Literature Review
Authors: Dean, B. B., Lam, J., Natoli, J. L., Butler, Q., Aguilar, D., Nordyke, R. J.
Affiliations:
Publications:
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


Erythropoiesis Stimulating Agent (ESA) Administration at Hb<10 G/Dl for Chemotherapy-Induced Anemia (CIA) Following the National Coverage Decision (NCD)
Authors: Hulnick, S. A., Hess, G., Hill, J., Viswanathan, H. N., Nordyke, R. J.
Affiliations:
Publications: Journal of Clinical Oncology, 27(suppl; abstract e20627): Pub only abstract for ASCO
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA) (2006~2008)
Authors: Hill, J., Cong, Z., Hess, G. P., Nordyke, R.
Affiliations:
Publications: Blood
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


NSAID use and risk of leukaemia: a population-based case-control study
Authors: Bhayat F, Das-Gupta E, Smith C & Hubbard R
Affiliations: Division of Epidemiology and Public Health, University of Nottingham
Publications: Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):833-6. doi: 10.1002/pds.1789.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19551758
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


The incidence of and mortality from leukaemias in the UK: a general population-based study
Authors: Bhayat F, Das-Gupta E, Smith C, McKeever T & Hubbard R
Affiliations: Division of Epidemiology and Public Health, University of Nottingham
Publications: BMC Cancer 2009, 9:252
Document Types: , Abstract
Countries: , UK
Abstract: http://www.biomedcentral.com/1471-2407/9/252
Condition	Year	Language	Analysis type
, Hematology, Oncology	2009	English	, Retrospective database analysis


Cancer incidence in The Health Improvement Network
Authors: Haynes K, Forde KA, Schinnar R, Wong P, Strom BL & Lewis JD
Affiliations: Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medic
Publications: Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):730-6. doi: 10.1002/pds.1774.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19479713
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom.
Authors: Arellano FM, Arana A, Wentworth CE, FernÃ¡ndez-Vidaurre C, Schlienger RG & Conde E
Affiliations: Risk MR, LLC, Bridgewater, NJ, USA
Publications: J Allergy Clin Immunol. 2009 May;123(5):1111-6, 116.e1-13. doi: 10.1016/j.jaci.2009.02.028. Epub 2009 Apr 10.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19361841
Condition	Year	Language	Analysis type
, Dermatology, Hematology, Oncology	2009	English	, Retrospective database analysis


The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study
Authors: Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T
Affiliations: Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol
Publications: BMC Medicine 2009, 7:17
Document Types: , Article
Countries: , UK
Abstract: http://www.biomedcentral.com/1741-7015/7/17
Condition	Year	Language	Analysis type
, Oncology	2009	English	, Retrospective database analysis


A Model to Demonstrate the Comparative Costs Between Panitumumab and Cetuximab for Third-line Metastatic Colorectal Cancer Patients in Italy
Authors: Bracco A1 Farrimond BJ2 Fitzgibbon JW2 Eggington SG2 Lavelle RJB2 Lamarque H1
Affiliations: 1Amgen, Zug, Switzerland; 2IMS Consulting, Cambridge, United Kingdom
Publications: ISPOR 11th Annual European Congress, 8 - 11November 2008, Athens, Greece
Document Types: , Poster
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Economic evaluation


Cost-Effectiveness of Pemetrexed Plus Cisplatin: Malignant Pleural Mesothelioma Treatment in UK Clinical Practice
Authors: Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J
Affiliations:
Publications: Value in Health 11 (1), 4â€“12.
Document Types: , Manuscript in preparation
Countries: , UK
Abstract: http://www.mesothelioma-line.com/articles/2008/02/02/cost-effectiveness-of-pemetrexed-plus-cisplatin-malignant-pleural-mesothelioma-treatment-in-uk-clinical-practice/trackback/
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost effectiveness


Impact of brain metastases on health care costs associated with the management of patients with metastatic breast cancer in France and Germany.
Authors: S Cottrell1, M Walker2, H Scheijbeler1, L Christova1, N Hertel3, B Hass3, M Behrens4, E Roux5, M Amonkar6, Aristides M1
Affiliations: 1 IMS HEOR, London, UK 2 GlaxoSmithKline, Greenford, UK 3 IMS HEOR, Nuremberg, Germany 4 GlaxoSmithKline, Munich, Germany 5 GlaxoSmithKline, Paris, France 6 GlaxoSmithKline, Philadelphia, USA
Publications: 6th European Breast Cancer Conference (EBCC-6), 15-19 April 2008, Berlin, Germany
Document Types: , Oral presentation
Countries: , France, Germany
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Budget impact


Can the Spanish care system assume the new costs of medications against cancer?
Authors: Camps C, Caballero C, Sirera R, Blasco A, Cayuela D, Gil M, Badia X
Affiliations:
Publications: Clin Transl Oncol 2008;10(2):96-101
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost consequence


Endoscopic ultrasound guided fine-needle aspiration for the staging of non-small cell lung cancer and the diagnosis of mediastinal masses
Authors: Medical Services Advisory Committee (assessors Pricing and Market Access, Sydney Australia)
Affiliations:
Publications: Commonwealth of Australia
Document Types: , Review
Countries: , Australia
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17296659?dopt=Abstract
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Review


Economic Burdern of Toxicities Associated with Salvage Treatment in Advanced and Metastic Breast Cancer.
Authors: Kowal-Podmore S1, Munakata J1, Tencer T, Smith TW1
Affiliations: 1 IMS Health, Falls Church, VA, US
Publications: ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008.
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost analysis


Five-Year Routine Cervical Cancer Screening Rates and Intervals in a United States Health Plan
Authors: Schabert VF, Ye X, Insinga RP, Singhal PK, Riedel AA
Affiliations:
Publications: Current Medical Research and Opinion 2008; 24(9):2429-2435.
Document Types: , Manuscript in preparation
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Observational study


Development of a questionnaire on the effects of hot flashes on the quality of life of patients with advanced prostatic cancer. ESCAPA study
Authors: Carballido RodrÃguez JA, Tisaire JL, Perulero N
Affiliations:
Publications: Medicina ClÃnica 2008;130(15):561-567
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	Spanish	, Quality of life


Cost-effectiveness analysis of darbepoetin alfa every three week versus its weekly administration in the treatment of chemotherapy-induced anemia
Authors: Riera M, PÃ©rez F, Vieta A, Arocho R
Affiliations:
Publications: Pharmacoeconomics Spanish Research Articles 2008;5(1):1-10
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	Spanish	, Cost effectiveness


Cost Utility Analysis of Alemtuzumab compared to chlorambucil in untreated patients with high-risk (17p-) Chronic Lymphocytic Leukemia in the United Kingdom.
Authors: Lloyd AC1,Valderrama A2,Ferguson J3, Gilmour L3, Ravndal F1
Affiliations: 1 IMS, London, United Kingdom, 2 Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA, 3 Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, United Kingdom
Publications: ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008.
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost utility


Cost Effectiveness of Cetuximab in first line treatment of Metastatic Colorectal Cancer: A Modelling Approach for the UK
Authors: Garrell D1, Griebsch I2, Samyshkin Y3
Affiliations: 1Merck Serono UK, Feltham, United Kingdom, 2Merck KGaA, Darmstadt, Germany, 3IMS Health, London, United Kingdom
Publications: ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost effectiveness


Cost-effectiveness and development of new drugs in oncology
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 2nd Symposium New Paradigms of quality of oncological assistance 2008 June 20. Valencia, Spain
Document Types: , Invited speaker
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	Spanish	, Cost effectiveness


Cost-utility analysis in a Spanish setting of adjuvant therapy with trastuzumab (HerceptinÂ®) in patients with her-2 positive breast cancer
Authors: Polanco C, Carulla M, Badia X, Ramirez-Arellano A
Affiliations:
Publications: ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost utility


Health economic evaluation of treating anemia in cancer patients receiving chemotherapy: a study in Belgian hospitals.
Authors: Spaepen E, Demarteau N, Van Belle S, Annemans L
Affiliations:
Publications: The Oncologist, 2008, 13: 596-607
Document Types: , Article
Countries: , Belgium
Abstract: http://theoncologist.alphamedpress.org/cgi/content/full/13/5/596
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost analysis


Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Authors: Annemans L, RÃ©my V, Lamure E, Spaepen E, Lamotte M, Muchada JP, Largeron N
Affiliations:
Publications: Journal of Medical Economics, 2008, 11: 135-150
Document Types: , Article
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Economic evaluation


Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities.
Authors: Van Vlaenderen I1, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L1
Affiliations: 1 IMS Health, Brussels, Belgium
Publications: Acta Clin Belg. 2009 Mar-Apr;64(2):100-12.
Document Types: , Article
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost utility


Deriving utility values from the general population for induction chemotherapy administered before concurrent chemotherapy-radiation therapy in the treatment of head and neck cancer
Authors: Cordony A, Yuen C, Kovacs G, Guarnieri C, Adams J
Affiliations:
Publications: ISPOR 11th Annual European Congress 8â€“11 November 2008 Athens Greece ISPOR 11th Annual European Congress, Athens Greece, November 2008
Document Types: , Oral presentation, Poster
Countries: , Australia
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Utility analysis


Erlotinib bei nichtkleinzelligem Lungenkarzinom in Deutschland - eine kostensparende Option [Erlotinib in Non-Smal Cell Lung Cancer (NSCLC) - A cost-saving second-line treatment option]
Authors: Gatzemeier U1,Kotowa W2, Pirk O2, Gabriel A2, Heigener D1
Affiliations: 1 Zentrum fÃ¼r Pneumologie und Thoraxchirurgie Krankenhaus GroÃŸhansdorf, GroÃŸhansdorf, Germany 2 IMS Health, Nuremberg, Germany
Publications: Tumordiagn u Ther 2008; 29:Â 211-217
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2008	German	, Cost minimization


Economic evaluation of use of pegfilgrastim versus filgrastim in primary profilaxis in patients with breast cancer with febril neutropenia risk in Spain
Authors: Mayordomo CÃ¡mara JI, LÃ³pez Pousa A, GimÃ©nez GarcÃa E, Badia Llach X, Lara Surinyach N, Sorio Vilela F, Liu Z, Arocho R
Affiliations:
Publications: Pharmacoeconomics Spanish Research Articles 2008;5(3):71-81
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2008	Spanish	, Economic evaluation


Payer costs of autologous stem cell transplant: results for a U.S. claims data analysis.
Authors: Pelletier EM1, Smith PJ1, Dembek CJ2
Affiliations: 1IMS Health, Watertown, MA, USA, 2Genzyme Corporation, Cambridge, MA, USA
Publications: American Society of Hematology (ASH) 50th Annual Meeting, 2008, December 6-9, San Francisco, CA, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost analysis


Patient out-of-pocket payments for oral oncologic therapies: results from a U.S. claims data analysis.
Authors: Pelletier EM1, Tierce J2, Reyes CM3
Affiliations: 1IMS Health, Watertown, MA, USA, 2IMS Health, Falls Church, VA, USA, 3Genetech Inc., South San Francisco, CA, USA
Publications: International Association for the Study of Lung Cancer (IASLC) Multidisciplinary Symposium in Thoracic Oncology, 2008, November 13-15, Chicago, IL, USA
Document Types: , Poster
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost analysis


Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a U.S. claims data analysis.
Authors: Pelletier EM1, Shim B1, Goodman S1, Amonkar MM2
Affiliations: 1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA
Publications: Breast Cancer Research and Treatment, 2008, 108(2): 297-305 (epub 2007 Jun 19)
Document Types: , Manuscript in preparation
Countries: , USA
Abstract: http://epidemiology.researchtoday.net/archive/4/2/1532.htm
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Burden of illness, Cost analysis


Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series
Authors: Wolf J, Richardson PG, Schuster M, LeBlanc A, Walters IB, Battleman DS1
Affiliations: 1 IMS Health, Falls Church, VA, US
Publications: Clin Adv Hematol Oncol. Oct;6(10):755-60. 2008
Document Types: , Manuscript in preparation
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost utility


Adherence to Guidelines for Use of Erythropoieses-Stimulating Agents in Patients with Chemotherapy-Induced Anemia: Results of a Retrospective Study of an Electronic Medical-Records Database in the United States, 2002-2006
Authors: Luo, W., Nordstrom, B. L., Fraeman, K., Nordyke, R., Ranganathan, G., Linz, H. E., Winterkorn, A., Stokes, M., Ross, S. D., Knopf, K.
Affiliations:
Publications: Clinical Therapeutics, 30(12):2423-35
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients with Hemoglobin Exceeding 12 Grams Per Deciliter
Authors: Nordstrom, B. L., Luo, W., Fraeman, K. H., Whyte, J. L., Nordyke, R. J.
Affiliations:
Publications: Journal of Managed Care Pharmacy, 14(9):858-69
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Utilization of Darbepoetin Alfa in Relation to Cancer Patients' Hemoblogin Levels
Authors: Hess, G., Hill, J., Clough, J., Hulnick, S., Nordyke, R. J.
Affiliations:
Publications: Current Medical Research Opinion, 24(3):815-19
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of ESA Treatments for Chemotherapy Induced Anemia
Authors: Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J. L., Kallich, J.
Affiliations:
Publications: Blood, 112(11):4695
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions
Authors: Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D.
Affiliations:
Publications: Journal of Clinical Oncology, 26:A20589)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study
Authors: Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J.
Affiliations:
Publications: Journal of Clinical Oncology, 26:A20623)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Synchronization of Treatment with Erythropoiesis Stimulating Agents and Chemotherapy
Authors: Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R.
Affiliations:
Publications: Journal of Managed Care Pharmacy, 14(7):694
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study
Authors: Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C.
Affiliations:
Publications: Supportive Care in Cancer Journal, A41
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


The Importance of Clinical Variables for Propensity Score Matching When Comparing Costs: the Case of EMA Treatments for Chemotherapy Induced Anemia
Authors: Polsky, D., Eremina, D., Hess, G., Hill, J., Hulnick, S., Roumm, A., Whyte, J., L., Kallich, J.
Affiliations:
Publications: Blood, 112(11):4695
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Effect of Changes in Labeling and Reimbursement on Use of ESAs and Transfusions
Authors: Hess, G., Nordyke, R. J., Pirolli, M., Hulnick, S., Curry, A., Gesme, D.
Affiliations:
Publications: Journal of Clinical Oncology, 26:A20589)
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study
Authors: Nordstrom, B. L., Fraeman, K. H., Luo, W., Collins, J. M., O'Malley, C. D., Nordyke, R. J.
Affiliations:
Publications: Journal of Clinical Oncology, 26:A20623
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Synchronization of Treatment with Erythropoiesis-Stimulating Agents and Chemotherapy
Authors: Nordstrom, B. L., Fraeman, K. H., Collins, J. M., Luo, W., O'Malley, C. D., Whyte, J. L., Nordyke, R.
Affiliations:
Publications: Journal of Managed Care Pharmacy, 14(7):694
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Red Blood Cell Transfusions Among Cancer Patients in Chemotherapy: A Descriptive Epidemiologic Study
Authors: Nordstrom, B., Fraeman, K., Luo, W., Collins, J., O'Malley, C.
Affiliations:
Publications: Supportive Care in Cancer Journal, A41
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Validation of the CAPER score for diagnosis for colorectal cancer and comparison with NICE guidance
Authors: Hamilton WT, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T
Affiliations: University of Birmingham
Publications: The Society For Academic Primary Care, 37th Annual Scientific Meeting
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.sd.imshealth.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Antibiotic use and the risk of lung cancer.
Authors: Zhang H, GarcÃa RodrÃguez LA & HernÃ¡ndez-DÃaz S.
Affiliations: Department Epidemiology, Harvard School of Public Health
Publications: Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1308-15. doi: 10.1158/1055-9965.EPI-07-2817. Epub 2008 Jun 10.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18544646
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Recording of pancreatic, colorectal, and lung cancer incidence in the Health Improvement Network (THIN)
Authors: Haynes K, Schinnar R, Wong P, Strom B & Lewis J
Affiliations: Healthcore Inc
Publications: Pharmacoepidemiology and Drug Safety 17(S38) Pharmacoepidemiology and drug safety 2008
Document Types: , Abstract
Countries: , UK
Condition	Year	Language	Analysis type
, Miscellaneous, Oncology	2008	English	, Retrospective database analysis


Validation of THIN data for non-melanoma skin cancer.
Authors: Meal A1, Leonardi-Bee J, Smith C, Hubbard R, Bath-Hextall F.
Affiliations: School of Nursing, University of Nottingham
Publications: Qual Prim Care. 2008;16(1):49-52.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18700078
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Validation of cases of lymphoma in THIN
Authors: Arellano F, Conde E, Wentworth C, Schlienger R, Fernandez-Vidauure C & Arana A
Affiliations: GSK
Publications: 24th International Conference on Pharmacoepidemiology. January 2008 Pharmacoepidemiology and Drug Safety 17(S87-S88)
Document Types: , Abstract, Poster
Countries: , UK
Abstract: https://www.rtihs.org/publications/validation-cases-lymphoma-thin
Condition	Year	Language	Analysis type
, Immunology and Vaccination, Oncology	2008	English	, Retrospective database analysis


The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records.
Authors: Hamilton W, Lancashire R, Sharp D, Peters T J, Cheng K & Marshall T
Affiliations: Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol
Publications: Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18219289
Condition	Year	Language	Analysis type
, Hematology, Oncology	2008	English	, Retrospective database analysis


The risk of colorectal cancer with symptoms at different ages and between the sexes: a case-control study
Authors: Hamilton W, Lancashire R, Sharp D, Peters TJ, Cheng K & Marshall T
Affiliations: Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol
Publications: BMC Medicine 17;7:17. doi: 10.1186/1741-7015-7-17
Document Types: , Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19374736
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Retrospective database analysis


Bendamustine
Authors: Keating M, Bach C, Yashothan U, Kirkpatrick P
Affiliations: IMS Health, London
Publications: Nature Reviews Drug Discovery, 2008, 7:473-474
Document Types: , Article
Countries: , UK
Abstract: http://www.nature.com/nrd/journal/v7/n6/box/nrd2596_BX1.html
Condition	Year	Language	Analysis type
, Oncology	2008	English


Topotecan NICE submission: response document.
Authors:
Affiliations: QuintilesIMS
Publications: NICE Guidance
Document Types: , Manuscript in preparation
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2008	English


Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain.
Authors: Benedict A, Black L, Stokes M, Dorval
Affiliations: 1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada
Publications: ISPOR 11th Annual European Congress
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf
Condition	Year	Language	Analysis type
, Oncology	2008	English	, Cost effectiveness


Resource use and time savings in Spain linked with new chemotherapy presentations: the case of oxaliplatin
Authors: BetegÃ³n L, Echevarria A, Soler F, Quer N
Affiliations:
Publications:
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Burden of illness


Economic burdenÂ of brain metastasesÂ in breast cancer patients in a U.S. managed-care population.
Authors: Amonkar MM1, Pelletier EM2, Shim B2
Affiliations: 1GlaxoSmithKline, Collegeville, PA, USA, 2IMS Health, Watertown, MA, USA
Publications: American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA Journal of Clinical Oncology, 2007, Part I. Vol 25, No 18S (June 20 Supplement): 17069
Document Types: , Poster
Countries: , USA
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost analysis


A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (q3w_da) compared to weekly epoetin alfa (qw_ea) or epoetin beta (qw_eb) in patients with chemotherapy-induced anemia (cia): the Italian case
Authors: Esposito G, Lamotte M, Annemans L, Bracco A
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Italy
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost consequence


A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (q3w_da) compared to weekly epoetin alfa (qw_ea) or epoetin beta (qw_eb) in patients with chemotherapy-induced anemia (cia): the German case.
Authors: Van Bellinghen LA, Esposito G, Lamotte M, Bracco A, Goertz A, Annemans L
Affiliations:
Publications: ISPOR 10th Annual European Congress Value in Health 10(6):A328 ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
Document Types: , Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost consequence


Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice.
Authors: Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J
Affiliations:
Publications: Value in Health. In press
Document Types: , Manuscript in preparation
Countries: , UK
Abstract: http://www.mesothelioma-line.com/articles/2008/02/02/cost-effectiveness-of-pemetrexed-plus-cisplatin-malignant-pleural-mesothelioma-treatment-in-uk-clinical-practice/trackback/
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Authors: Lordick F, Ehlken B, Ihbe-Heffinger A, Berger K, Krobot KJ, Pellissier J, Davies G, Deuson R.
Affiliations:
Publications: Eur J Cancer 2007; 43(2): 299-307
Document Types: , Manuscript in preparation
Countries: , Germany
Abstract: http://www.druglib.com/abstract/lo/lordick-f_eur-j-cancer_20070100.html
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Cost-effectiveness and cost-utility of rituximab maintenance therapy for patients with relapsed/refractory follicular lymphoma in French setting.
Authors: Pacull A, Coudray-Omnes C, Brice P, Deconinck E, Le Pen C, Miadi-Fargier H
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Estimating the cost effectiveness of prophylactic cervical cancer vaccination in ireland using a mathematical model
Authors: S. Redmond N Demarteau
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries:
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Evaluating the clinical effects and the cost-effectiveness of prophylactic cervical cancer vaccination within an organised population-based screening setting ? case Finland
Authors: Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Finland, Nordic
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Adjuvant trastuzumab treatment in early stage breast cancer: cost-effectiveness in the Belgian healthcare setting
Authors: Van Vlaenderen I, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost effectiveness


Incidence and prevalenceÂ of brain metastases among patients withÂ advanced breast cancer in a U.S. managed-care population
Authors: Pelletier EM1, Amonkar MM2, Shim B1
Affiliations: 1IMS Health, Watertown, MA, USA, 2GlaxoSmithKline, Collegeville, PA, USA
Publications: American Society of Clinical Oncology (ASCO) 43rd Annual Meeting, 2007, June, Chicago, IL, USA
Document Types: , Poster
Countries: , USA
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=47&abstractID=33687
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Epidemiological study


Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia.
Authors: Sureda A, Isla D, CÃ³zar JM, Ruiz M, Domine M, MargelÃ M, Adrover E, Ramos M, Pastor M, MartÃn A, Llombart A, Massuti B, MuÃ±oz M, Barnadas A, FernÃ¡ndez J, colomer R, Allepuz C, Gilabert M, Badia X
Affiliations:
Publications: J Medical Econ 2007;10:27-39
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Quality of life


Behandlungsmuster und Kosten bei der Neueinstellung von onkologischen Patienten mit mÃ¤ÃŸig starken bis starken, nicht akuten Schmerzen auf transdermale Opioidanalgetika.
Authors: Paessens B, Lippert B, Ehlken B, Berger K, Amann S, Bernard R, Ihbe-Heffinger A.
Affiliations:
Publications: Krankenhauspharmazie 2007; 28 (2): 47-53
Document Types: , Manuscript in preparation
Countries:
Abstract: http://www.adka.de/daten/any/Opioidanalgetika.pdf
Condition	Year	Language	Analysis type
, Oncology	2007	German


A health economic evaluation of hexvix as adjunct to standard white light cystoscopy in the management of superficial bladder cancer
Authors: Demarteau N, Braeckman J, Michielsen D, Sweet A, Zyczynski T, Lamotte M
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2007	English


Treatment patterns for patients with glioblastoma multiforme (GBM) in Germany
Authors: Jenkins A, Aristides M, Liepa AM, Relf C, Feilding B.
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English


Adaptation of a health economic model of the natural history of HPV infection and cervical cancer in a well functioning population-based screening system ? a model calibration to Finland
Authors: Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , Finland, Nordic
Condition	Year	Language	Analysis type
, Oncology	2007	English


Impact of the allowable gap on persistence in the bisphosphonate market
Authors: Scott C. Henderson, Heather von Allmen, Thomas W. Weiss
Affiliations:
Publications: ISPOR 2007 10th Annual European Congress
Document Types:
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2007	English


Cost of management of metastatic soft tissue sarcoma.
Authors: Judson I1, Al-Muderis O1, Scott D2, Lloyd A2, Garcia B3.
Affiliations: 1 The Institute of Cancer Research, Royal Marsden Hospital, London, UK 2 Fourth Hurdle Consulting Ltd., London, UK 3 PharmaMar, Madrid, Spain
Publications: NCRI Cancer Conference, Birmingham, UK, 2007.
Document Types: , Poster
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost of illness


on the individual: a discrete-event simulation model of HPV infection, progression and control.
Authors: Thompson WA1, Kretzschmar M2
Affiliations: 1 IMS Health, London, UK, 2 University of Bielefeld, Germany
Publications: IV Annual Meeting Health Technology Assessment International, 17th-20th June, Barcelona, Spain.
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2007	English


Second-line treatment of non-small lung cancer (NSCLC) with erlotinib is potentially cost-saving for the German healthcare system
Authors: Gatzemeier U1, Pirk O2, Kotowa W2, Erhardt W3, Gabriel A2
Affiliations: 1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland
Publications: 12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul
Document Types: , Abstract
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost minimization


A comparison of the estimated cost of erlotinib, docetaxel and pemetrexed for the second-lne treatment of non-small cell lung cancer from the German healthcare perspective
Authors: Kotowa W1 , Gatzemeier U2, Pirk O1, Gabriel A1 , Heigener D2
Affiliations: 1 Center for Pneumology and Thoracic Surgery, Hospital Grosshansdorf, Grosshansdorf, Germany 2 IMS Health, Nuremberg, Germany 3 F. Hoffmann-La Roche AG, Basel, Switzerland
Publications: 12th World Conference on Lung Cancer, Sep. 2-6, 2007, Seoul Journal of Medical Economics; 10:255-271
Document Types: , Article, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Cost minimization


Endoscopic ultrasound for evaluating pancreatic, gastric, oesophageal and hepatobiliary neoplasms
Authors: Medical Services Advisory Committee (assessors Pricing and Market Access Sydney Australia)
Affiliations:
Publications: Commonwealth of Australia
Document Types: , Review
Countries:
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Review


Questionnaire of treatment preferences in patients with advanced non-small cell lung cancer
Authors: Garcia R, Juan O, VÃ¡zquez S, Barneto I, Cardenal F, Varela C, Perulero N
Affiliations:
Publications: ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Quality of life


Factores econÃ³micos de los avances en oncologÃa [Economic factors of advances in oncology]
Authors: Faull I1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: Congreso anual de la SEFH (Sociedad EspaÃ±ola de Farmacia Hospitalaria)2007 Septembre 27. Tenerife, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2007	Spanish


Treatment patterns and costs at the point of initiation of oncology patients with moderate to severe pain, not urgent transdermal Opioidanalgetika [Neueinstellung onkologischer Patienten auf transdermale Opioid-Analgetika - Behandlungsmuster und Kosten]
Authors: Paessens B 1, Lippert B 2, Ehlken B 2, Berger K 2, Amann S 1, Bernard R 1, Ihbe-Heffinger A 1.
Affiliations: 1 Klinikum rechts der Isar der Technischen UniversitÃ¤t MÃ¼nchen, Apotheke, Munich, Germany 2 IMS Health, Munich, Germany
Publications: Krankenhauspharmazie 2007; 28 (2): 47-53.
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2007	German	, Prospective study


Risk of Renal Failure Associated with IV Bisphosphonate Use in Patients with Multiple Myeloma
Authors: Joyce A, Harrison D, Jun S, Feliu A, Anthony M
Affiliations:
Publications: American Society of Clinical Oncology Annual Meeting, 2007, June 1-5, Chicago, USA
Document Types: , Oral presentation
Countries: , USA
Abstract: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_category_abstracts_view&confID=47&subCatID=44
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Differences in alpha blocker usage among enlarged prostate patients receiving combination therapy with 5 ARIs.
Authors: NaslundÂ M, BlackÂ L, EaddyÂ M, BatisteÂ L
Affiliations:
Publications: Am J Manag Care. Â 2007; 13 Suppl 1:S17-22
Document Types: , Article
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Finasteride versus dutasteride: a real-world economic evaluation.
Authors: FenterÂ T, RunkenÂ M, BlackÂ L, EaddyÂ M
Affiliations:
Publications: Am J Manag Care., 2007, 13 Suppl 1:S23-8
Document Types: , Article
Countries: , USA
Abstract: http://www.druglib.com/abstract/fe/fenter-tc_am-j-manag-care_20070200.html
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels
Authors: Hess, G., Hill, J., Hulnick, S., Nordyke, R.
Affiliations:
Publications: Blood, 110(11):3756
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records
Authors: Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S.
Affiliations:
Publications: Supportive Care in Cancer, 15(6):757
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients
Authors: Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L.
Affiliations:
Publications: Supportive Care in Cancer, 15(6):758
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


The Utilization of Darbepoetin Alfa (DA) in Relation to Cancer Patients' Hemoglobin Levels
Authors: Hess, G., Hill, J., Hulnick, S., Nordyke, R.
Affiliations:
Publications: Blood, 110(11):3756
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Adherence to Guidelines for Use of Erythropoiesis Stimulating Proteins in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records
Authors: Luo, W., Nordstrom, B., Ranganathan, G., Fraeman, K., Linz, H., Stokes, M., Knopf, K., Ross, S.
Affiliations:
Publications: Supportive Care in Cancer, 15(6):757
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Use Patterns of Erythropoiesis Stimulating Agent in Electronic Medical Records of Cancer Patients
Authors: Hess, G. P., Hulnick, S. A., Kallich, J. D., Whyte, J. L.
Affiliations:
Publications: Supportive Care in Cancer, 15(6):758
Document Types: , Abstract
Countries: , USA
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK.
Authors: Le Jeune I, Gribbin J, West J, Smith C, Cullinan P & Hubbard R
Affiliations: Division of Epidemiology and Public Health, University of Nottingham
Publications: Respir Med. 2007 Dec;101(12):2534-40. Epub 2007 Sep 17.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17870458
Condition	Year	Language	Analysis type
, Oncology, Respiratory disease	2007	English	, Retrospective database analysis


Use of antidepressants and risk of lung cancer.
Authors: Toh S, GarcÃa RodrÃguez LA & HernÃ¡ndez-DÃaz S
Affiliations: Department of Epidemiology, Harvard School of Public Health, Boston
Publications: Cancer Causes Control. 2007 Dec;18(10):1055-64. Epub 2007 Aug 8.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17682831
Condition	Year	Language	Analysis type
, Mental health, Oncology	2007	English	, Retrospective database analysis


Use of antidepressants and risk of lung cancer.
Authors: Toh S, GarcÃa RodrÃguez LA & HernÃ¡ndez-DÃaz S
Affiliations:
Publications: Cancer Causes Control. 2007 Dec;18(10):1055-64. Epub 2007 Aug 8.
Document Types: , Abstract
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17682831
Condition	Year	Language	Analysis type
, Mental health, Oncology	2007	English


Non-steroidal anti-inflammatory drugs and risk of lung cancer
Authors: Hernandez-Diaz S & Garcia Rodriguez LA
Affiliations: Department of Epidemiology, Harvard School of Public Health, Boston
Publications: Int J Cancer. 2007 Apr 1;120(7):1565-72.
Document Types: , Abstract, Article
Countries: , UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17205530
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Risk factors for the development of oesophageal cancer in Barrettâ€™s oesophagus: a primary care cohort study
Authors: Cooper SC, Graham P & Trudgill NJ
Affiliations: Department of Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust
Publications: Gastroenterology 132(4) Suppl 2: A420
Document Types: , Abstract
Countries: , UK
Abstract: http://ueg.sagepub.com/content/2/2/91.full
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


Trends in incidence of skin basal cell carcinom: Additional evidence from a UK primary care database study
Authors: Bath-Hextall F , Leonardi-Bee J, Smith C, Meal A & Hubbard R
Affiliations: Centre for Evidence-Based Dermatology, School of Nursing, University of Nottingham
Publications: International Journal of Cancer 121(9):2105-8
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2007	English	, Retrospective database analysis


The effect of cancer drug vintage on cancer survival and mortality.
Authors:
Affiliations: IMS Health
Publications: 2007 European Society of Medical Oncology
Document Types: , Article
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer
Condition	Year	Language	Analysis type
, Oncology	2007	English


A comparative budget impact (BI) analysis of AranespÂ® (darbepoetin alfa) 500ÂµG Q3W versus other erythropoiesis stimulating proteins (ESP) in chemotherapy-induced anemia (CIA) in Spain
Authors: PÃ©rez AlcÃ ntara F, Badia X, Arocho R
Affiliations: 1Health Outcomes Research, Barcelona, Barcelona, Spain, 2 Health Outcomes Research Europe, IMS Health, Barcelona, Spain, 3Amgen SA, Barcelona, Barcelona, Spain
Publications: ISPOR 9th Annual European Congress, 28-31 October 2006, Copenhagen, Denmark
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/denmark1006/posters2.asp#Cancer
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Budget impact


Treatment of actinic keratosis (AK) and basal cell carcinoma (BCC) with MetvixÂ® (MAL-PDT) in real life practice: a cost of illness and model validation study.
Authors: Caekelbergh K1, Annemans L1
Affiliations: 1 IMS Health, Brussels, Belgium
Publications: ISPOR 9th Annual European Congress, 2006, October 29-31, Copenhagen, Denmark
Document Types: , Poster
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost of illness


Cost analysis of febrile neutropenia management of breast cancer patients in clinical practice in Spain.
Authors: Mayordomo JI, Castellanos J, Pernas S, Ruiz-Borrego M, Velasco A, Frau A, Lamas MJ, Lara N.
Affiliations:
Publications: 31st European Society of Medical Oncology congress (ESMO), Estambul (Tukey) 29 Septiember-03 October
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Burden of illness


Cost of febrile neutropenia management in cancer patients in Spain.
Authors: Mayordomo JI, Lopez A, ViÃ±olas N, Castellanos J, Pernas S, Alonso JD, Frau A, Layola M, Gasquet JA, Sanchez JA, on behalf of the ENIA Study Group.
Affiliations:
Publications: American Society of Clinical Oncology (ASCO) Annual Meeting 2006, Atlanta (GA, US) 2-6 June
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Burden of illness


A cost-consequence analysis of darbepoetin alfa administered every 3 weeks (Q3W_DA) compared to weekly epoetin alfa (QW_EA) or epoetin beta (WQ_EB) in patients with chemotherapy-induced anemia (CIA): A retrospective study.
Authors: Van Bellinghen LA, Demarteau N, Annemans, Bracco A
Affiliations:
Publications: ISPOR 9th Annual European Congress, 2006, October 29-31, Copenhagen, Denmark
Document Types: , Poster
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost consequence


Cost effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain
Authors: Brosa M, Robinson P Brown B
Affiliations: Max Brosa, , Director1, Paul Robinson, BSc, MSc, Senior Economist2, Ben Brown, MSc, Economist21Oblikue Consulting, Barcelona, SC, Spain; 2 IMS Health Economics & Outcomes Research, London, United Kingdom
Publications: ISPOR Ninth Annual European Congress Copenhagen, Denmark October, 2006
Document Types: , Poster
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Cost-effectiveness of cetuximab (ErbituxÂ®) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France
Authors: Brown B, Roninson P, Launois R, Griebsch I
Affiliations:
Publications:
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Cost-effectiveness analysis of adjuvant therapy with trastuzumab (Herceptin) for the treatment of breast cancer in inicial stages.
Authors: Polanco SÃ¡nchez C, RodrÃguez SÃ¡nchez C, SÃ¡nchez-Rovira P, Barnadas Molins A, Sabater Torres FJ, Ãlvarez Sanz C.
Affiliations:
Publications: VII Scientific Meeting of the AsociaciÃ³n EspaÃ±ola de EvaluaciÃ³n de TecnologÃas Sanitarias (Spanish Association of Health Technology Evaluation), Sevilla (Spain) 16-17 November
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Cost-effectiveness of pemetrexed plus cisplatin versus cisplatin alone in the treatment of malignant pleural mesothelioma
Authors: Davey P, Cordony A, Rajan N, Arora B, Pavlakis N.
Affiliations:
Publications: ISPOR 2nd Asia-Pacific conference ISPOR 2nd Asia-Pacific conference, Worldfield Convention Hotel, Shanghai, China
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology, Respiratory disease	2006	English	, Cost effectiveness


Cost-effectiveness of pemetrexedplus cisplatin versus cisplatin alone in the treatment of malignant pleuralmesothelioma.
Authors: Davey P, Cordony a, Rajan N, Arora B, Pavlakis
Affiliations:
Publications: ISPOR 2nd Asia-Pacific Congress,Shanghai, China
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Economic evaluation of treatments for non-microcytic lung cancer
Authors: Alberola V, AntÃ³n A, Carrato A, CortÃ©s-Funes H, Guillem V, Le Lay K, et al.
Affiliations:
Publications: Rev Esp Econ Salud 2007;6(4):242-9
Document Types: , Manuscript in preparation
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2006	Spanish	, Economic evaluation


Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC).
Authors: Martin M, Lluch A, Segui MA, Ruiz A, Ramos M, Adrover E, et al.
Affiliations:
Publications: Ann Oncol 2006;17(8):1205-12
Document Types: , Manuscript in preparation
Countries:
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Quality of life


European organisation for research and treatment of cancer. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
Authors: Repetto L, Moeremans K, Annemans L
Affiliations:
Publications: Cancer Treat Rev., 2006, 32(Suppl 2): S5-9
Document Types: , Manuscript in preparation
Countries: , Europe
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Quality of life


Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma
Authors: Vanaclocha F, Badia X, GuillÃ©n V, SÃ¡nchez J, SÃ¡inz de los Terreros M, Llorens MA.
Affiliations:
Publications: Br J Dermatol. 2007 Apr;156(4):769-71.
Document Types: , Article
Countries: , Spain
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0
Condition	Year	Language	Analysis type
, Health economics, Oncology	2006	English


An update: Health economics of managing multiple myeloma
Authors: K Moeremans, L Annemans.
Affiliations:
Publications: European Journal of Cancer, 2006; 42(11):1684-96
Document Types: , Manuscript in preparation
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2006	English


High energy transurethral microwave thermotherapy for benign prostatic hyperplasia. Assessment report.
Authors: Medicare Services Advisory Committee (MSAC).
Affiliations:
Publications: Department of Health and Ageing, Commonwealth of Australia. Canberra.
Document Types: , Manuscript in preparation
Countries: , Australia
Condition	Year	Language	Analysis type
, Oncology	2006	English


Long term clinical effect of an HPV-vaccine for the prevention of cervical cancer in France in relation to age of vaccination: Results from a markov model
Authors: Demarteau N, Detournay B, El Hansnaoui A Standaert B, Annemans L
Affiliations:
Publications:
Document Types: , Poster
Countries: , France
Condition	Year	Language	Analysis type
, Oncology	2006	English


Erlotinib in non-small cell lung cancer (NSCLC) in Germany - A cost-saving second-line treatment option?
Authors: Gabriel A1, Pirk O1, Kotowa W1
Affiliations: 1 IMS Health, Nuremberg, Germany
Publications: Value in Health 2006, 9(6): A278
Document Types: , Abstract, Oral presentation
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost minimization


Costs of chemotherapy for indolent follicular nonHodgkinâ€™s lymphoma in the UK: an observational study.
Authors: Hutchinson J1, Lloyd A1, Gray A2, Gale R3, Hancock B4.
Affiliations: 1 Fourth Hurdle Consulting, London, UK 2 Health Economics Research Centre, Oxford University, Oxford UK 3 Schering Health Care, West Sussex, UK 4 School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
Publications: Acta Haematol. 2006;115(1-2):28-34.
Document Types: , Manuscript in preparation
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost of illness


Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the Patient preference and willingnesss-to-pay for pemetrexed versus docetaxel in the second-line treatment of advanced non-small cell lung cancer: a discrete choice conjoint analysis
Authors: Brown A, Aristides M, FitzGerald P, Liepa A, Boyer M, Clarke S
Affiliations:
Publications: ISPOR 2nd Asia-Pacific conference
Document Types: , Poster
Countries:
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Willingness to pay


Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia
Authors: Carballido J, Badia X, Gimeno A, Regadera L, Dal-RÃ© L, Guilera M
Affiliations:
Publications: Actas Urol Esp 2006;30(7):667-4
Document Types: , Article
Countries: , Spain
Condition	Year	Language	Analysis type
, Oncology	2006	Spanish	, Quality of life


Adjuvant trastuzumab treatment in early stage breast cancer: cost-effectiveness in the Belgian healthcare setting.
Authors: Van Vlaenderen I, Canon JL, Cocquyt V, Jerusalem G, Machiels JP, Neven P, Nechelput M, Delabaye I, Gyldmark M, Annemans L
Affiliations:
Publications: Value in Health, 10(6): A336
Document Types: , Oral presentation
Countries: , Belgium
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost utility


Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany.
Authors: Lordick F 1, Ehlken B 2, Ihbe-Heffinger A 3, Berger K 2, Krobot KJ 4, Pellissier J 5, Davies G 5, Deuson R 6.
Affiliations: 1 Third Medical Department, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 2 IMS Health, Munich, Germany 3 Dept. of Pharmacy, Klinikum rechts der Isar, Technische UniversitÃ¤t MÃ¼nchen, Munich, Germany 4 Outcomes Research, MSD Sharp & Dohme GmbH, Haar, Germany 5 Health Economic Statistics, Merck & Co. Inc., 10 Sentry Pkwy, Blue Bell, USA 6 Outcomes Research, Merck & Co. Inc., One Merck Drive, Whitehouse Station, NJ, USA
Publications: Eur J Cancer 2007; 43(2): 299-307
Document Types: , Article
Countries: , Germany
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness


Nelarabine
Authors: Gandhi V, Keating M, Bate G, Kirkpatrick P
Affiliations: IMS Consulting and Services, IMS Health, London
Publications: Nature Reviews Drug Discovery, 2006, 5:17-18
Document Types: , Article
Countries: , UK
Condition	Year	Language	Analysis type
, Oncology	2006	English


NICE implementation uptake report: Capecitabine and oxaliplatin for colon cancer.
Authors:
Affiliations: IMS Oncology Analyzer (IMS OA), QuintilesIMS
Publications: NICE Guidance
Document Types: , Article
Countries: , UK
Abstract: http://www.nice.org.uk/media/543/99/UptakeReportTA100CapecitabineOxaliplatin.pdf
Condition	Year	Language	Analysis type
, Oncology	2006	English	, Cost effectiveness

Selection from HEOR Bibliography